<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The First Cohort</title><description>Independent reporting on medical research: what the evidence actually shows.</description><link>https://thefirstcohort.com/</link><item><title>A Brain Protein Made Female Mice Overeat Fat, and the $441,000 Obesity Drug Worked Weakest on Them</title><link>https://thefirstcohort.com/articles/2026-08-15-a-brain-protein-made-female-mice-overeat-fat-and-the-441-000-obesity-drug-worked</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-15-a-brain-protein-made-female-mice-overeat-fat-and-the-441-000-obesity-drug-worked</guid><description>Dietary fat switches on an appetite-protecting brain protein in male mice but not females. Delete it and the females overeat fat, gain more weight, and setmelanotide, the $441,000-a-year MC4R obesity drug, loses much of its appetite-suppressing punch on them.</description><pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>obesity</category><category>metabolic</category><category>mc4r</category><category>sex-differences</category><category>setmelanotide</category><author>Sarah Okonkwo</author></item><item><title>For Thirty Years, Doctors Here Were Taught North Carolina Had No Lyme. The Ticks Disagree.</title><link>https://thefirstcohort.com/articles/2026-08-15-for-thirty-years-doctors-here-were-taught-north-carolina-had-no-lyme-the-ticks-d</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-15-for-thirty-years-doctors-here-were-taught-north-carolina-had-no-lyme-the-ticks-d</guid><description>Nearly 40 percent of the adult blacklegged ticks sampled in one western North Carolina town carried the Lyme bacterium, in a state where doctors were trained for thirty years that the disease barely exists.</description><pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>lyme disease</category><category>ticks</category><category>north carolina</category><category>infectious disease</category><category>public health</category><author>Sarah Okonkwo</author></item><item><title>For Twenty Years, Women Were Warned That Estrogen Raised Their Dementia Risk. Stanford&apos;s Autopsies Point the Other Way.</title><link>https://thefirstcohort.com/articles/2026-08-15-for-twenty-years-women-were-warned-that-estrogen-raised-their-dementia-risk-stan</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-15-for-twenty-years-women-were-warned-that-estrogen-raised-their-dementia-risk-stan</guid><description>A randomized federal trial spent two decades warning that hormone therapy raised older women&apos;s dementia risk. A Stanford autopsy study just found the opposite association. The catch: both studied women who started the drug far too late to settle it.</description><pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>hormone-therapy</category><category>alzheimers</category><category>menopause</category><category>womens-health</category><category>brain-aging</category><author>Lena Marshall</author></item><item><title>&apos;No Falsification&apos;: JAMA Keeps a Purdue-Funded Opioid Paper Its Own Retraction Rule Says to Pull</title><link>https://thefirstcohort.com/articles/2026-08-15-no-falsification-jama-keeps-a-purdue-funded-opioid-paper-its-own-retraction-rule</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-15-no-falsification-jama-keeps-a-purdue-funded-opioid-paper-its-own-retraction-rule</guid><description>Court records from a 2007 federal case show Purdue had flagged 8 possible-withdrawal cases a year before its 2000 study called withdrawal rare. The journal says that isn&apos;t falsification, so the paper stays in print.</description><pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>opioids</category><category>purdue-pharma</category><category>retraction</category><category>research-integrity</category><category>jama</category><category>oxycontin</category><author>Mira Petrov</author></item><item><title>For Forty Years They Said Skim the Fat. This Trial Fed People Full-Fat Dairy and the Cholesterol Held.</title><link>https://thefirstcohort.com/articles/2026-08-14-for-forty-years-they-said-skim-the-fat-this-trial-fed-people-full-fat-dairy-and</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-14-for-forty-years-they-said-skim-the-fat-this-trial-fed-people-full-fat-dairy-and</guid><description>In a 74-adult trial, the group assigned three servings of full-fat dairy a day for twelve weeks held steady on weight, body fat, cholesterol and insulin resistance, and their blood pressure improved, against advice the guidelines have pushed since 1980.</description><pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>dairy</category><category>nutrition</category><category>dietary-guidelines</category><category>cholesterol</category><category>metabolic-health</category><category>full-fat</category><author>Sarah Okonkwo</author></item><item><title>The FDA Put an Emergency Label on a Zoetis Dog Pill for a Screwworm America Erased in 1966 Without a Single Drug</title><link>https://thefirstcohort.com/articles/2026-08-14-the-fda-put-an-emergency-label-on-a-zoetis-dog-pill-for-a-screwworm-america-eras</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-14-the-fda-put-an-emergency-label-on-a-zoetis-dog-pill-for-a-screwworm-america-eras</guid><description>The sterile-fly barrier that kept the flesh-eating screwworm out of America for sixty years gave way, and Washington&apos;s answer has been a run of emergency drug authorizations, the newest for a Zoetis dog pill whose maker&apos;s own release cites no efficacy data against the parasite.</description><pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>screwworm</category><category>fda</category><category>emergency-use-authorization</category><category>zoetis</category><category>parasites</category><category>public-health</category><author>Marcus Chen</author></item><item><title>The Peptide Boom Hides One Divide: Human Trials on a Few, Rodent Data and Case Reports on the Rest</title><link>https://thefirstcohort.com/articles/2026-08-14-the-peptide-boom-hides-one-divide-human-trials-on-a-few-rodent-data-and-case-rep</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-14-the-peptide-boom-hides-one-divide-human-trials-on-a-few-rodent-data-and-case-rep</guid><description>Semaglutide and tirzepatide erased up to 22 percent of body weight in trials with thousands of patients. The research-only peptides sold beside them, like BPC-157, have not completed a single published human efficacy trial. A popular 2026 guide lists them as equals.</description><pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>peptides</category><category>glp-1</category><category>weight-loss</category><category>fda</category><category>bpc-157</category><author>Sarah Okonkwo</author></item><item><title>Warmer, Saltier, Fed on Sewage: Why a Flesh-Eating Bacterium Is Getting Meaner as It Moves North</title><link>https://thefirstcohort.com/articles/2026-08-14-warmer-saltier-fed-on-sewage-why-a-flesh-eating-bacterium-is-getting-meaner-as-i</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-14-warmer-saltier-fed-on-sewage-why-a-flesh-eating-bacterium-is-getting-meaner-as-i</guid><description>Vibrio vulnificus kills roughly one in five people it infects, and its northern edge has climbed about 30 miles a year since 1998. The big paper this week reached instead for grief and eco-anxiety.</description><pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>vibrio</category><category>marine-heatwaves</category><category>algal-blooms</category><category>seafood-safety</category><category>infectious-disease</category><author>Sarah Okonkwo</author></item><item><title>Your Antibodies Are Still Fighting the 2020 Virus</title><link>https://thefirstcohort.com/articles/2026-08-14-your-antibodies-are-still-fighting-the-2020-virus</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-14-your-antibodies-are-still-fighting-the-2020-virus</guid><description>For two years the message was that another ancestral booster would keep pace with the virus. The immunology says the opposite can happen: repeated shots against the 2020 strain can lock your antibodies onto a version of SARS-CoV-2 that stopped circulating, and in 2023 the WHO named immune imprinting</description><pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>immune-imprinting</category><category>covid-vaccines</category><category>immunology</category><category>mrna</category><category>original-antigenic-sin</category><author>Sarah Okonkwo</author></item><item><title>A Sauna Floods Your Blood With Immune Cells. It&apos;s a Flush, Not a Boost.</title><link>https://thefirstcohort.com/articles/2026-08-13-a-sauna-floods-your-blood-with-immune-cells-it-s-a-flush-not-a-boost</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-13-a-sauna-floods-your-blood-with-immune-cells-it-s-a-flush-not-a-boost</guid><description>Fifty-one Finns sat in a 73°C sauna for half an hour, and every white blood cell type poured into their blood. Half an hour later the neutrophils and lymphocytes were back to baseline, and the immune system&apos;s chemical alarm had barely rung.</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>sauna</category><category>immune-system</category><category>wellness</category><category>longevity</category><category>heat-therapy</category><author>Sarah Okonkwo</author></item><item><title>King&apos;s College London Turned Sheep&apos;s Wool Into a Bone Scaffold, and Called It a Milestone Before a Single Human Trial</title><link>https://thefirstcohort.com/articles/2026-08-13-king-s-college-london-turned-sheep-s-wool-into-a-bone-scaffold-and-called-it-a-m</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-13-king-s-college-london-turned-sheep-s-wool-into-a-bone-scaffold-and-called-it-a-m</guid><description>The wool membrane grew more organized bone than collagen in a rat&apos;s skull. Collagen still grew more of it, the sample size never made the press release, and no one has put the material in a person.</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>biomaterials</category><category>keratin</category><category>bone-regeneration</category><category>dentistry</category><category>preclinical</category><author>Lena Marshall</author></item><item><title>NIH Said Its Cervical-Cancer AI Beat Human Doctors. Six Years Later, Its Own Author Called It Overfitting.</title><link>https://thefirstcohort.com/articles/2026-08-13-nih-said-its-cervical-cancer-ai-beat-human-doctors-six-years-later-its-own-autho</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-13-nih-said-its-cervical-cancer-ai-beat-human-doctors-six-years-later-its-own-autho</guid><description>In 2019, NIH announced an algorithm that read cervix photos better than doctors, an AUC of 0.91. Its senior author has since written that the number came from overfitting and that the follow-on projects failed. Nature Medicine is now calling the same idea the &apos;missing piece.&apos;</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>medical-research</category><author>Lena Marshall</author></item><item><title>The Checklist Drove ICU Infections to Zero. The Federal Ethics Office Halted the Study.</title><link>https://thefirstcohort.com/articles/2026-08-13-the-checklist-drove-icu-infections-to-zero-the-federal-ethics-office-halted-the</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-13-the-checklist-drove-icu-infections-to-zero-the-federal-ethics-office-halted-the</guid><description>A five-step checklist cut central-line infections 66 percent and was credited with 1,500 lives saved in Michigan ICUs. Then the federal office that guards research ethics ordered it halted, because the hospitals had never run it past an institutional review board.</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>research-ethics</category><category>irb</category><category>patient-safety</category><category>medical-bureaucracy</category><category>regulatory-capture</category><author>Sarah Okonkwo</author></item><item><title>Why Anti-TNF Keeps Failing So Many Crohn&apos;s Patients: The Drug Never Reached the Cell Holding the Disease Open</title><link>https://thefirstcohort.com/articles/2026-08-13-why-anti-tnf-keeps-failing-so-many-crohn-s-patients-the-drug-never-reached-the-c</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-13-why-anti-tnf-keeps-failing-so-many-crohn-s-patients-the-drug-never-reached-the-c</guid><description>Anti-TNF biologics have muzzled the immune system for 25 years, and up to 46 percent of Crohn&apos;s patients still fail them. A single-cell atlas points at the structural cells of the gut wall, epigenetically rewired into a state the drugs were never built to reach.</description><pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>crohns-disease</category><category>autoimmune</category><category>fibroblasts</category><category>anti-tnf</category><category>epigenetics</category><author>Sarah Okonkwo</author></item><item><title>A Brown-Fat Gene Turns Out to Be the Dial Between a Heart Cell Dividing and Growing Up</title><link>https://thefirstcohort.com/articles/2026-08-12-a-brown-fat-gene-turns-out-to-be-the-dial-between-a-heart-cell-dividing-and-grow</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-a-brown-fat-gene-turns-out-to-be-the-dial-between-a-heart-cell-dividing-and-grow</guid><description>Turn PRDM16 down and lab-grown heart cells start dividing again but stay weak. Turn it up and they mature but quit the cell cycle. It&apos;s the same gene that decides whether a cell becomes calorie-burning brown fat.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>heart-regeneration</category><category>prdm16</category><category>stem-cells</category><category>cardiomyocytes</category><category>brown-fat</category><category>cell-biology</category><author>Sarah Okonkwo</author></item><item><title>Britain, France, and Germany Don&apos;t Put COVID Shots on the Childhood Schedule. A US Order to Match Them Got Called &apos;Anti-Science.&apos;</title><link>https://thefirstcohort.com/articles/2026-08-12-britain-france-and-germany-don-t-put-covid-shots-on-the-childhood-schedule-a-us</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-britain-france-and-germany-don-t-put-covid-shots-on-the-childhood-schedule-a-us</guid><description>Britain, France, and Germany already keep routine COVID shots off the schedule for healthy children. When a US executive order moved the same way, the AMA, Paul Offit, and the press answered with &apos;zero data&apos; instead of a debate.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>medical-research</category><author>Marcus Chen</author></item><item><title>Feed These Bacteria a Splash of Glycerol, and 95% of the Uranium Leaves the Water</title><link>https://thefirstcohort.com/articles/2026-08-12-feed-these-bacteria-a-splash-of-glycerol-and-95-of-the-uranium-leaves-the-water</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-feed-these-bacteria-a-splash-of-glycerol-and-95-of-the-uranium-leaves-the-water</guid><description>Microbes in a flooded German uranium mine turned 95 percent of the dissolved metal into an iron compound that held together when oxygen returned, the exact failure that has always defeated standard cleanup.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>uranium</category><category>bioremediation</category><category>environmental-health</category><category>water-contamination</category><category>microbiome</category><author>Sarah Okonkwo</author></item><item><title>Months Before Officials Told Pregnant Women the COVID Shot Was Safe, Fauci Privately Flagged a Theoretical First-Trimester Miscarriage Risk</title><link>https://thefirstcohort.com/articles/2026-08-12-months-before-officials-told-pregnant-women-the-covid-shot-was-safe-fauci-privat</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-months-before-officials-told-pregnant-women-the-covid-shot-was-safe-fauci-privat</guid><description>Senators Ron Johnson and Rand Paul pulled the first messages off Fauci&apos;s government iPhone: a January 2021 chain in which he privately flagged a theoretical first-trimester miscarriage risk, months before official guidance told pregnant women the shot carried no such concern.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>fauci</category><category>covid-19</category><category>mrna-vaccines</category><category>pregnancy</category><category>regulatory-capture</category><category>accountability</category><author>Marcus Chen</author></item><item><title>One Irish Plant Releases Both of Sanofi&apos;s Pompe Enzymes. In June, the FDA Called Its Drugs &apos;Adulterated.&apos;</title><link>https://thefirstcohort.com/articles/2026-08-12-one-irish-plant-releases-both-of-sanofi-s-pompe-enzymes-in-june-the-fda-called-i</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-one-irish-plant-releases-both-of-sanofi-s-pompe-enzymes-in-june-the-fda-called-i</guid><description>One Irish plant runs the final release for both of Sanofi&apos;s lifelong Pompe enzymes. It just failed an FDA inspection on that exact step, and now the company says the fix could take months while patients confirm their next shipments.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>pompe-disease</category><category>enzyme-replacement</category><category>drug-shortage</category><category>sanofi</category><category>fda</category><category>rare-disease</category><author>Sarah Okonkwo</author></item><item><title>One Protein Keeps Your Immune System&apos;s Peacekeeper Cells From Switching Sides</title><link>https://thefirstcohort.com/articles/2026-08-12-one-protein-keeps-your-immune-system-s-peacekeeper-cells-from-switching-sides</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-one-protein-keeps-your-immune-system-s-peacekeeper-cells-from-switching-sides</guid><description>Regulatory T cells are supposed to be the immune system&apos;s off switch. Strip out a protein called TIF1γ and, under inflammation, they lose that identity, start producing an inflammatory cytokine, and join the attack.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>tregs</category><category>autoimmunity</category><category>cell-biology</category><category>inflammation</category><category>immunology</category><author>Sarah Okonkwo</author></item><item><title>RFK Jr. Promised Radical Transparency. His HHS Gutted the Staff Who Release FDA Inspection Reports and CDC Outbreak Data.</title><link>https://thefirstcohort.com/articles/2026-08-12-rfk-jr-promised-radical-transparency-his-hhs-gutted-the-staff-who-release-fda-in</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-rfk-jr-promised-radical-transparency-his-hhs-gutted-the-staff-who-release-fda-in</guid><description>The FDA, CDC, and NIH fielded more than 15,000 records requests in 2024. In April 2025 HHS fired the staff who answer them, rehired some FDA workers a month later under legal pressure, and by August 2026 the federal records backlog had only grown.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>foia</category><category>transparency</category><category>hhs</category><category>fda</category><category>cdc</category><author>Mira Petrov</author></item><item><title>Seven Weeks, 345 People Sick, and Not One Recall Notice With a Lot Code</title><link>https://thefirstcohort.com/articles/2026-08-12-seven-weeks-345-people-sick-and-not-one-recall-notice-with-a-lot-code</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-seven-weeks-345-people-sick-and-not-one-recall-notice-with-a-lot-code</guid><description>The FDA said the outbreak jalapeños did not reach grocery stores directly. Two days later the USDA named eighteen grocery products made with them, sold in 23 states. Seven weeks in, not one recall notice carries a lot code.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>medical-research</category><author>Marcus Chen</author></item><item><title>The FDA Approved Moderna&apos;s mRNA Flu Shot for Seniors Without Proving It Works in Them</title><link>https://thefirstcohort.com/articles/2026-08-12-the-fda-approved-moderna-s-mrna-flu-shot-for-seniors-without-proving-it-works-in</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-the-fda-approved-moderna-s-mrna-flu-shot-for-seniors-without-proving-it-works-in</guid><description>In February the FDA&apos;s own vaccine chief refused to even review it. One week later the agency reversed course, and the trial data never changed.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>mrna vaccine</category><category>flu vaccine</category><category>fda</category><category>moderna</category><category>accelerated approval</category><category>regulatory capture</category><author>Marcus Chen</author></item><item><title>The Finest Immune Map of the Sarcoid Lung Explains Why Its Targeted Drugs Keep Failing</title><link>https://thefirstcohort.com/articles/2026-08-12-the-finest-immune-map-of-the-sarcoid-lung-explains-why-its-targeted-drugs-keep-f</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-the-finest-immune-map-of-the-sarcoid-lung-explains-why-its-targeted-drugs-keep-f</guid><description>National Jewish Health charted more than 150,000 immune cells from sixteen sarcoidosis patients and found a disease with too many moving parts for any single drug to switch off. The targeted therapy that got furthest had already failed Phase 3 and erased 83 percent of its maker&apos;s value.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>sarcoidosis</category><category>single-cell-sequencing</category><category>pharma-conflicts</category><category>fda</category><category>autoimmune</category><category>lung-disease</category><author>Lena Marshall</author></item><item><title>The Juice Industry Paid for the Study Telling You a Daily Glass Lowers Depression Scores</title><link>https://thefirstcohort.com/articles/2026-08-12-the-juice-industry-paid-for-the-study-telling-you-a-daily-glass-lowers-depressio</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-the-juice-industry-paid-for-the-study-telling-you-a-daily-glass-lowers-depressio</guid><description>In a 42-person trial, the group that added a daily glass of juice improved on depression scores while the group that added only whole fruits and vegetables didn&apos;t, and the European juice trade body paid for the whole thing.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>medical-research</category><author>Sarah Okonkwo</author></item><item><title>The Stress Hormone Was Already High Before Daily Cannabis Users Woke Up</title><link>https://thefirstcohort.com/articles/2026-08-12-the-stress-hormone-was-already-high-before-daily-cannabis-users-woke-up</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-the-stress-hormone-was-already-high-before-daily-cannabis-users-woke-up</guid><description>Oregon State measured the morning stress hormone in 39 daily users and 43 non-users. The people reaching for cannabis to unwind started every day with cortisol already running higher, and it tracked with the cannabis-related consequences they reported.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>cannabis</category><category>cortisol</category><category>stress</category><category>hpa-axis</category><category>endocannabinoid</category><category>mental-health</category><author>Sarah Okonkwo</author></item><item><title>They Measured the Forever Chemicals in the Umbilical Cord Itself. The Babies With the Most Scored Lower at Two.</title><link>https://thefirstcohort.com/articles/2026-08-12-they-measured-the-forever-chemicals-in-the-umbilical-cord-itself-the-babies-with</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-they-measured-the-forever-chemicals-in-the-umbilical-cord-itself-the-babies-with</guid><description>Scientists skipped the usual stand-in and measured the forever chemicals in the umbilical cord blood itself. By age two, the babies carrying more of them scored lower on communication and motor development, and the companies that made these chemicals knew the risk for decades.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>pfas</category><category>neurodevelopment</category><category>pregnancy</category><category>forever-chemicals</category><category>folate</category><category>environmental-health</category><author>Sarah Okonkwo</author></item><item><title>This Week&apos;s Autism &apos;Breakthrough&apos;: A Rare Mutation, an Injection Into Mice, and Not One Human Patient</title><link>https://thefirstcohort.com/articles/2026-08-12-this-week-s-autism-breakthrough-a-rare-mutation-an-injection-into-mice-and-not-o</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-12-this-week-s-autism-breakthrough-a-rare-mutation-an-injection-into-mice-and-not-o</guid><description>An injection that silences one gene rescued social behavior in mutant mice and a dish of human cells. The headlines called it an autism therapy. No autistic person has received it, and the gene it targets is mutated in a small fraction of cases.</description><pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>autism</category><category>nmda-receptor</category><category>antisense-oligonucleotide</category><category>preclinical</category><category>shank3</category><category>drug-development</category><author>Lena Marshall</author></item><item><title>Chemists Cracked Unsorted Plastic Into Hydrogen With Lye, and Trapped Three-Quarters of the Carbon Instead of Torching It</title><link>https://thefirstcohort.com/articles/2026-08-09-chemists-cracked-unsorted-plastic-into-hydrogen-with-lye-and-trapped-three-quart</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-chemists-cracked-unsorted-plastic-into-hydrogen-with-lye-and-trapped-three-quart</guid><description>Most plastic never gets recycled. It gets burned or buried, and polyethylene keeps turning up in human brain tissue. A UCLA and Ewha team cracked mixed, unsorted trash into more than 90 percent pure hydrogen at low heat and trapped 75 percent of the carbon instead of letting it escape.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>microplastics</category><category>plastic-waste</category><category>hydrogen</category><category>environmental-health</category><category>recycling</category><category>brain</category><author>Sarah Okonkwo</author></item><item><title>Europe&apos;s Wildfire Smoke Has a Second Blast Radius: Stopped Hearts and Mood-Disorder ER Visits Far From the Flames</title><link>https://thefirstcohort.com/articles/2026-08-09-europe-s-wildfire-smoke-has-a-second-blast-radius-stopped-hearts-and-mood-disord</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-europe-s-wildfire-smoke-has-a-second-blast-radius-stopped-hearts-and-mood-disord</guid><description>When California&apos;s wildfire PM2.5 climbed, depression ED visits rose 15 percent and mood-disorder visits 29 percent up to a week later, and per microgram that smoke was tied to larger health effects than ordinary city smog.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>wildfire smoke</category><category>air pollution</category><category>mental health</category><category>cardiovascular</category><category>pm2.5</category><category>public health</category><author>Sarah Okonkwo</author></item><item><title>For Years the Muscle Aches Were Called a Nocebo Effect. A McMaster Lab Found Statins Injuring the Muscle Cell Itself.</title><link>https://thefirstcohort.com/articles/2026-08-09-for-years-the-muscle-aches-were-called-a-nocebo-effect-a-mcmaster-lab-found-stat</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-for-years-the-muscle-aches-were-called-a-nocebo-effect-a-mcmaster-lab-found-stat</guid><description>An estimated 7 to 29 percent of statin users report muscle pain. The flagship trial called most of it a placebo response. In mouse and human muscle cells, a McMaster team has now traced a cholesterol-independent pathway by which statins damage muscle directly.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>statins</category><category>muscle-pain</category><category>cholesterol</category><category>nlrp3</category><category>drug-safety</category><author>Lena Marshall</author></item><item><title>The Body&apos;s Own Brake on Inflammation: Mapped in 2015, Still Not in a Pill</title><link>https://thefirstcohort.com/articles/2026-08-09-the-body-s-own-brake-on-inflammation-mapped-in-2015-still-not-in-a-pill</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-the-body-s-own-brake-on-inflammation-mapped-in-2015-still-not-in-a-pill</guid><description>A kinase called MST4 rides the brake on TRAF6, the protein that lets inflammation spiral, doing gently from inside the cell what broad autoimmune drugs force from the outside. Researchers mapped it in 2015. No pill uses it yet.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>inflammation</category><category>autoimmune</category><category>traf6</category><category>cell-biology</category><category>drug-targets</category><author>Sarah Okonkwo</author></item><item><title>The Cancer Trials That Buried Vitamin C Never Put It in a Vein</title><link>https://thefirstcohort.com/articles/2026-08-09-the-cancer-trials-that-buried-vitamin-c-never-put-it-in-a-vein</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-the-cancer-trials-that-buried-vitamin-c-never-put-it-in-a-vein</guid><description>Mayo&apos;s famous trials gave advanced cancer patients vitamin C by mouth and found nothing. A randomized trial that delivered it by IV, at a dose pills cannot reach, doubled survival in metastatic pancreatic cancer.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>cancer</category><category>vitamin-c</category><category>pancreatic-cancer</category><category>clinical-trials</category><category>ascorbate</category><category>oncology</category><author>Lena Marshall</author></item><item><title>The FDA Approved Narcolepsy&apos;s First Orexin Agonist. Takeda&apos;s Last One Was Pulled for Liver Injury.</title><link>https://thefirstcohort.com/articles/2026-08-09-the-fda-approved-narcolepsy-s-first-orexin-agonist-takeda-s-last-one-was-pulled</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-the-fda-approved-narcolepsy-s-first-orexin-agonist-takeda-s-last-one-was-pulled</guid><description>Takeda&apos;s oveporexton switches on the orexin receptor that narcolepsy type 1 patients can no longer signal. The company&apos;s last orexin drug was halted in 2021 after patients crossed serious liver-injury thresholds.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>narcolepsy</category><category>orexin</category><category>fda-approval</category><category>takeda</category><category>drug-safety</category><author>Marcus Chen</author></item><item><title>The FDA Said No to Moderna&apos;s mRNA Flu Shot in February. By August, the Two Men Who Said No Were Gone.</title><link>https://thefirstcohort.com/articles/2026-08-09-the-fda-said-no-to-moderna-s-mrna-flu-shot-in-february-by-august-the-two-men-who</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-the-fda-said-no-to-moderna-s-mrna-flu-shot-in-february-by-august-the-two-men-who</guid><description>The FDA refused to even review Moderna&apos;s mRNA flu shot in February because it was never tested against the enhanced vaccines seniors are steered toward. The two officials who objected are gone, and the agency approved it anyway, for the oldest patients, on a promise to prove it works later.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>mrna</category><category>flu-vaccine</category><category>fda</category><category>moderna</category><category>regulatory-capture</category><category>rfk</category><author>Marcus Chen</author></item><item><title>The Screwworm America Eradicated Is Back, and the FDA&apos;s First Move Was an Unapproved Spray</title><link>https://thefirstcohort.com/articles/2026-08-09-the-screwworm-america-eradicated-is-back-and-the-fda-s-first-move-was-an-unappro</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-the-screwworm-america-eradicated-is-back-and-the-fda-s-first-move-was-an-unappro</guid><description>The fly the US drove off the continent in 1966 has crossed the border again, and the FDA&apos;s emergency answer is a wound spray that never cleared its own approval process. The method that actually won the war is the sterile fly, and Texas is racing to rebuild the factory it let die.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>medical-research</category><author>Marcus Chen</author></item><item><title>The Study Telling You Not to Bother Cutting Sweet Foods Was Co-Funded by the Soda and Sweetener Industry</title><link>https://thefirstcohort.com/articles/2026-08-09-the-study-telling-you-not-to-bother-cutting-sweet-foods-was-co-funded-by-the-sod</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-09-the-study-telling-you-not-to-bother-cutting-sweet-foods-was-co-funded-by-the-sod</guid><description>The Sweet Tooth Trial found no reason to reduce sweet-tasting foods. Its private funders include the soda industry&apos;s trade group and the International Sweeteners Association.</description><pubDate>Sun, 09 Aug 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>sugar</category><category>sweeteners</category><category>conflict-of-interest</category><category>nutrition</category><category>cravings</category><category>metabolic</category><author>Sarah Okonkwo</author></item><item><title>A Map of 1.1 Million Lung Immune Cells Finds the Genetic Risk for Autoimmune Disease in Tissue, Not Blood</title><link>https://thefirstcohort.com/articles/2026-08-08-a-map-of-1-1-million-lung-immune-cells-finds-the-genetic-risk-for-autoimmune-dis</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-08-a-map-of-1-1-million-lung-immune-cells-finds-the-genetic-risk-for-autoimmune-dis</guid><description>Researchers at La Jolla mapped genetic activity in 1.1 million lung immune cells and found about 1,000 genes whose activity is tuned by disease-risk variants only inside tissue, plus 1,700 that read differently in women than in men.</description><pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>autoimmune</category><category>lupus</category><category>womens-health</category><category>genetics</category><category>immunology</category><author>Sarah Okonkwo</author></item><item><title>Arkansas Cut 18,000 Eligible People From Medicaid Over Paperwork, and the 2027 Fix Is AI Its Own Authors Say Will Reproduce the Bias</title><link>https://thefirstcohort.com/articles/2026-08-08-arkansas-cut-18-000-eligible-people-from-medicaid-over-paperwork-and-the-2027-fi</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-08-arkansas-cut-18-000-eligible-people-from-medicaid-over-paperwork-and-the-2027-fi</guid><description>A federal work requirement hits ACA Medicaid on January 1, 2027. Health-policy academics propose using AI to verify, screen, and manage the rollout, and the paper&apos;s lead author admits the system will &quot;100% reproduce&quot; the biases baked into the data.</description><pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>medicaid</category><category>health-policy</category><category>artificial-intelligence</category><category>work-requirements</category><category>regulatory</category><author>Marcus Chen</author></item><item><title>Cancer Drugs Starve Tumors of Arginine. A Rockefeller Lab Says the Immune System May Need It to See Them.</title><link>https://thefirstcohort.com/articles/2026-08-08-cancer-drugs-starve-tumors-of-arginine-a-rockefeller-lab-says-the-immune-system</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-08-cancer-drugs-starve-tumors-of-arginine-a-rockefeller-lab-says-the-immune-system</guid><description>Some cancer therapies deliberately strip arginine from the body to starve tumors. Rockefeller researchers found that in mice the same depletion can hide tumors, flu, and SARS-CoV-2 from the immune system.</description><pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>arginine</category><category>immune-system</category><category>cancer</category><category>viral-infection</category><category>supplements</category><category>amino-acids</category><author>Sarah Okonkwo</author></item><item><title>Mexican Jalapeños Sickened 1,400 Americans in 2008. Eighteen Years Later, a Different Farm and the Same Import Gap Did It Again.</title><link>https://thefirstcohort.com/articles/2026-08-08-mexican-jalape-os-sickened-1-400-americans-in-2008-eighteen-years-later-a-differ</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-08-mexican-jalape-os-sickened-1-400-americans-in-2008-eighteen-years-later-a-differ</guid><description>Salmonella Javiana in jalapeños from Sinaloa has sickened 345 people across 27 states. It is the second time in eighteen years that imported Mexican peppers have done this, and the FDA still physically inspects only about 1 to 2 percent of the food crossing the border.</description><pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>salmonella</category><category>food-safety</category><category>produce-imports</category><category>foodborne-illness</category><category>fda</category><category>antibiotic-resistance</category><author>Marcus Chen</author></item><item><title>The FDA Twice Called This Melanoma Trial Uninterpretable. Then It Approved the Drug, at $450,000 a Course.</title><link>https://thefirstcohort.com/articles/2026-08-08-the-fda-twice-called-this-melanoma-trial-uninterpretable-then-it-approved-the-dr</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-08-the-fda-twice-called-this-melanoma-trial-uninterpretable-then-it-approved-the-dr</guid><description>Federal reviewers rejected Replimune&apos;s melanoma therapy twice, faulting a single-arm trial they called not adequate and well-controlled and its results uninterpretable. No new controlled data ever answered them. After a 10-3 advisory vote, the FDA approved it anyway, at $450,000 a course.</description><pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>melanoma</category><category>fda</category><category>immunotherapy</category><category>accelerated-approval</category><category>replimune</category><category>oncology</category><author>Lena Marshall</author></item><item><title>They Gave PTSD Patients THC Drops at Bedtime. More Than a Third Stopped Having Nightmares Entirely.</title><link>https://thefirstcohort.com/articles/2026-08-08-they-gave-ptsd-patients-thc-drops-at-bedtime-more-than-a-third-stopped-having-ni</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-08-they-gave-ptsd-patients-thc-drops-at-bedtime-more-than-a-third-stopped-having-ni</guid><description>Dronabinol beat placebo on the nightmare symptom the VA&apos;s longtime standby flunked, and the company that sells dronabinol helped fund the trial that found it worked.</description><pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>medical-research</category><author>Sarah Okonkwo</author></item><item><title>Christof Koch Bet a Case of Wine That Science Would Find Consciousness in the Brain by 2023. He Lost.</title><link>https://thefirstcohort.com/articles/2026-08-07-christof-koch-bet-a-case-of-wine-that-science-would-find-consciousness-in-the-br</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-07-christof-koch-bet-a-case-of-wine-that-science-would-find-consciousness-in-the-br</guid><description>At a symposium in Portugal, the neuroscientist who spent 25 years hunting consciousness inside the brain conceded the field&apos;s central promise is still unpaid, and floated that consciousness might be fundamental to reality rather than manufactured by neurons.</description><pubDate>Fri, 07 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>consciousness</category><category>neuroscience</category><category>integrated-information-theory</category><category>terminal-lucidity</category><category>mind</category><author>Sarah Okonkwo</author></item><item><title>Chemo-Surviving Ovarian Cancer Cells Release Fructose to Loosen the Tumor Next Door</title><link>https://thefirstcohort.com/articles/2026-08-06-chemo-surviving-ovarian-cancer-cells-release-fructose-to-loosen-the-tumor-next-d</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-06-chemo-surviving-ovarian-cancer-cells-release-fructose-to-loosen-the-tumor-next-d</guid><description>The same cholesterol-starving mechanism that loosens tumor cells implicates statins, the pills 39 million Americans take, yet the researchers who found it say keep taking them anyway.</description><pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate><category>cancer</category><category>ovarian-cancer</category><category>fructose</category><category>metastasis</category><category>statins</category><category>senescence</category><category>chemotherapy</category><author>Lena Marshall</author></item><item><title>Gilead Priced Its Near-Perfect HIV Shot Out of the Countries Where the Virus Is Spreading Fastest</title><link>https://thefirstcohort.com/articles/2026-08-06-gilead-priced-its-near-perfect-hiv-shot-out-of-the-countries-where-the-virus-is</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-06-gilead-priced-its-near-perfect-hiv-shot-out-of-the-countries-where-the-virus-is</guid><description>Lenacapavir drove new HIV infections to nearly zero across two Gilead trials and a year-long extension. Gilead lists it at $28,218 a year in America; researchers estimate generics could be made for as little as $25, and the fastest-growing epidemics were left off the cheap-generic map.</description><pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>medical-research</category><author>Lena Marshall</author></item><item><title>The Fat Rebound Pediatricians Watch For at Age Six: Measure the Waist, and It Turns Out to Be Muscle and Bone</title><link>https://thefirstcohort.com/articles/2026-08-06-the-fat-rebound-pediatricians-watch-for-at-age-six-measure-the-waist-and-it-turn</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-06-the-fat-rebound-pediatricians-watch-for-at-age-six-measure-the-waist-and-it-turn</guid><description>Waist-to-height ratio tracks body fat with about 90 percent accuracy. In 2,410 American kids it kept falling straight through the age when BMI says the fat comes roaring back.</description><pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>childhood-obesity</category><category>bmi</category><category>metabolic</category><category>obesity-diagnosis</category><category>novo-nordisk</category><author>Sarah Okonkwo</author></item><item><title>The Lungs May Be Where Rheumatoid Arthritis Actually Starts</title><link>https://thefirstcohort.com/articles/2026-08-06-the-lungs-may-be-where-rheumatoid-arthritis-actually-starts</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-06-the-lungs-may-be-where-rheumatoid-arthritis-actually-starts</guid><description>Across Italy, South Korea, and California, higher fine-particle pollution tracks more RA flares and more new cases, and the biology keeps pointing at the airway, not the knee.</description><pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>rheumatoid-arthritis</category><category>air-pollution</category><category>autoimmune</category><category>pm2.5</category><category>environmental-health</category><category>inflammation</category><author>Sarah Okonkwo</author></item><item><title>The Prescription Vitamin D Added to Protect Failing Kidneys Made Them Decline Four Times Faster</title><link>https://thefirstcohort.com/articles/2026-08-06-the-prescription-vitamin-d-added-to-protect-failing-kidneys-made-them-decline-fo</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-06-the-prescription-vitamin-d-added-to-protect-failing-kidneys-made-them-decline-fo</guid><description>Chasing a parathyroid-hormone target, doctors added active vitamin D to a kidney drug. The hormone dropped 35 percent, and the kidneys declined four times faster.</description><pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>vitamin-d</category><category>kidney-disease</category><category>fgf23</category><category>overtreatment</category><category>pharma-funding</category><author>Sarah Okonkwo</author></item><item><title>MIT Put an AI Skin Doctor in Front of 776 People. Its Friendliest Feature Fooled the Ones Who Needed Help Most.</title><link>https://thefirstcohort.com/articles/2026-08-05-mit-put-an-ai-skin-doctor-in-front-of-776-people-its-friendliest-feature-fooled</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-05-mit-put-an-ai-skin-doctor-in-front-of-776-people-its-friendliest-feature-fooled</guid><description>623 lay people and 153 doctors used the same AI to read skin conditions. The doctors shrugged off its bad advice. Everyone else trusted it more the more fluently it explained itself.</description><pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>medical-ai</category><category>explainable-ai</category><category>dermatology</category><category>automation-bias</category><category>skin-cancer</category><author>Sarah Okonkwo</author></item><item><title>The Licensed Ebola Vaccine Was Never Proven to Stop the Strain Now Killing Congo</title><link>https://thefirstcohort.com/articles/2026-08-05-the-licensed-ebola-vaccine-was-never-proven-to-stop-the-strain-now-killing-congo</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-05-the-licensed-ebola-vaccine-was-never-proven-to-stop-the-strain-now-killing-congo</guid><description>Bundibugyo virus has driven the fastest-growing Ebola outbreak on record, with 1,707 deaths across eastern Congo and nearly 90 percent of cases in Ituri, and the WHO&apos;s own experts say the one licensed Ebola vaccine should not be used against it.</description><pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>ebola</category><category>bundibugyo</category><category>congo</category><category>outbreak</category><category>public-health</category><category>vaccines</category><author>Marcus Chen</author></item><item><title>They Doubled the Recommended Protein This Year. 350 Studies Say That&apos;s Backwards for Sedentary Adults.</title><link>https://thefirstcohort.com/articles/2026-08-05-they-doubled-the-recommended-protein-this-year-350-studies-say-that-s-backwards</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-05-they-doubled-the-recommended-protein-this-year-350-studies-say-that-s-backwards</guid><description>Federal guidance now tells you to eat nearly twice the protein it used to. A University of Wisconsin review of more than 350 studies argues that for people who don&apos;t train hard, the extra may be speeding up the aging they&apos;re trying to outrun.</description><pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>protein</category><category>longevity</category><category>metabolism</category><category>aging</category><category>nutrition</category><category>fgf21</category><author>Sarah Okonkwo</author></item><item><title>U.S. Special Operators Carried French Freeze-Dried Plasma for 15 Years Before the FDA Licensed an American One</title><link>https://thefirstcohort.com/articles/2026-08-05-u-s-special-operators-carried-french-freeze-dried-plasma-for-15-years-before-the</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-05-u-s-special-operators-carried-french-freeze-dried-plasma-for-15-years-before-the</guid><description>Allied militaries and U.S. commandos have relied on freeze-dried plasma for years. Washington licensed its own version this week, decades after an American doctor first invented the powder.</description><pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>freeze-dried-plasma</category><category>fda</category><category>trauma</category><category>transfusion</category><category>military-medicine</category><category>hemorrhage</category><author>Sarah Okonkwo</author></item><item><title>Your Fat Cells Remember Being Fat, and That Memory Outlasts the Weight Loss</title><link>https://thefirstcohort.com/articles/2026-08-05-your-fat-cells-remember-being-fat-and-that-memory-outlasts-the-weight-loss</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-05-your-fat-cells-remember-being-fat-and-that-memory-outlasts-the-weight-loss</guid><description>Your body defends its heaviest weight for years after you lose it, which is why the rebound isn&apos;t weak willpower and why the injection only works while you keep paying for it.</description><pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>weight-regain</category><category>glp-1</category><category>metabolism</category><category>obesity</category><category>epigenetics</category><author>Sarah Okonkwo</author></item><item><title>A Toxicologist Mapped 800 Shared Causes Across 4,000 Diseases. His Protocol Treats Them by Subtraction, Not Prescription.</title><link>https://thefirstcohort.com/articles/2026-08-04-a-toxicologist-mapped-800-shared-causes-across-4-000-diseases-his-protocol-treat</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-a-toxicologist-mapped-800-shared-causes-across-4-000-diseases-his-protocol-treat</guid><description>Ronald Kostoff argues chronic and infectious disease grow from the same toxic soil, a damaged immune system, and that removing the cause has to come before any drug can work.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>chronic-disease</category><category>infectious-disease</category><category>toxicology</category><category>immune-system</category><category>exposome</category><category>prevention</category><author>Marcus Chen</author></item><item><title>Built to Find Nothing: Merck Tested Gardasil&apos;s Safety Against Its Own Aluminum Adjuvant</title><link>https://thefirstcohort.com/articles/2026-08-04-built-to-find-nothing-merck-tested-gardasil-s-safety-against-its-own-aluminum-ad</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-built-to-find-nothing-merck-tested-gardasil-s-safety-against-its-own-aluminum-ad</guid><description>In ten of eleven pivotal trials, Merck&apos;s Gardasil &apos;placebo&apos; was 225 micrograms of the same aluminum adjuvant that is in the vaccine, and serious harms counted only inside a 14-day window.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>gardasil</category><category>merck</category><category>hpv-vaccine</category><category>clinical-trials</category><category>regulatory-capture</category><category>aluminum-adjuvant</category><author>Mira Petrov</author></item><item><title>Glioblastoma Craves Sugar. Oregon State Coated a Gene Therapy in It and Rode Straight Past the Blood-Brain Barrier.</title><link>https://thefirstcohort.com/articles/2026-08-04-glioblastoma-craves-sugar-oregon-state-coated-a-gene-therapy-in-it-and-rode-stra</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-glioblastoma-craves-sugar-oregon-state-coated-a-gene-therapy-in-it-and-rode-stra</guid><description>Glioblastoma overexpresses the same sugar transporter that guards the brain. Oregon State researchers used that greed to smuggle a tumor-suppressor gene into tumors, and mouse survival rose 50 percent.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>cancer</category><category>glioblastoma</category><category>brain-cancer</category><category>nanoparticles</category><category>gene-therapy</category><category>blood-brain-barrier</category><category>mrna</category><author>Sarah Okonkwo</author></item><item><title>In 2021, Creatine Spread Cancer in Mice. This Week, a UCLA Lab Said It Fights It.</title><link>https://thefirstcohort.com/articles/2026-08-04-in-2021-creatine-spread-cancer-in-mice-this-week-a-ucla-lab-said-it-fights-it</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-in-2021-creatine-spread-cancer-in-mice-this-week-a-ucla-lab-said-it-fights-it</guid><description>A UCLA study found creatine energized cancer-fighting immune cells in mice and lab dishes. It was never tested in a patient, and a separate line of research says the same supplement feeds metastasis.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>cancer</category><category>creatine</category><category>cancer</category><category>immunotherapy</category><category>supplements</category><category>dendritic-cells</category><category>preclinical</category><author>Lena Marshall</author></item><item><title>In Tuberculosis, the Cell We Called &apos;Neutral&apos; Is the One Torching the Lung</title><link>https://thefirstcohort.com/articles/2026-08-04-in-tuberculosis-the-cell-we-called-neutral-is-the-one-torching-the-lung</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-in-tuberculosis-the-cell-we-called-neutral-is-the-one-torching-the-lung</guid><description>In the people whose latent TB roared into active disease, the airways filled with neutrophils, half of them flipping on an interferon alarm, while their T cells were pushed to exhaustion and death.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>tuberculosis</category><category>immunology</category><category>neutrophils</category><category>infectious-disease</category><category>lung</category><author>Sarah Okonkwo</author></item><item><title>Rare but Real: The Autoimmune Hepatitis After mRNA That VAERS Was Built to Miss</title><link>https://thefirstcohort.com/articles/2026-08-04-rare-but-real-the-autoimmune-hepatitis-after-mrna-that-vaers-was-built-to-miss</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-rare-but-real-the-autoimmune-hepatitis-after-mrna-that-vaers-was-built-to-miss</guid><description>Twenty-seven biopsy-confirmed cases of autoimmune hepatitis after an mRNA dose, jaundice and an ALT of 1,092 that resolved on steroids. The disproportionality math found &apos;no safety signal.&apos; It was measuring a reporting system, not the liver.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>covid-19</category><category>vaccine-safety</category><category>autoimmune-hepatitis</category><category>vaers</category><category>molecular-mimicry</category><category>mrna</category><author>Marcus Chen</author></item><item><title>Scientists Watched the Flu Dissolve Structures Inside the Nucleus, in Every Cell and Every Strain They Tried</title><link>https://thefirstcohort.com/articles/2026-08-04-scientists-watched-the-flu-dissolve-structures-inside-the-nucleus-in-every-cell</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-scientists-watched-the-flu-dissolve-structures-inside-the-nucleus-in-every-cell</guid><description>Influenza reaches into the nucleus and takes apart droplets that may be part of the cell&apos;s own defense. Scientists have now mapped how. The drug targets that map supposedly unlocks are still hypothetical.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>influenza</category><category>virology</category><category>cell-biology</category><category>paraspeckles</category><category>antivirals</category><author>Lena Marshall</author></item><item><title>The Fat Molecule That Rides From Your Waistline to Your Brain, and Feeds Alzheimer&apos;s Once It Gets There</title><link>https://thefirstcohort.com/articles/2026-08-04-the-fat-molecule-that-rides-from-your-waistline-to-your-brain-and-feeds-alzheime</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-the-fat-molecule-that-rides-from-your-waistline-to-your-brain-and-feeds-alzheime</guid><description>In obese mice, a membrane fat called phosphatidylethanolamine packed into tiny vesicles, rode to the brain, and sabotaged the immune cells that clear amyloid. An investigational drug reversed it, in mice.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>obesity</category><category>metabolic-health</category><category>lipids</category><category>microglia</category><category>neuroinflammation</category><author>Sarah Okonkwo</author></item><item><title>The FDA Cleared a CRISPR Cure for Two-Year-Olds Whose Own Trial Enrolled No One That Young</title><link>https://thefirstcohort.com/articles/2026-08-04-the-fda-cleared-a-crispr-cure-for-two-year-olds-whose-own-trial-enrolled-no-one</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-the-fda-cleared-a-crispr-cure-for-two-year-olds-whose-own-trial-enrolled-no-one</guid><description>Casgevy&apos;s pediatric trials enrolled 11 children aged five and up, yet the FDA extended the $2.2 million therapy down to age two, where the conditioning chemo can permanently sterilize a child too young to bank eggs or sperm.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>gene-therapy</category><category>sickle-cell</category><category>fda</category><category>crispr</category><category>fertility</category><category>casgevy</category><author>Lena Marshall</author></item><item><title>The Genes Driving Cancer&apos;s Growth Are the Same Ones It Keeps Breaking</title><link>https://thefirstcohort.com/articles/2026-08-04-the-genes-driving-cancer-s-growth-are-the-same-ones-it-keeps-breaking</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-the-genes-driving-cancer-s-growth-are-the-same-ones-it-keeps-breaking</guid><description>The same super-enhancers that make a tumor grow keep snapping its DNA, and the botched repairs are where the next mutations come from. The finding is real, careful, and already a year old.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>cancer</category><category>cancer</category><category>dna-damage</category><category>super-enhancers</category><category>genomic-instability</category><category>oncology</category><author>Lena Marshall</author></item><item><title>The Reason Immunotherapy Bounces Off Prostate Cancer: Tumors Chew Off a Genetic Tail to Blind the Immune System</title><link>https://thefirstcohort.com/articles/2026-08-04-the-reason-immunotherapy-bounces-off-prostate-cancer-tumors-chew-off-a-genetic-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-the-reason-immunotherapy-bounces-off-prostate-cancer-tumors-chew-off-a-genetic-t</guid><description>Prostate tumors overproduce a protein that destroys the immune system&apos;s docking targets. A CRISPR tool that blocks the trick made checkpoint drugs work again, so far only in mice.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>cancer</category><category>prostate-cancer</category><category>immunotherapy</category><category>crispr</category><category>oncology</category><category>checkpoint-inhibitors</category><author>Lena Marshall</author></item><item><title>Two Scientists Nominated Fauci for Cash Prizes. Then His Agency Funded Them by the Hundreds of Millions.</title><link>https://thefirstcohort.com/articles/2026-08-04-two-scientists-nominated-fauci-for-cash-prizes-then-his-agency-funded-them-by-th</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-two-scientists-nominated-fauci-for-cash-prizes-then-his-agency-funded-them-by-th</guid><description>The emails Rand Paul released July 24 show Fauci&apos;s taxpayer-funded staff drafting his award nominations, and two scientists who submitted them going on to draw large NIAID grants.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>fauci</category><category>nih</category><category>conflicts-of-interest</category><category>covid-origins</category><category>accountability</category><author>Mira Petrov</author></item><item><title>Two Vaccine Injury Programs, One Country: COVID Claims Landed in the One That Almost Never Pays</title><link>https://thefirstcohort.com/articles/2026-08-04-two-vaccine-injury-programs-one-country-covid-claims-landed-in-the-one-that-almo</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-two-vaccine-injury-programs-one-country-covid-claims-landed-in-the-one-that-almo</guid><description>The federal fund for routine vaccine injuries has paid $5.2 billion to nearly 10,000 people. The program COVID shots were routed into has compensated 34 claims, and RFK Jr. wants to change the math.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>covid-vaccine</category><category>vaccine-injury</category><category>cicp</category><category>rfk-jr</category><category>prep-act</category><author>Marcus Chen</author></item><item><title>Vitamin K Shot Refusals Nearly Doubled Since 2017. A Cancer Scare Refuted Twenty Years Ago Still Shadows It.</title><link>https://thefirstcohort.com/articles/2026-08-04-vitamin-k-shot-refusals-nearly-doubled-since-2017-a-cancer-scare-refuted-twenty</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-08-04-vitamin-k-shot-refusals-nearly-doubled-since-2017-a-cancer-scare-refuted-twenty</guid><description>Refusal of the newborn vitamin K shot has nearly doubled since 2017. The injection all but erases a bleed that kills roughly one in five infants it reaches, and the cancer scare still shadowing it was refuted twenty years ago. The institutions losing these parents will not even count the damage.</description><pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate><category>investigations</category><category>vitamin-k</category><category>newborn-health</category><category>vkdb</category><category>public-trust</category><category>refusal-trend</category><author>Mira Petrov</author></item><item><title>A 30-Minute Sauna Floods the Blood With Immune Cells, and the Heat Isn&apos;t What Triggers Them</title><link>https://thefirstcohort.com/articles/2026-07-31-a-30-minute-sauna-floods-the-blood-with-immune-cells-and-the-heat-isn-t-what-tri</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-31-a-30-minute-sauna-floods-the-blood-with-immune-cells-and-the-heat-isn-t-what-tri</guid><description>Finnish researchers put 51 people in a 73-degree sauna and watched every class of white blood cell surge, then found the surge had almost nothing to do with how hot anyone actually got.</description><pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>sauna</category><category>immune-system</category><category>inflammation</category><category>longevity</category><category>wellness</category><category>finland</category><author>Sarah Okonkwo</author></item><item><title>A Gene-Editing Trial Killed a Six-Year-Old. The Only Official Penalty Was a $3,500 Fine.</title><link>https://thefirstcohort.com/articles/2026-07-31-a-gene-editing-trial-killed-a-six-year-old-the-only-official-penalty-was-a-3-500</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-31-a-gene-editing-trial-killed-a-six-year-old-the-only-official-penalty-was-a-3-500</guid><description>Xinhua Hospital paid about 24,000 yuan in September 2025. The death it was fined over stayed out of the medical literature for another ten months, and out of the Nature paper entirely.</description><pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>gene-editing</category><category>research-integrity</category><category>china</category><category>crispr</category><category>regulatory-capture</category><category>accountability</category><author>Mira Petrov</author></item><item><title>A Microwave Can Fry a Potato That Soaks Up Less Oil: That Isn&apos;t the Same as a Healthier Fry</title><link>https://thefirstcohort.com/articles/2026-07-31-a-microwave-can-fry-a-potato-that-soaks-up-less-oil-that-isn-t-the-same-as-a-hea</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-31-a-microwave-can-fry-a-potato-that-soaks-up-less-oil-that-isn-t-the-same-as-a-hea</guid><description>University of Illinois engineers made French fries that hold less oil by frying them from the inside. Nobody ran a taste test, nobody measured the acrylamide, and the pitch was aimed at food manufacturers.</description><pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>nutrition</category><category>food-processing</category><category>acrylamide</category><category>frying</category><category>metabolic</category><author>Sarah Okonkwo</author></item><item><title>A Week Instead of a Month: The Faster Prostate Radiation Was Only &quot;As Safe&quot; on the Coarser Ruler</title><link>https://thefirstcohort.com/articles/2026-07-31-a-week-instead-of-a-month-the-faster-prostate-radiation-was-only-as-safe-on-the</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-31-a-week-instead-of-a-month-the-faster-prostate-radiation-was-only-as-safe-on-the</guid><description>PACE-C put five-fraction radiation against the four-week course in 1,208 men. On the old grading scale they matched. On the finer one the short course logged 17 percent bowel toxicity against 10 percent, and the trial still can&apos;t say whether the shorter beam controls cancer as well.</description><pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>prostate-cancer</category><category>radiotherapy</category><category>sbrt</category><category>clinical-trials</category><category>oncology</category><author>Lena Marshall</author></item><item><title>The Phone-Radiation Study Everyone Called a Debunking Was Too Small to Find the Tumor</title><link>https://thefirstcohort.com/articles/2026-07-31-the-phone-radiation-study-everyone-called-a-debunking-was-too-small-to-find-the</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-31-the-phone-radiation-study-everyone-called-a-debunking-was-too-small-to-find-the</guid><description>Japan and Korea spent two years &apos;validating&apos; the NIH finding that cell-phone radiation gave rats heart tumors. They used one dose, one sex, and too few animals to detect it. Korea&apos;s rats grew the tumor anyway.</description><pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>rf-radiation</category><category>cell-phones</category><category>carcinogenicity</category><category>ntp</category><category>regulatory-capture</category><category>cancer</category><author>Sarah Okonkwo</author></item><item><title>Histamine Was Always the Wrong Target for the Eczema Itch</title><link>https://thefirstcohort.com/articles/2026-07-30-histamine-was-always-the-wrong-target-for-the-eczema-itch</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-30-histamine-was-always-the-wrong-target-for-the-eczema-itch</guid><description>Eczema itch runs on cytokines, not mainly histamine, which is why the pills in the allergy aisle keep failing the trials, and a network meta-analysis just said so one more time.</description><pubDate>Thu, 30 Jul 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>eczema</category><category>atopic-dermatitis</category><category>antihistamines</category><category>itch</category><category>dermatology</category><category>evidence</category><author>Marcus Chen</author></item><item><title>No One Guards the Toddler Food Aisle: 81 Percent of Its Foods Are Ultra-Processed</title><link>https://thefirstcohort.com/articles/2026-07-30-no-one-guards-the-toddler-food-aisle-81-percent-of-its-foods-are-ultra-processed</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-30-no-one-guards-the-toddler-food-aisle-81-percent-of-its-foods-are-ultra-processed</guid><description>Parents assume the baby aisle is vetted. It isn&apos;t. No US rule makes toddler food meet a nutrient standard, and an Austin audit of 2,783 products marketed for 6-to-36-month-olds found 81 percent ultra-processed and nearly half failing a WHO benchmark.</description><pubDate>Thu, 30 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>ultra-processed foods</category><category>toddler nutrition</category><category>added sugar</category><category>food industry</category><category>regulation</category><category>microbiome</category><author>Sarah Okonkwo</author></item><item><title>Rice Chemists Taught an Enzyme to Recycle Drug Synthesis&apos;s Most Expensive Ingredient</title><link>https://thefirstcohort.com/articles/2026-07-30-rice-chemists-taught-an-enzyme-to-recycle-drug-synthesis-s-most-expensive-ingred</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-30-rice-chemists-taught-an-enzyme-to-recycle-drug-synthesis-s-most-expensive-ingred</guid><description>The chemistry that builds drugs like Spinraza just got cheaper. The $125,000 price tag never had much to do with the chemistry.</description><pubDate>Thu, 30 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>drug-synthesis</category><category>antisense-oligonucleotides</category><category>biocatalysis</category><category>drug-pricing</category><category>enzymes</category><author>Sarah Okonkwo</author></item><item><title>Same Diet, Same 15 Pounds: Only the Women Who Ate in an 8-Hour Window Got Sharper</title><link>https://thefirstcohort.com/articles/2026-07-30-same-diet-same-15-pounds-only-the-women-who-ate-in-an-8-hour-window-got-sharper</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-30-same-diet-same-15-pounds-only-the-women-who-ate-in-an-8-hour-window-got-sharper</guid><description>Two groups of older women cut the same calories and lost the same 15 pounds over six months. The ones who packed eating into an 8-hour window still scored better on problem-solving, from a 47-person pilot that hasn&apos;t been peer-reviewed.</description><pubDate>Thu, 30 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>time-restricted-eating</category><category>cognitive-decline</category><category>longevity</category><category>metabolic-health</category><category>womens-health</category><author>Sarah Okonkwo</author></item><item><title>A Daily Scoop of Chicory Fiber Eased Knee Arthritis, and It Moved the Same Gut Hormone as Ozempic</title><link>https://thefirstcohort.com/articles/2026-07-28-a-daily-scoop-of-chicory-fiber-eased-knee-arthritis-and-it-moved-the-same-gut-ho</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-28-a-daily-scoop-of-chicory-fiber-eased-knee-arthritis-and-it-moved-the-same-gut-ho</guid><description>Twenty grams of chicory fiber a day matched a physiotherapy app for knee arthritis pain, and only one person in the fiber group quit. The hormone it nudged is the one Ozempic is built to imitate.</description><pubDate>Tue, 28 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>knee osteoarthritis</category><category>inulin</category><category>prebiotic fiber</category><category>glp-1</category><category>gut microbiome</category><author>Sarah Okonkwo</author></item><item><title>Pregnant Women&apos;s Blood Pressure Registers Every Smoke Day. A Federal Rule Lets States Erase Those Days From the Record.</title><link>https://thefirstcohort.com/articles/2026-07-28-pregnant-women-s-blood-pressure-registers-every-smoke-day-a-federal-rule-lets-st</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-28-pregnant-women-s-blood-pressure-registers-every-smoke-day-a-federal-rule-lets-st</guid><description>On heavy smoke days, adults&apos; systolic pressure ran nearly 4 mmHg higher; across eight southwestern states, gestational smoke exposure raised the odds of gestational hypertension 12 percent. Since 2016, regulators have won EPA approval to erase wildfire smoke from the Clean Air Act record in more tha</description><pubDate>Tue, 28 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>wildfire-smoke</category><category>maternal-health</category><category>air-pollution</category><category>pregnancy</category><category>epa</category><author>Sarah Okonkwo</author></item><item><title>The FDA Approved the First Cholesterol Pill of Its Kind Before Its Trial Could Show It Prevents Heart Attacks or Deaths</title><link>https://thefirstcohort.com/articles/2026-07-28-the-fda-approved-the-first-cholesterol-pill-of-its-kind-before-its-trial-could-s</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-28-the-fda-approved-the-first-cholesterol-pill-of-its-kind-before-its-trial-could-s</guid><description>Lipfendra lowers LDL cholesterol by up to 60 percent. The 14,550-patient trial that would show whether that prevents heart attacks or deaths does not finish until November 2029, and Merck is charging roughly $3,800 a year in the meantime.</description><pubDate>Tue, 28 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>medical-research</category><author>Lena Marshall</author></item><item><title>The NIH Weighed Every Meal to a Tenth of a Gram. Four AI Calorie Apps Undercounted by up to 345.</title><link>https://thefirstcohort.com/articles/2026-07-28-the-nih-weighed-every-meal-to-a-tenth-of-a-gram-four-ai-calorie-apps-undercounte</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-28-the-nih-weighed-every-meal-to-a-tenth-of-a-gram-four-ai-calorie-apps-undercounte</guid><description>In a locked NIH metabolic kitchen where every ingredient was weighed to 0.1 grams, MyFitnessPal, Lose It!, CalAI, and Appediet each read a plate and undercounted it by a quarter to a third, missing the fat most of all.</description><pubDate>Tue, 28 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>calorie-tracking</category><category>ai-apps</category><category>nutrition</category><category>weight-loss</category><category>keto</category><category>metabolic</category><author>Sarah Okonkwo</author></item><item><title>The Same Cancer Mutation, Opposite Effects: What 581 Mouse Tumors Say About Who Gets Sick</title><link>https://thefirstcohort.com/articles/2026-07-28-the-same-cancer-mutation-opposite-effects-what-581-mouse-tumors-say-about-who-ge</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-28-the-same-cancer-mutation-opposite-effects-what-581-mouse-tumors-say-about-who-ge</guid><description>Cambridge and Yale gave four strains of mice one identical dose of a carcinogen. The tumors converged on the same pathway but took four different genetic routes to get there, and today&apos;s screening ignores the reason.</description><pubDate>Tue, 28 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>cancer</category><category>oncology</category><category>genetics</category><category>screening</category><category>precision-medicine</category><author>Lena Marshall</author></item><item><title>BPA Sits in 90% of Us. The Cancer Studies Sample It With a Method That Was Never Going to Find Anything.</title><link>https://thefirstcohort.com/articles/2026-07-27-bpa-sits-in-90-of-us-the-cancer-studies-sample-it-with-a-method-that-was-never-g</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-27-bpa-sits-in-90-of-us-the-cancer-studies-sample-it-with-a-method-that-was-never-g</guid><description>Bisphenol A shows up in more than nine of ten Americans, yet California&apos;s reviewers just called the cancer evidence &apos;inadequate,&apos; because the studies measure a chemical the body clears in hours from a single urine sample.</description><pubDate>Mon, 27 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>bpa</category><category>endocrine-disruptors</category><category>cancer</category><category>chemical-regulation</category><category>exposure-assessment</category><author>Sarah Okonkwo</author></item><item><title>The American Diabetes Association Had Police Remove the Editor of Its Own Journal. Then It Refused to Print His Reply.</title><link>https://thefirstcohort.com/articles/2026-07-27-the-american-diabetes-association-had-police-remove-the-editor-of-its-own-journa</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-27-the-american-diabetes-association-had-police-remove-the-editor-of-its-own-journa</guid><description>Steven Kahn edits the ADA&apos;s own journal. In June its meeting had state police walk him out for handing out one of its editorials. In July it refused to print the response he and his colleagues wrote. He calls it what it is: pure censorship.</description><pubDate>Mon, 27 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>censorship</category><category>diabetes</category><category>academic-freedom</category><category>institutional-capture</category><category>nih-funding</category><category>free-speech</category><author>Lena Marshall</author></item><item><title>A Gene-Editing Trial Killed a 6-Year-Old. Nature Published the Science and Left Her Out of the Record.</title><link>https://thefirstcohort.com/articles/2026-07-26-a-gene-editing-trial-killed-a-6-year-old-nature-published-the-science-and-left-h</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-26-a-gene-editing-trial-killed-a-6-year-old-nature-published-the-science-and-left-h</guid><description>Her parents paid $860,000 to base-edit their daughter&apos;s brain. She died of an immune reaction within a week, the trial&apos;s fatal outcome was never disclosed, and the Nature paper built on the same work never names her.</description><pubDate>Sun, 26 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>gene-editing</category><category>base-editing</category><category>research-integrity</category><category>regulatory-oversight</category><category>china</category><author>Mira Petrov</author></item><item><title>Orforglipron Reaches Deep Into the Brain&apos;s Reward Circuit and Turns the Dopamine Down</title><link>https://thefirstcohort.com/articles/2026-07-26-orforglipron-reaches-deep-into-the-brain-s-reward-circuit-and-turns-the-dopamine</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-26-orforglipron-reaches-deep-into-the-brain-s-reward-circuit-and-turns-the-dopamine</guid><description>In mice engineered with human GLP-1 receptors, the new oral pills reached the central amygdala, a deep reward hub, and thinned the dopamine payoff of eating for pleasure. The government&apos;s addiction institute is already watching.</description><pubDate>Sun, 26 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>orforglipron</category><category>dopamine</category><category>obesity</category><category>addiction</category><category>brain-reward</category><author>Sarah Okonkwo</author></item><item><title>Pepsi Paid $1.95 Billion for Poppi, in a Category That Averages as Much Sugar as Fiber</title><link>https://thefirstcohort.com/articles/2026-07-26-pepsi-paid-1-95-billion-for-poppi-in-a-category-that-averages-as-much-sugar-as-f</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-26-pepsi-paid-1-95-billion-for-poppi-in-a-category-that-averages-as-much-sugar-as-f</guid><description>UNC researchers read the labels on 108 prebiotic sodas and found roughly 5 grams of fiber, 5 grams of sugar, and, in most cans, a non-nutritive sweetener. Poppi agreed to an $8.9 million settlement over its gut-health claims; months later Pepsi paid $1.95 billion for it.</description><pubDate>Sun, 26 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>prebiotic soda</category><category>gut health</category><category>food labeling</category><category>health halo</category><category>poppi</category><author>Lena Marshall</author></item><item><title>The Evolutionary Fix for Drug Resistance Works Best on a Tumor Too Small to Find</title><link>https://thefirstcohort.com/articles/2026-07-26-the-evolutionary-fix-for-drug-resistance-works-best-on-a-tumor-too-small-to-find</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-26-the-evolutionary-fix-for-drug-resistance-works-best-on-a-tumor-too-small-to-find</guid><description>City St George&apos;s mathematicians say hitting a tumor at its weakest moment can drive it extinct. Their own model clears 95 percent only below 7 million cells, far smaller than any tumor a scan can find.</description><pubDate>Sun, 26 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>cancer</category><category>oncology</category><category>drug-resistance</category><category>evolutionary-therapy</category><category>clinical-trials</category><author>Lena Marshall</author></item><item><title>A Chinese Bark Compound Reached the Black-Box Arthritis Drugs&apos; Pathway From Upstream, in Rats</title><link>https://thefirstcohort.com/articles/2026-07-25-a-chinese-bark-compound-reached-the-black-box-arthritis-drugs-pathway-from-upstr</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-25-a-chinese-bark-compound-reached-the-black-box-arthritis-drugs-pathway-from-upstr</guid><description>In rats, a compound from the bark of the Amur cork tree reached the same JAK-STAT pathway as Xeljanz and its black-box cousins, but by rebalancing the cell&apos;s fat metabolism instead of blocking the pathway directly.</description><pubDate>Sat, 25 Jul 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>rheumatoid-arthritis</category><category>autoimmune</category><category>natural-compounds</category><category>jak-inhibitors</category><category>metabolism</category><author>Sarah Okonkwo</author></item><item><title>The FDA Revoked Two Petroleum Dyes That Industry Abandoned Before Most Americans Were Born</title><link>https://thefirstcohort.com/articles/2026-07-25-the-fda-revoked-two-petroleum-dyes-that-industry-abandoned-before-most-americans</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-25-the-fda-revoked-two-petroleum-dyes-that-industry-abandoned-before-most-americans</guid><description>Orange B was last certified in 1978. Citrus Red No. 2 has painted Florida oranges since 1959. The six petroleum dyes actually in the food supply remain on a voluntary timeline no manufacturer has publicly signed.</description><pubDate>Sat, 25 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>food-dyes</category><category>fda</category><category>maha</category><category>petroleum-dyes</category><category>food-safety</category><category>citrus-red-2</category><author>Marcus Chen</author></item><item><title>The Fruit Juice Sold to Parents as the Healthy Choice Tracks With Higher Blood Pressure 25 Years Later</title><link>https://thefirstcohort.com/articles/2026-07-25-the-fruit-juice-sold-to-parents-as-the-healthy-choice-tracks-with-higher-blood-p</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-25-the-fruit-juice-sold-to-parents-as-the-healthy-choice-tracks-with-higher-blood-p</guid><description>One daily glass of orange juice tracked with 20 percent higher blood pressure risk. The whole fruit tracked with nothing.</description><pubDate>Sat, 25 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>fruit juice</category><category>hypertension</category><category>childhood nutrition</category><category>fructose</category><category>metabolic health</category><author>Sarah Okonkwo</author></item><item><title>In the Lab, Coffee Flipped an Anti-Aging Switch. The Caffeine Barely Did.</title><link>https://thefirstcohort.com/articles/2026-07-23-in-the-lab-coffee-flipped-an-anti-aging-switch-the-caffeine-barely-did</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-23-in-the-lab-coffee-flipped-an-anti-aging-switch-the-caffeine-barely-did</guid><description>Stephen Safe&apos;s lab reported that coffee&apos;s polyphenols, more than its caffeine, switch on a cellular stress-defense receptor. Every experiment ran in a dish, and the anti-aging headline traveled a great deal further than the data.</description><pubDate>Thu, 23 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>coffee</category><category>polyphenols</category><category>aging</category><category>nr4a1</category><category>cell-study</category><author>Lena Marshall</author></item><item><title>The AHA Says Coffee Is Safe to Five Cups a Day. The Energy Shot&apos;s Problem Isn&apos;t the Caffeine.</title><link>https://thefirstcohort.com/articles/2026-07-23-the-aha-says-coffee-is-safe-to-five-cups-a-day-the-energy-shot-s-problem-isn-t-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-23-the-aha-says-coffee-is-safe-to-five-cups-a-day-the-energy-shot-s-problem-isn-t-t</guid><description>Up to 400 mg a day, roughly three to five cups of regular black coffee, is generally safe for most adults and may be linked to lower cardiovascular risk. The concentrated shot in the gym-bag can is a different animal, and the reason isn&apos;t the caffeine.</description><pubDate>Thu, 23 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>caffeine</category><category>coffee</category><category>energy-drinks</category><category>heart-health</category><category>blood-pressure</category><category>nutrition</category><author>Sarah Okonkwo</author></item><item><title>The GLP-1s That Barely Move the Scale Don&apos;t Cause Hair Loss, and That&apos;s the Clue Everyone Missed</title><link>https://thefirstcohort.com/articles/2026-07-23-the-glp-1s-that-barely-move-the-scale-don-t-cause-hair-loss-and-that-s-the-clue</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-23-the-glp-1s-that-barely-move-the-scale-don-t-cause-hair-loss-and-that-s-the-clue</guid><description>Women on semaglutide shed hair at about twice the rate of men, and the weakest GLP-1s show almost no signal, which points the cause away from the follicle and straight at how fast the weight comes off.</description><pubDate>Thu, 23 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>semaglutide</category><category>hair-loss</category><category>weight-loss</category><category>womens-health</category><category>metabolic</category><author>Sarah Okonkwo</author></item><item><title>The Sweeteners Sold to Diabetics as the Safe Swap Tracked With Faster Brain Aging</title><link>https://thefirstcohort.com/articles/2026-07-23-the-sweeteners-sold-to-diabetics-as-the-safe-swap-tracked-with-faster-brain-agin</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-23-the-sweeteners-sold-to-diabetics-as-the-safe-swap-tracked-with-faster-brain-agin</guid><description>Brazilian researchers followed 12,772 adults for eight years. The ones consuming the most artificial sweeteners, about a diet soda&apos;s worth a day, showed cognitive decline equal to 1.6 extra years of brain aging, and diabetics fared worst.</description><pubDate>Thu, 23 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>artificial-sweeteners</category><category>cognitive-decline</category><category>diabetes</category><category>gut-brain-axis</category><category>aspartame</category><category>metabolic-health</category><author>Sarah Okonkwo</author></item><item><title>A Petri Dish of Angry Immune Cells, a Little Ultrasound, and a Very Big Headline</title><link>https://thefirstcohort.com/articles/2026-07-14-a-petri-dish-of-angry-immune-cells-a-little-ultrasound-and-a-very-big-headline</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-14-a-petri-dish-of-angry-immune-cells-a-little-ultrasound-and-a-very-big-headline</guid><description>UAH researchers used sound waves to shift immune cells from attack mode toward repair. The press release said &apos;stop arthritis before it starts.&apos; The experiment never touched a joint.</description><pubDate>Tue, 14 Jul 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>ultrasound</category><category>macrophages</category><category>inflammation</category><category>osteoarthritis</category><category>joint-health</category><category>preclinical</category><author>Sarah Okonkwo</author></item><item><title>A Gut Microbe Was Feeding Ammonia to Sick Livers. A Michigan Peptide Cut Off the Supply in Monkeys.</title><link>https://thefirstcohort.com/articles/2026-07-13-a-gut-microbe-was-feeding-ammonia-to-sick-livers-a-michigan-peptide-cut-off-the</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-13-a-gut-microbe-was-feeding-ammonia-to-sick-livers-a-michigan-peptide-cut-off-the</guid><description>The compound reversed severe fatty liver in monkeys by starving one ammonia-making gut bacterium. It also comes from a company its lead inventor founded, and no human has taken it for this.</description><pubDate>Mon, 13 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>fatty-liver</category><category>mash</category><category>gut-microbiome</category><category>metabolic</category><category>liver</category><category>preclinical</category><author>Sarah Okonkwo</author></item><item><title>Anti-Tau Alzheimer&apos;s Drugs Keep Hitting Their Target and Missing the Disease</title><link>https://thefirstcohort.com/articles/2026-07-13-anti-tau-alzheimer-s-drugs-keep-hitting-their-target-and-missing-the-disease</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-13-anti-tau-alzheimer-s-drugs-keep-hitting-their-target-and-missing-the-disease</guid><description>Tau is the new headliner at the Alzheimer&apos;s conference, but the anti-tau antibodies keep proving they bind the protein while doing nothing for patients. The clearest win so far is a blood test.</description><pubDate>Mon, 13 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>tau</category><category>blood-test</category><category>biomarkers</category><category>pharma</category><category>neurology</category><author>Sarah Okonkwo</author></item><item><title>The Mice Ate More and Got Leaner. The Switch Was One Amino Acid, Turned Down.</title><link>https://thefirstcohort.com/articles/2026-07-13-the-mice-ate-more-and-got-leaner-the-switch-was-one-amino-acid-turned-down</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-13-the-mice-ate-more-and-got-leaner-the-switch-was-one-amino-acid-turned-down</guid><description>USC mice on a low-protein, methionine-tuned diet ate as many calories as the junk-food group and still lost fat, while their own bodies pumped out more GLP-1. The scientist behind it also owns the company selling longevity diets.</description><pubDate>Mon, 13 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>longevity</category><category>metabolic</category><category>methionine</category><category>glp-1</category><category>diet</category><category>protein</category><author>Sarah Okonkwo</author></item><item><title>A Pharma-Funded Nonprofit Is Lobbying the FDA to Kill Seven Peptides It Can&apos;t Sell You</title><link>https://thefirstcohort.com/articles/2026-07-12-a-pharma-funded-nonprofit-is-lobbying-the-fda-to-kill-seven-peptides-it-can-t-se</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-12-a-pharma-funded-nonprofit-is-lobbying-the-fda-to-kill-seven-peptides-it-can-t-se</guid><description>The Partnership for Safe Medicines has deep ties to the drug lobby. Now it&apos;s urging the FDA to permanently block BPC-157, MOTS-c and five other off-patent peptides that compounding pharmacies sell cheap.</description><pubDate>Sun, 12 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>peptides</category><category>bpc-157</category><category>compounding</category><category>fda</category><category>big-pharma</category><category>longevity</category><author>Sarah Okonkwo</author></item><item><title>The Anti-Inflammatory Worm That Only Works If You Feed It Fiber</title><link>https://thefirstcohort.com/articles/2026-07-12-the-anti-inflammatory-worm-that-only-works-if-you-feed-it-fiber</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-12-the-anti-inflammatory-worm-that-only-works-if-you-feed-it-fiber</guid><description>Feed a rat plenty of fiber and a harmless tapeworm reaches full size and quiets the immune system. Cut the fiber to Western levels and the same worm shrinks, stops reproducing, and its anti-inflammatory power switches off.</description><pubDate>Sun, 12 Jul 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>microbiome</category><category>fiber</category><category>helminth-therapy</category><category>autoimmune</category><category>gut-health</category><category>inflammation</category><author>Sarah Okonkwo</author></item><item><title>The Blue Light Over Your Fish Tank Is Now Building Drug Molecules</title><link>https://thefirstcohort.com/articles/2026-07-12-the-blue-light-over-your-fish-tank-is-now-building-drug-molecules</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-12-the-blue-light-over-your-fish-tank-is-now-building-drug-molecules</guid><description>University at Buffalo chemists swapped harsh UV for a soft blue LED and got something the old chemistry rarely gives: two modifications to a molecule from a single reaction step.</description><pubDate>Sun, 12 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>photochemistry</category><category>drug-discovery</category><category>medicinal-chemistry</category><category>nih-funding</category><category>chemistry</category><author>Sarah Okonkwo</author></item><item><title>Your First Pregnancy Rewires the Brain for One Baby. Your Second Rewires It for the Chaos of Two.</title><link>https://thefirstcohort.com/articles/2026-07-12-your-first-pregnancy-rewires-the-brain-for-one-baby-your-second-rewires-it-for-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-12-your-first-pregnancy-rewires-the-brain-for-one-baby-your-second-rewires-it-for-t</guid><description>Amsterdam researchers scanned 110 women and found each pregnancy leaves its own mark, and the brain changes tied to maternal depression showed up months earlier the second time around.</description><pubDate>Sun, 12 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>pregnancy</category><category>maternal-brain</category><category>neuroscience</category><category>peripartum-depression</category><category>womens-health</category><author>Sarah Okonkwo</author></item><item><title>Berlin Physicists Bolted a Metamaterial to a 7-Tesla MRI, and the Living Eye Came Into Focus</title><link>https://thefirstcohort.com/articles/2026-07-11-berlin-physicists-bolted-a-metamaterial-to-a-7-tesla-mri-and-the-living-eye-came</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-11-berlin-physicists-bolted-a-metamaterial-to-a-7-tesla-mri-and-the-living-eye-came</guid><description>It clips onto a 7-tesla scanner a hospital already owns, draws no extra power, and lifted the signal inside a living human eye by up to half.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>mri</category><category>imaging</category><category>metamaterials</category><category>ophthalmology</category><category>neuroimaging</category><category>medical-devices</category><author>Sarah Okonkwo</author></item><item><title>For Years, a Foreign Factory Could Put the Active Ingredient in Your Medicine and Never Tell the FDA</title><link>https://thefirstcohort.com/articles/2026-07-11-for-years-a-foreign-factory-could-put-the-active-ingredient-in-your-medicine-and</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-11-for-years-a-foreign-factory-could-put-the-active-ingredient-in-your-medicine-and</guid><description>The FDA led with a paperwork convenience for manufacturers. Buried underneath was the admission that it can&apos;t always trace where a drug&apos;s active ingredient was made, a blind spot Congress had to order it to close.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>drug-supply-chain</category><category>active-pharmaceutical-ingredients</category><category>manufacturing</category><category>china</category><category>regulation</category><author>Lena Marshall</author></item><item><title>The Allergy Cell Everyone Wanted Dead Turns Out to Run Your Gut Lining and Your Metabolism</title><link>https://thefirstcohort.com/articles/2026-07-11-the-allergy-cell-everyone-wanted-dead-turns-out-to-run-your-gut-lining-and-your</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-11-the-allergy-cell-everyone-wanted-dead-turns-out-to-run-your-gut-lining-and-your</guid><description>Eosinophils were the villain of asthma and allergy, the cell whole-body drugs are built to erase. A decade of tissue biology says they also seal your gut, feed your antibodies, and tune your fat, and the trials never measured any of it.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>eosinophils</category><category>gut-health</category><category>metabolism</category><category>immunology</category><category>asthma-biologics</category><category>microbiome</category><author>Sarah Okonkwo</author></item><item><title>A $440,000 Drug Proved This Obesity Was Never About Willpower</title><link>https://thefirstcohort.com/articles/2026-07-10-a-440-000-drug-proved-this-obesity-was-never-about-willpower</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-10-a-440-000-drug-proved-this-obesity-was-never-about-willpower</guid><description>Brain-tumor surgery can wreck the hypothalamus and leave hunger permanently switched on. Setmelanotide restored the missing signal in a real placebo-controlled trial, then arrived priced near half a million dollars a year.</description><pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>setmelanotide</category><category>hypothalamic-obesity</category><category>drug-pricing</category><category>fda-approval</category><category>rare-disease</category><author>Lena Marshall</author></item><item><title>For Thirty Years the Model Said Blue Cones Drift Out of Sharp Vision. They Were Turning Into Red and Green.</title><link>https://thefirstcohort.com/articles/2026-07-10-for-thirty-years-the-model-said-blue-cones-drift-out-of-sharp-vision-they-were-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-10-for-thirty-years-the-model-said-blue-cones-drift-out-of-sharp-vision-they-were-t</guid><description>Johns Hopkins researchers grew human retinas in a dish and watched blue cones convert into the red and green cones behind sharp central vision. The three-decade-old migration model was wrong.</description><pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>vision</category><category>retina</category><category>organoids</category><category>vitamin-a</category><category>thyroid-hormone</category><category>developmental-biology</category><author>Lena Marshall</author></item><item><title>Scientists Measured the Salt in 39 Takeaways. Nearly Half Had More Than the Label Claimed.</title><link>https://thefirstcohort.com/articles/2026-07-10-scientists-measured-the-salt-in-39-takeaways-nearly-half-had-more-than-the-label</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-10-scientists-measured-the-salt-in-39-takeaways-nearly-half-had-more-than-the-label</guid><description>Chemists at the University of Reading ran 39 takeaway dishes through a mass spectrometer. Almost half the labeled ones held more salt than the menu admitted, and one pasta dish carried nearly two days&apos; worth.</description><pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>salt</category><category>sodium</category><category>takeaway</category><category>blood-pressure</category><category>food-labeling</category><category>public-health</category><author>Sarah Okonkwo</author></item><item><title>Both Groups Lost the Same Seven Kilos. Only the Calorie Counters Had to White-Knuckle It.</title><link>https://thefirstcohort.com/articles/2026-07-09-both-groups-lost-the-same-seven-kilos-only-the-calorie-counters-had-to-white-knu</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-09-both-groups-lost-the-same-seven-kilos-only-the-calorie-counters-had-to-white-knu</guid><description>In an 18-month Adelaide trial, fasting and daily calorie-cutting stripped off the same seven kilos, but for the counters part of that loss ran on constant conscious restraint the fasters&apos; scores never showed.</description><pubDate>Thu, 09 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>intermittent-fasting</category><category>weight-loss</category><category>metabolic</category><category>eating-behavior</category><category>obesity</category><category>glp-1</category><author>Sarah Okonkwo</author></item><item><title>Nearly Half of America&apos;s ER Substance-Use Visits Involve Someone the Justice System Already Booked</title><link>https://thefirstcohort.com/articles/2026-07-09-nearly-half-of-america-s-er-substance-use-visits-involve-someone-the-justice-sys</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-09-nearly-half-of-america-s-er-substance-use-visits-involve-someone-the-justice-sys</guid><description>Forty-four percent of Americans who go to an emergency room for substance use have a booking in their past. A survey of 139,524 people measured how much the jail and the ER share a population.</description><pubDate>Thu, 09 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>emergency-medicine</category><category>substance-use</category><category>mental-health</category><category>criminal-justice</category><category>public-health</category><author>Lena Marshall</author></item><item><title>A Brain Full of Plaques and a Mind That Held: The Cells That May Explain Alzheimer&apos;s Resilient Third</title><link>https://thefirstcohort.com/articles/2026-07-08-a-brain-full-of-plaques-and-a-mind-that-held-the-cells-that-may-explain-alzheime</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-08-a-brain-full-of-plaques-and-a-mind-that-held-the-cells-that-may-explain-alzheime</guid><description>About a third of people whose brains show the full pathology of Alzheimer&apos;s never develop dementia. Dutch researchers say the difference may not be how many young neurons they have, but whether those cells switch on a survival program instead of dying.</description><pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>neuroscience</category><category>brain-aging</category><category>neurogenesis</category><category>cognitive-resilience</category><author>Sarah Okonkwo</author></item><item><title>David Ho&apos;s Lab Built an Antibody to Neutralize Nearly Every Strain of HIV. Its First Test in People With the Virus Held for Two Weeks.</title><link>https://thefirstcohort.com/articles/2026-07-08-david-ho-s-lab-built-an-antibody-to-neutralize-nearly-every-strain-of-hiv-its-fi</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-08-david-ho-s-lab-built-an-antibody-to-neutralize-nearly-every-strain-of-hiv-its-fi</guid><description>Fifty-four volunteers, nine with HIV, and just three with virus still in their blood. The engineered antibody drove their viral load down as much as ninetyfold, then lost the ground within a week as it drained away.</description><pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>hiv</category><category>broadly-neutralizing-antibodies</category><category>clinical-trials</category><category>drug-development</category><category>nih-funding</category><author>Lena Marshall</author></item><item><title>For Forty Years He Said the Standard Cholesterol Target Was Wrong. A Computer Finally Agreed.</title><link>https://thefirstcohort.com/articles/2026-07-08-for-forty-years-he-said-the-standard-cholesterol-target-was-wrong-a-computer-fin</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-08-for-forty-years-he-said-the-standard-cholesterol-target-was-wrong-a-computer-fin</guid><description>A Northwestern model projects that the little-used apoB test would prevent more heart attacks and strokes than the LDL number your doctor chases. And non-HDL, a number already printed free on your standard lab report, beat LDL too. No trial has tested any of it on a patient.</description><pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>cholesterol</category><category>apob</category><category>heart-disease</category><category>statins</category><category>prevention</category><author>Lena Marshall</author></item><item><title>Pregnancy Stations Killer T Cells in the Milk Ducts, and a Decade Later They Haven&apos;t Left</title><link>https://thefirstcohort.com/articles/2026-07-08-pregnancy-stations-killer-t-cells-in-the-milk-ducts-and-a-decade-later-they-have</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-08-pregnancy-stations-killer-t-cells-in-the-milk-ducts-and-a-decade-later-they-have</guid><description>Melbourne researchers found that pregnancy stations killer T cells in the milk ducts, where they persist for at least a decade and track with better breast cancer outcomes. Now the race is on to summon them with a hormone shot instead of a pregnancy.</description><pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>cancer</category><category>breast-cancer</category><category>pregnancy</category><category>immunology</category><category>womens-health</category><author>Sarah Okonkwo</author></item><item><title>Your Retina Starts Failing Before Any Scan Can See It. Now Someone Wants to Turn That Into a Panel.</title><link>https://thefirstcohort.com/articles/2026-07-08-your-retina-starts-failing-before-any-scan-can-see-it-now-someone-wants-to-turn</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-08-your-retina-starts-failing-before-any-scan-can-see-it-now-someone-wants-to-turn</guid><description>Delayed dark adaptation flagged people who would develop early macular degeneration three years later. Now an optometrist has folded that finding into a &apos;retinal reserve&apos; framework, bloodwork and all, that no trial has tested.</description><pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>retinal reserve</category><category>dark adaptation</category><category>macular degeneration</category><category>early detection</category><category>functional testing</category><author>Lena Marshall</author></item><item><title>In Mice, Early Stress-Drinking Corroded a Brain Region a Long Sobriety Couldn&apos;t Repair</title><link>https://thefirstcohort.com/articles/2026-07-07-in-mice-early-stress-drinking-corroded-a-brain-region-a-long-sobriety-couldn-t-r</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-07-in-mice-early-stress-drinking-corroded-a-brain-region-a-long-sobriety-couldn-t-r</guid><description>In mice, pairing alcohol with stress in early adulthood damaged a tiny noradrenaline hub in the brainstem, and a prolonged stretch of abstinence didn&apos;t reverse it. The cognitive cost surfaced in middle age.</description><pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alcohol</category><category>brain-aging</category><category>stress</category><category>cognitive-decline</category><category>neuroscience</category><author>Sarah Okonkwo</author></item><item><title>Old Muscle Forgets How to Clean Itself. A Gene Called DEAF1 Is Why, and Exercise Silences It.</title><link>https://thefirstcohort.com/articles/2026-07-07-old-muscle-forgets-how-to-clean-itself-a-gene-called-deaf1-is-why-and-exercise-s</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-07-old-muscle-forgets-how-to-clean-itself-a-gene-called-deaf1-is-why-and-exercise-s</guid><description>In aging muscle one gene keeps the growth pathway jammed on and the cleanup crew locked out. Exercise suppresses it in flies and mice, no pill required.</description><pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>muscle aging</category><category>exercise</category><category>longevity</category><category>mtorc1</category><category>sarcopenia</category><category>autophagy</category><author>Sarah Okonkwo</author></item><item><title>The Kratom Crackdown Its Biggest Trade Defenders Wanted</title><link>https://thefirstcohort.com/articles/2026-07-07-the-kratom-crackdown-its-biggest-trade-defenders-wanted</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-07-the-kratom-crackdown-its-biggest-trade-defenders-wanted</guid><description>A concentrated 7-OH compound reported at up to 40 times morphine&apos;s receptor potency is sold in gas stations as herbal kratom. The plant&apos;s biggest trade defenders are cheering the DEA for banning it.</description><pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>medical-research</category><author>Sarah Okonkwo</author></item><item><title>The Nose-Spray TB Vaccine in Your Feed This Week Has Only Ever Worked in Mice</title><link>https://thefirstcohort.com/articles/2026-07-07-the-nose-spray-tb-vaccine-in-your-feed-this-week-has-only-ever-worked-in-mice</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-07-the-nose-spray-tb-vaccine-in-your-feed-this-week-has-only-ever-worked-in-mice</guid><description>Johns Hopkins fused two genes into a nasal spray, added it to a drug cocktail, and cleared tuberculosis faster in mice. DNA vaccines have dazzled mice for thirty years and disappointed humans nearly every time. This one has not been in a person yet.</description><pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>tuberculosis</category><category>dna-vaccine</category><category>preclinical</category><category>johns-hopkins</category><category>infectious-disease</category><category>vaccine-hype</category><author>Lena Marshall</author></item><item><title>Whether a T Cell Keeps Killing Cancer or Quits Is Written in How Its Genome Folds</title><link>https://thefirstcohort.com/articles/2026-07-07-whether-a-t-cell-keeps-killing-cancer-or-quits-is-written-in-how-its-genome-fold</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-07-whether-a-t-cell-keeps-killing-cancer-or-quits-is-written-in-how-its-genome-fold</guid><description>Exhausted CD8 T cells are why checkpoint drugs and CAR-T so often stall. New maps of the 3D genome show their fate is set by how the DNA is physically folded, and by CTCF, the protein that does the folding.</description><pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>immunotherapy</category><category>t-cell-exhaustion</category><category>epigenetics</category><category>cancer</category><category>cell-biology</category><category>car-t</category><author>Sarah Okonkwo</author></item><item><title>A Michigan Lab Grew a Living Skull Joint That Wouldn&apos;t Fuse. In Mice, It Held.</title><link>https://thefirstcohort.com/articles/2026-07-06-a-michigan-lab-grew-a-living-skull-joint-that-wouldn-t-fuse-in-mice-it-held</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-06-a-michigan-lab-grew-a-living-skull-joint-that-wouldn-t-fuse-in-mice-it-held</guid><description>Craniosynostosis surgery reopens a fused infant skull; in some of the hardest cases it fuses right back and the child goes under the knife again. A triphasic scaffold kept the joint open in mice.</description><pubDate>Mon, 06 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>craniosynostosis</category><category>tissue-engineering</category><category>regenerative-medicine</category><category>stem-cells</category><category>pediatric-surgery</category><category>skull</category><author>Lena Marshall</author></item><item><title>Longevity Clinics Sell Growth Hormone by the Vial. In Deep Sleep, Your Brain Makes It Free.</title><link>https://thefirstcohort.com/articles/2026-07-06-longevity-clinics-sell-growth-hormone-by-the-vial-in-deep-sleep-your-brain-makes</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-06-longevity-clinics-sell-growth-hormone-by-the-vial-in-deep-sleep-your-brain-makes</guid><description>The muscle-building, fat-burning hormone that anti-aging clinics inject at a premium is the same one your hypothalamus releases every night you reach deep sleep. Berkeley mapped how, in mice, and the headline is already running ahead of the biology.</description><pubDate>Mon, 06 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>sleep</category><category>growth hormone</category><category>metabolism</category><category>neuroscience</category><category>longevity</category><author>Sarah Okonkwo</author></item><item><title>NEJM Retracted the Study That Approved Amgen&apos;s Vasculitis Drug. It Had Never Done That in 200 Years.</title><link>https://thefirstcohort.com/articles/2026-07-06-nejm-retracted-the-study-that-approved-amgen-s-vasculitis-drug-it-had-never-done</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-06-nejm-retracted-the-study-that-approved-amgen-s-vasculitis-drug-it-had-never-done</guid><description>The FDA says the drug&apos;s superiority result came from re-scoring nine patients after the trial was unblinded. It is still on U.S. shelves while Amgen fights the withdrawal.</description><pubDate>Mon, 06 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>retraction</category><category>fda</category><category>ema</category><category>clinical-trials</category><category>data-integrity</category><category>pharma</category><author>Mira Petrov</author></item><item><title>Australia Switched Off Social Media for a Generation of Kids. Nepal Already Ran That Experiment.</title><link>https://thefirstcohort.com/articles/2026-07-05-australia-switched-off-social-media-for-a-generation-of-kids-nepal-already-ran-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-05-australia-switched-off-social-media-for-a-generation-of-kids-nepal-already-ran-t</guid><description>The ban is sold as youth mental-health protection, but its own university researchers call the harm evidence overblown, and the one nation that already banned a platform got ID checks and VPN workarounds, not healthier kids.</description><pubDate>Sun, 05 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>social-media-ban</category><category>youth-mental-health</category><category>age-verification</category><category>digital-id</category><category>australia</category><author>Lena Marshall</author></item><item><title>Five Years After COVID, Japan Is Still Dying at Pandemic Rates, and Confirmed COVID Explains Only a Tenth</title><link>https://thefirstcohort.com/articles/2026-07-05-five-years-after-covid-japan-is-still-dying-at-pandemic-rates-and-confirmed-covi</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-05-five-years-after-covid-japan-is-still-dying-at-pandemic-rates-and-confirmed-covi</guid><description>Japan&apos;s excess deaths peaked at 7.55 percent in 2022 and still ran at 5.76 percent through 2023, after Tokyo downgraded COVID to a routine infectious disease, in one of the most heavily mRNA-dosed countries on earth.</description><pubDate>Sun, 05 Jul 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>covid</category><category>excess-mortality</category><category>japan</category><category>mrna-vaccines</category><category>public-health</category><author>Marcus Chen</author></item><item><title>The Box-and-Banana Test Was Built for Apes. A Bumble Bee Worked It Out on Its Own.</title><link>https://thefirstcohort.com/articles/2026-07-05-the-box-and-banana-test-was-built-for-apes-a-bumble-bee-worked-it-out-on-its-own</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-05-the-box-and-banana-test-was-built-for-apes-a-bumble-bee-worked-it-out-on-its-own</guid><description>Researchers in Finland trained bumble bees on two unrelated facts, a flower with sugar and a ball that rolls. With the flower moved out of reach, the bees combined the two into a solution nobody had shown them, on a task built for apes.</description><pubDate>Sun, 05 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>cognition</category><category>neuroscience</category><category>animal-intelligence</category><category>problem-solving</category><category>insects</category><author>Sarah Okonkwo</author></item><item><title>Against Omicron, a Second COVID Dose Added Almost Nothing for Kids Who Were Already Infected</title><link>https://thefirstcohort.com/articles/2026-07-04-against-omicron-a-second-covid-dose-added-almost-nothing-for-kids-who-were-alrea</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-04-against-omicron-a-second-covid-dose-added-almost-nothing-for-kids-who-were-alrea</guid><description>In Austria&apos;s own registry, one dose protected previously infected people slightly better than two; in children against the omicron they actually faced, the second dose&apos;s benefit could not be told apart from zero. The guidance never moved.</description><pubDate>Sat, 04 Jul 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>covid-19</category><category>natural immunity</category><category>children</category><category>hybrid immunity</category><category>vaccine policy</category><author>Marcus Chen</author></item><item><title>For Decades They Treated This Stroke Like a Clog. The Arteries Were Actually Too Wide.</title><link>https://thefirstcohort.com/articles/2026-07-04-for-decades-they-treated-this-stroke-like-a-clog-the-arteries-were-actually-too</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-04-for-decades-they-treated-this-stroke-like-a-clog-the-arteries-were-actually-too</guid><description>People with widened brain arteries were four times more likely to have had a lacunar stroke, the type doctors have treated for decades as if it were a clog.</description><pubDate>Sat, 04 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>stroke</category><category>small-vessel-disease</category><category>brain-aging</category><category>dementia</category><category>generic-drugs</category><category>neurology</category><author>Sarah Okonkwo</author></item><item><title>Switch Off One Protein Called Mitch, and Cells Start Eating Their Own Fat</title><link>https://thefirstcohort.com/articles/2026-07-04-switch-off-one-protein-called-mitch-and-cells-start-eating-their-own-fat</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-04-switch-off-one-protein-called-mitch-and-cells-start-eating-their-own-fat</guid><description>Women with obesity carry more of it. Disable it in mice and they turn lean and muscular at once, the opposite of what the injectable weight-loss drugs do to your body.</description><pubDate>Sat, 04 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>obesity</category><category>glp-1</category><category>mitochondria</category><category>metabolism</category><category>muscle</category><category>weight-loss</category><author>Sarah Okonkwo</author></item><item><title>The Last Time Washington Went After Hospital Drug Markups, the Supreme Court Blocked It. This Time CMS Brought Receipts.</title><link>https://thefirstcohort.com/articles/2026-07-04-the-last-time-washington-went-after-hospital-drug-markups-the-supreme-court-bloc</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-04-the-last-time-washington-went-after-hospital-drug-markups-the-supreme-court-bloc</guid><description>In 2018 the Supreme Court blocked CMS from cutting the markup 340B hospitals charge Medicare for discounted drugs, because the agency skipped a required survey. CMS ran the survey this time, and found seniors paying co-pays bigger than what the hospital paid for the drug.</description><pubDate>Sat, 04 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>medicare</category><category>340b</category><category>drug-pricing</category><category>hospitals</category><category>cms</category><category>part-b</category><author>Marcus Chen</author></item><item><title>The FDA Cleared a Sickle-Cell Cure for Two-Year-Olds in 53 Days. It Starts With Chemo That Can Sterilize Them.</title><link>https://thefirstcohort.com/articles/2026-07-03-the-fda-cleared-a-sickle-cell-cure-for-two-year-olds-in-53-days-it-starts-with-c</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-03-the-fda-cleared-a-sickle-cell-cure-for-two-year-olds-in-53-days-it-starts-with-c</guid><description>Casgevy is a real advance against a brutal disease. It is also a $2.2 million therapy that requires sterilizing chemotherapy, saw a child die in trials, and reached toddlers on a 53-day review Makary&apos;s FDA hands out as a favor.</description><pubDate>Fri, 03 Jul 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>sickle-cell</category><category>gene-therapy</category><category>fda</category><category>casgevy</category><category>crispr</category><category>regulatory-voucher</category><author>Lena Marshall</author></item><item><title>Two Journals That Buried the Lab-Leak Question Now Warn of a &apos;Gilded Age&apos; in American Science</title><link>https://thefirstcohort.com/articles/2026-07-03-two-journals-that-buried-the-lab-leak-question-now-warn-of-a-gilded-age-in-ameri</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-03-two-journals-that-buried-the-lab-leak-question-now-warn-of-a-gilded-age-in-ameri</guid><description>The Lancet and Science marked America&apos;s 250th by casting the administration&apos;s research cuts as vandalism. Both journals spent the public trust they now invoke, and the editorials never mention how.</description><pubDate>Fri, 03 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>nih</category><category>science-funding</category><category>lancet</category><category>covid-origins</category><category>regulatory-capture</category><category>public-trust</category><author>Marcus Chen</author></item><item><title>A Juice Company Built a Department Inside a Japanese University. Its Scientists Just Found Vitamin C Guards the Aging Brain.</title><link>https://thefirstcohort.com/articles/2026-07-02-a-juice-company-built-a-department-inside-a-japanese-university-its-scientists-j</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-02-a-juice-company-built-a-department-inside-a-japanese-university-its-scientists-j</guid><description>Kagome, Japan&apos;s largest vegetable-juice maker, funded the work, employs two of its authors, and measured the vitamin itself. The gray-matter correlation it reported is real, and small enough to miss.</description><pubDate>Thu, 02 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>vitamin c</category><category>brain aging</category><category>conflict of interest</category><category>nutrition</category><category>observational study</category><author>Lena Marshall</author></item><item><title>Alzheimer&apos;s Hitches a Ride on a Virus Your Neurons Tamed for Memory</title><link>https://thefirstcohort.com/articles/2026-07-02-alzheimer-s-hitches-a-ride-on-a-virus-your-neurons-tamed-for-memory</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-02-alzheimer-s-hitches-a-ride-on-a-virus-your-neurons-tamed-for-memory</guid><description>In mice and in human Alzheimer&apos;s brains, toxic tau rides a protein called Arc, a virus your neurons domesticated for memory, from sick cells into healthy ones. Delete Arc and the spread nearly stops.</description><pubDate>Thu, 02 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>tau</category><category>neuroscience</category><category>brain-aging</category><category>extracellular-vesicles</category><category>arc</category><author>Sarah Okonkwo</author></item><item><title>Kennedy Ended the COVID Emergency Authorizations. The Document That Blocks Injury Lawsuits Wasn&apos;t the One He Signed.</title><link>https://thefirstcohort.com/articles/2026-07-02-kennedy-ended-the-covid-emergency-authorizations-the-document-that-blocks-injury</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-02-kennedy-ended-the-covid-emergency-authorizations-the-document-that-blocks-injury</guid><description>The emergency use authorizations wind down within a year. The liability shield that routes injured people to a program denying more than 98% of claims runs untouched through 2029.</description><pubDate>Thu, 02 Jul 2026 00:00:00 GMT</pubDate><category>investigations</category><category>prep-act</category><category>covid</category><category>liability</category><category>vaccine-injury</category><category>cicp</category><category>rfk-jr</category><author>Mira Petrov</author></item><item><title>Obesity Stopped Denting Older Adults&apos; Metabolic Numbers: In the Young It&apos;s Biting Harder Than Ever</title><link>https://thefirstcohort.com/articles/2026-07-02-obesity-stopped-denting-older-adults-metabolic-numbers-in-the-young-it-s-biting</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-02-obesity-stopped-denting-older-adults-metabolic-numbers-in-the-young-it-s-biting</guid><description>For middle-aged and older adults, extra weight no longer tracks with the cardiovascular damage it once did. For the young, the same fat is biting harder and earlier. The lab panels converged; the fat didn&apos;t.</description><pubDate>Thu, 02 Jul 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>obesity</category><category>metabolic-health</category><category>bmi</category><category>visceral-fat</category><category>cardiovascular-risk</category><category>glp-1</category><author>Sarah Okonkwo</author></item><item><title>One Protein Keeps Your T Cells in the Fight. The Same Protein Feeds Autoimmune Disease.</title><link>https://thefirstcohort.com/articles/2026-07-02-one-protein-keeps-your-t-cells-in-the-fight-the-same-protein-feeds-autoimmune-di</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-02-one-protein-keeps-your-t-cells-in-the-fight-the-same-protein-feeds-autoimmune-di</guid><description>In mice, deleting the LEF1 gene collapsed the reserve T cells that sustain the fight against chronic infection and cancer. The same deletion protected against autoimmune diabetes.</description><pubDate>Thu, 02 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>t-cells</category><category>immunotherapy</category><category>car-t</category><category>autoimmunity</category><category>cancer</category><author>Marcus Chen</author></item><item><title>Lead Strips Dopamine From the Exact Brain Circuit ADHD Drugs Are Built to Rescue</title><link>https://thefirstcohort.com/articles/2026-07-01-lead-strips-dopamine-from-the-exact-brain-circuit-adhd-drugs-are-built-to-rescue</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-01-lead-strips-dopamine-from-the-exact-brain-circuit-adhd-drugs-are-built-to-rescue</guid><description>Childhood lead keeps landing on the same target: the striatal dopamine circuit that ADHD drugs are built to rescue. A Philadelphia cohort just tied it to real diagnoses, not test scores.</description><pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>lead</category><category>adhd</category><category>children</category><category>neurotoxicity</category><category>dopamine</category><category>environmental-health</category><author>Sarah Okonkwo</author></item><item><title>No Gene Editing, No Catheter Into the Skull: A Pediatric Brain-Cancer T-Cell Trial Reported One Complete Response in 33 Young Patients</title><link>https://thefirstcohort.com/articles/2026-07-01-no-gene-editing-no-catheter-into-the-skull-a-pediatric-brain-cancer-t-cell-trial</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-01-no-gene-editing-no-catheter-into-the-skull-a-pediatric-brain-cancer-t-cell-trial</guid><description>Children with diffuse pontine glioma rarely live past a year. A first-in-human trial infused 33 young patients with pediatric brain tumors, including DIPG, with T cells trained on three tumor proteins, no genetic engineering, and reported one complete response and three survivors still alive years l</description><pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate><category>cancer</category><category>pediatric-oncology</category><category>dipg</category><category>cell-therapy</category><category>immunotherapy</category><category>brain-tumors</category><category>clinical-trials</category><author>Lena Marshall</author></item><item><title>Senescence Built Your Hands Before It Ever Aged Your Skin</title><link>https://thefirstcohort.com/articles/2026-07-01-senescence-built-your-hands-before-it-ever-aged-your-skin</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-07-01-senescence-built-your-hands-before-it-ever-aged-your-skin</guid><description>Cellular senescence, the process blamed for aging and disease, is also how an embryo sculpts fingers and clears its own tissue. That double life scrambles the anti-aging industry&apos;s tidy &apos;kill the zombie cells&apos; pitch.</description><pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>senescence</category><category>embryology</category><category>aging</category><category>fertility</category><category>cell-biology</category><category>longevity</category><author>Sarah Okonkwo</author></item><item><title>A Federally Backed Trial Got High-Dose Fish Oil Into the Brain Fluid. The Memory Scores Never Moved.</title><link>https://thefirstcohort.com/articles/2026-06-30-a-federally-backed-trial-got-high-dose-fish-oil-into-the-brain-fluid-the-memory</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-30-a-federally-backed-trial-got-high-dose-fish-oil-into-the-brain-fluid-the-memory</guid><description>DHA in the spinal fluid climbed 17 percent. Cognitive scores rose 2.76 points on fish oil, 2.67 on placebo. Two years of high-dose pills bought a rounding error.</description><pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>omega-3</category><category>fish-oil</category><category>alzheimers</category><category>brain-aging</category><category>supplements</category><category>dha</category><author>Sarah Okonkwo</author></item><item><title>A Road Made From Recycled Fishing Nets Shed Less Microplastic Than the Tires Rolling Over It</title><link>https://thefirstcohort.com/articles/2026-06-30-a-road-made-from-recycled-fishing-nets-shed-less-microplastic-than-the-tires-rol</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-30-a-road-made-from-recycled-fishing-nets-shed-less-microplastic-than-the-tires-rol</guid><description>Hawaii scientists laid ocean-net plastic into a real Oahu street, then measured what came off. The recycled plastic barely registered. Tire wear, the source almost nobody regulates, swamped it by orders of magnitude.</description><pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>microplastics</category><category>tire-wear</category><category>ocean-plastic</category><category>recycling</category><category>environmental-health</category><category>6ppd</category><author>Sarah Okonkwo</author></item><item><title>Group Mindfulness Beat Standard Back-Pain Care for a Full Year, No Prescription Required</title><link>https://thefirstcohort.com/articles/2026-06-30-group-mindfulness-beat-standard-back-pain-care-for-a-full-year-no-prescription-r</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-30-group-mindfulness-beat-standard-back-pain-care-for-a-full-year-no-prescription-r</guid><description>Boston researchers taught 451 patients to work with their pain instead of medicating it, and the gains outlasted the program. The university&apos;s press release skipped the part where the edge over usual care fell short of the bar the team set for itself.</description><pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>chronic-pain</category><category>mindfulness</category><category>back-pain</category><category>non-pharmacological</category><category>nih-funding</category><author>Sarah Okonkwo</author></item><item><title>The FDA Office That Vets Gene Therapy Has Run Through Its Entire Top Tier in a Year</title><link>https://thefirstcohort.com/articles/2026-06-30-the-fda-office-that-vets-gene-therapy-has-run-through-its-entire-top-tier-in-a-y</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-30-the-fda-office-that-vets-gene-therapy-has-run-through-its-entire-top-tier-in-a-y</guid><description>The office that decides whether gene therapies reach patients has lost its director, her deputy, and the man brought in to replace them, all inside twelve months.</description><pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>gene-therapy</category><category>regulatory-capture</category><category>cber</category><category>drug-safety</category><category>sarepta</category><author>Lena Marshall</author></item><item><title>A Federal Court Put This Pesticide Back on Your Food. UCLA Just Showed It More Than Doubles Parkinson&apos;s Risk.</title><link>https://thefirstcohort.com/articles/2026-06-29-a-federal-court-put-this-pesticide-back-on-your-food-ucla-just-showed-it-more-th</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-a-federal-court-put-this-pesticide-back-on-your-food-ucla-just-showed-it-more-th</guid><description>Chlorpyrifos was pulled from American homes in 2001 and ordered off food crops in 2021. A manufacturer sued, won, and it&apos;s back on apples and strawberries while the science against it gets stronger.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>parkinsons</category><category>chlorpyrifos</category><category>pesticides</category><category>dopamine</category><category>autophagy</category><category>epa</category><author>Sarah Okonkwo</author></item><item><title>Europe Called Medical AI &apos;High Risk&apos; and Still Gave Patients No Right to Refuse It</title><link>https://thefirstcohort.com/articles/2026-06-29-europe-called-medical-ai-high-risk-and-still-gave-patients-no-right-to-refuse-it</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-europe-called-medical-ai-high-risk-and-still-gave-patients-no-right-to-refuse-it</guid><description>An algorithm once cut the extra care flagged for Black patients by more than half, and ran for years before anyone noticed. A commentary in the Journal of the Royal Society of Medicine says the rules now governing medical AI would not have caught it.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>medical-ai</category><category>ai-regulation</category><category>patient-rights</category><category>algorithmic-bias</category><category>eu-ai-act</category><author>Marcus Chen</author></item><item><title>For Twenty Years, a Vitamin B12 Cancer Drug Has Worked in Mice, Dogs, and Rats. It Still Hasn&apos;t Reached a Human Trial.</title><link>https://thefirstcohort.com/articles/2026-06-29-for-twenty-years-a-vitamin-b12-cancer-drug-has-worked-in-mice-dogs-and-rats-it-s</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-for-twenty-years-a-vitamin-b12-cancer-drug-has-worked-in-mice-dogs-and-rats-it-s</guid><description>Nitrosylcobalamin crossed the blood-brain barrier and pooled in a rat&apos;s brain tumor. This study didn&apos;t shrink one, the synergy ran in a petri dish, and the scientist behind the headlines holds the patents.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>glioblastoma</category><category>vitamin-b12</category><category>brain-cancer</category><category>preclinical</category><category>research-hype</category><author>Lena Marshall</author></item><item><title>The FDA Pulled Infigratinib as a Cancer Drug in 2024. It Just Passed Phase 3 in Children With Dwarfism.</title><link>https://thefirstcohort.com/articles/2026-06-29-the-fda-pulled-infigratinib-as-a-cancer-drug-in-2024-it-just-passed-phase-3-in-c</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-the-fda-pulled-infigratinib-as-a-cancer-drug-in-2024-it-just-passed-phase-3-in-c</guid><description>The FDA pulled infigratinib as a failed cancer drug in 2024. Now its maker says the same pill grows children with dwarfism faster, on a surrogate no one has yet shown reaches adulthood.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>achondroplasia</category><category>infigratinib</category><category>fgfr3</category><category>surrogate-endpoints</category><category>bridgebio</category><category>drug-repurposing</category><author>Lena Marshall</author></item><item><title>The FDA&apos;s Fix for a $10 Billion Flood of Chinese Vapes Is a Form the Smugglers Will Ignore</title><link>https://thefirstcohort.com/articles/2026-06-29-the-fda-s-fix-for-a-10-billion-flood-of-chinese-vapes-is-a-form-the-smugglers-wi</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-the-fda-s-fix-for-a-10-billion-flood-of-chinese-vapes-is-a-form-the-smugglers-wi</guid><description>Foreign manufacturers ship most of America&apos;s vapes and falsify the customs forms to do it. Washington&apos;s answer is to ask them to register with the agency they already evade.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>tobacco</category><category>e-cigarettes</category><category>fda</category><category>china</category><category>youth-vaping</category><category>regulation</category><author>Marcus Chen</author></item><item><title>The Same System Now Racing to Test a Bundibugyo Ebola Vaccine Had Nineteen Years to Build One</title><link>https://thefirstcohort.com/articles/2026-06-29-the-same-system-now-racing-to-test-a-bundibugyo-ebola-vaccine-had-nineteen-years</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-the-same-system-now-racing-to-test-a-bundibugyo-ebola-vaccine-had-nineteen-years</guid><description>Bundibugyo Ebola was identified in 2007. By the time this year&apos;s outbreak passed 1,200 cases there was still no licensed vaccine and none in clinical development. Now roughly $75 million is moving to test three experimental shots on the people dying from it.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>ebola</category><category>bundibugyo</category><category>vaccines</category><category>barda</category><category>outbreak-preparedness</category><category>public-health</category><author>Marcus Chen</author></item><item><title>The Standard Treatment for Nerve Damage Was Never Built to Repair a Nerve</title><link>https://thefirstcohort.com/articles/2026-06-29-the-standard-treatment-for-nerve-damage-was-never-built-to-repair-a-nerve</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-the-standard-treatment-for-nerve-damage-was-never-built-to-repair-a-nerve</guid><description>Gabapentin is the seventh most prescribed drug in America, handed out for neuropathy it was never shown to reverse. A retired researcher&apos;s drug-free protocol asks the question the pharmacy aisle can&apos;t: what if you removed the cause instead?</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>peripheral-neuropathy</category><category>gabapentin</category><category>diabetic-neuropathy</category><category>metformin</category><category>root-cause</category><category>drug-free</category><author>Lena Marshall</author></item><item><title>Twenty Years of Nothing on Brain Cancer, and the Best New Lead Is a Vitamin Nobody Can Patent</title><link>https://thefirstcohort.com/articles/2026-06-29-twenty-years-of-nothing-on-brain-cancer-and-the-best-new-lead-is-a-vitamin-nobod</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-29-twenty-years-of-nothing-on-brain-cancer-and-the-best-new-lead-is-a-vitamin-nobod</guid><description>A University of Calgary trial added high-dose niacin to standard glioblastoma treatment and reported 82% of 24 patients progression-free at six months. The design is single-arm and early, but the molecule is a cheap, unpatentable vitamin.</description><pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>glioblastoma</category><category>niacin</category><category>immunotherapy</category><category>brain-cancer</category><category>clinical-trials</category><author>Lena Marshall</author></item><item><title>Fibrolamellar Carcinoma Hides Immune Cells in Scar Tissue. A Drug Approved in 2008 Pulled Them Back Out.</title><link>https://thefirstcohort.com/articles/2026-06-28-fibrolamellar-carcinoma-hides-immune-cells-in-scar-tissue-a-drug-approved-in-200</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-fibrolamellar-carcinoma-hides-immune-cells-in-scar-tissue-a-drug-approved-in-200</guid><description>Fibrolamellar carcinoma mostly kills young adults, and checkpoint immunotherapy bounces off it. Researchers found the tumor herds T cells into fibrous bands, and a drug shelved for stem-cell work since 2008 freed them in patient tissue. No human trial has started.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>fibrolamellar-carcinoma</category><category>liver-cancer</category><category>immunotherapy</category><category>drug-repurposing</category><category>plerixafor</category><category>cxcr4</category><author>Lena Marshall</author></item><item><title>For Forty Years, Margarine Was the &apos;Healthy&apos; Choice. The Chemistry Was Never on Its Side.</title><link>https://thefirstcohort.com/articles/2026-06-28-for-forty-years-margarine-was-the-healthy-choice-the-chemistry-was-never-on-its</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-for-forty-years-margarine-was-the-healthy-choice-the-chemistry-was-never-on-its</guid><description>The spread your doctor pushed for decades delivered trans fats, then got rebuilt with a modified fat that raised fasting glucose 22 percent in one trial. Butter, the supposed villain, turned out roughly neutral for your heart.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>margarine</category><category>butter</category><category>seed-oils</category><category>ultraprocessed</category><category>trans-fats</category><category>saturated-fat</category><author>Sarah Okonkwo</author></item><item><title>Same Calories, Different Wiring: Why Fructose Leaves Your Hunger Neurons Running</title><link>https://thefirstcohort.com/articles/2026-06-28-same-calories-different-wiring-why-fructose-leaves-your-hunger-neurons-running</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-same-calories-different-wiring-why-fructose-leaves-your-hunger-neurons-running</guid><description>Glucose flips off the brain cells that drive hunger. Fructose barely nudges them, and the corn-syrup blend in your soda quiets them even better, which is exactly why it&apos;s so easy to keep drinking.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>fructose</category><category>high-fructose-corn-syrup</category><category>metabolic</category><category>gut-brain-axis</category><category>appetite</category><category>obesity</category><author>Sarah Okonkwo</author></item><item><title>The Belly Fat You Gain After 40 Comes From a Cell That Barely Existed in Your Twenties</title><link>https://thefirstcohort.com/articles/2026-06-28-the-belly-fat-you-gain-after-40-comes-from-a-cell-that-barely-existed-in-your-tw</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-the-belly-fat-you-gain-after-40-comes-from-a-cell-that-barely-existed-in-your-tw</guid><description>Transplant old fat stem cells into a young mouse and they keep churning out fat; young ones in an old mouse stay quiet. In mice, the fat-making program travels with the cell, not the body around it.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>belly fat</category><category>aging</category><category>metabolic</category><category>stem cells</category><category>longevity</category><category>obesity</category><author>Sarah Okonkwo</author></item><item><title>The Gut Lining Starves Salmonella of Iron, a Trick We Thought Only Immune Cells Knew</title><link>https://thefirstcohort.com/articles/2026-06-28-the-gut-lining-starves-salmonella-of-iron-a-trick-we-thought-only-immune-cells-k</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-the-gut-lining-starves-salmonella-of-iron-a-trick-we-thought-only-immune-cells-k</guid><description>Salmonella sickens more than a million Americans a year. University of Vermont researchers found the cells it invades fight back by withholding the iron and manganese the bacteria need, a defense the textbooks credited mainly to immune cells.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>salmonella</category><category>nutritional-immunity</category><category>infectious-disease</category><category>iron</category><category>food-safety</category><author>Marcus Chen</author></item><item><title>The WHO Invented Osteopenia for Statisticians. Merck Turned It Into 34 Million Patients.</title><link>https://thefirstcohort.com/articles/2026-06-28-the-who-invented-osteopenia-for-statisticians-merck-turned-it-into-34-million-pa</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-the-who-invented-osteopenia-for-statisticians-merck-turned-it-into-34-million-pa</guid><description>The man who chaired the 1992 WHO meeting says they never imagined osteopenia would be treated as a disease. Three years later Merck launched Fosamax and started putting bone scanners in doctors&apos; offices.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>osteopenia</category><category>bone-density</category><category>disease-mongering</category><category>merck</category><category>fosamax</category><category>bisphosphonates</category><author>Lena Marshall</author></item><item><title>Your Brain Has 170 Billion Cells and No Blueprint. Here&apos;s How One Cell Pulls It Off.</title><link>https://thefirstcohort.com/articles/2026-06-28-your-brain-has-170-billion-cells-and-no-blueprint-here-s-how-one-cell-pulls-it-o</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-28-your-brain-has-170-billion-cells-and-no-blueprint-here-s-how-one-cell-pulls-it-o</guid><description>For fifty years the textbook said chemical gradients tell brain cells where to go. A new model says cells inherit their address from their family tree instead.</description><pubDate>Sun, 28 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>neuroscience</category><category>brain-development</category><category>cell-biology</category><category>neurons</category><category>developmental-biology</category><author>Sarah Okonkwo</author></item><item><title>Most of These Ebola Patients Aren&apos;t Bleeding. That&apos;s Why It&apos;s Spreading.</title><link>https://thefirstcohort.com/articles/2026-06-26-most-of-these-ebola-patients-aren-t-bleeding-that-s-why-it-s-spreading</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-26-most-of-these-ebola-patients-aren-t-bleeding-that-s-why-it-s-spreading</guid><description>A Bundibugyo virus outbreak in DRC and Uganda has topped 1,100 confirmed cases, yet roughly nine in ten patients show no bleeding, the symptom everyone is trained to look for.</description><pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>ebola</category><category>bundibugyo</category><category>infectious-disease</category><category>public-health</category><category>outbreak</category><category>who</category><author>Marcus Chen</author></item><item><title>Most People&apos;s Bodies Quietly Beat TB. The Ones Who Lose Are Drowning Their Own T Cells.</title><link>https://thefirstcohort.com/articles/2026-06-26-most-people-s-bodies-quietly-beat-tb-the-ones-who-lose-are-drowning-their-own-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-26-most-people-s-bodies-quietly-beat-tb-the-ones-who-lose-are-drowning-their-own-t</guid><description>A new single-cell study of the airways of TB-exposed people finds that progression to disease tracks with a neutrophil flood that smothers protective T cells, with type I interferon as the switch.</description><pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>tuberculosis</category><category>immunology</category><category>neutrophils</category><category>interferon</category><category>infectious-disease</category><category>t-cells</category><author>Sarah Okonkwo</author></item><item><title>The Immune System&apos;s Guardrails Were Too Rare to Study. A Bonn Lab Just Grew Them in a Dish.</title><link>https://thefirstcohort.com/articles/2026-06-26-the-immune-system-s-guardrails-were-too-rare-to-study-a-bonn-lab-just-grew-them</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-26-the-immune-system-s-guardrails-were-too-rare-to-study-a-bonn-lab-just-grew-them</guid><description>A German lab built a way to grow follicular regulatory T cells from precursors in a dish, opening a notoriously hard-to-study brake on antibody production to direct experiment.</description><pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>medical-research</category><author>Lena Marshall</author></item><item><title>They Call It Aging. Sometimes It&apos;s a Vitamin Your Doctor Forgot to Check.</title><link>https://thefirstcohort.com/articles/2026-06-26-they-call-it-aging-sometimes-it-s-a-vitamin-your-doctor-forgot-to-check</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-26-they-call-it-aging-sometimes-it-s-a-vitamin-your-doctor-forgot-to-check</guid><description>New Cornell research explains how B12 deficiency starves muscle of energy, and why the standard test your doctor orders can call the problem aging.</description><pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>vitamin-b12</category><category>aging</category><category>mitochondria</category><category>nutrition</category><category>muscle</category><author>Lena Marshall</author></item><item><title>They Told Older Adults the Pill Was Fake. Their Memory Got Better Anyway.</title><link>https://thefirstcohort.com/articles/2026-06-26-they-told-older-adults-the-pill-was-fake-their-memory-got-better-anyway</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-26-they-told-older-adults-the-pill-was-fake-their-memory-got-better-anyway</guid><description>A 90-person Italian trial gave older adults inert pills and told one group flat-out they were fake. That group improved as much as the deceived one. Here is what that does and doesn&apos;t prove.</description><pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>placebo</category><category>longevity</category><category>cognition</category><category>aging</category><category>mind-body</category><author>Sarah Okonkwo</author></item><item><title>His Heart Was Pumping at 10 Percent. The Real Question Is Why It Took an Algorithm to Notice.</title><link>https://thefirstcohort.com/articles/2026-06-25-his-heart-was-pumping-at-10-percent-the-real-question-is-why-it-took-an-algorith</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-25-his-heart-was-pumping-at-10-percent-the-real-question-is-why-it-took-an-algorith</guid><description>An AI tool flagged a 45-year-old&apos;s hidden heart failure and the story became &apos;AI beats your doctor.&apos; The case actually documents a missed standard workup, and it dropped the same week as the FDA clearance.</description><pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>ai-diagnostics</category><category>heart-failure</category><category>ecg</category><category>medical-hype</category><category>fda</category><author>Sarah Okonkwo</author></item><item><title>Summer Sun Won&apos;t Save You: A Vitamin D Study Funded by the People Who Sell the Spray</title><link>https://thefirstcohort.com/articles/2026-06-25-summer-sun-won-t-save-you-a-vitamin-d-study-funded-by-the-people-who-sell-the-sp</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-25-summer-sun-won-t-save-you-a-vitamin-d-study-funded-by-the-people-who-sell-the-sp</guid><description>A Newcastle screening study found vitamin D deficiency persists through summer in older and ethnic-minority adults in northern Britain. The funder sells the fix.</description><pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>vitamin-d</category><category>supplements</category><category>nutrition</category><category>public-health</category><category>conflict-of-interest</category><category>deficiency</category><author>Lena Marshall</author></item><item><title>The Gene That Decides Whether Smoggy Air Wrecks Your Lungs</title><link>https://thefirstcohort.com/articles/2026-06-25-the-gene-that-decides-whether-smoggy-air-wrecks-your-lungs</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-25-the-gene-that-decides-whether-smoggy-air-wrecks-your-lungs</guid><description>A University of Pittsburgh study of nearly 1,000 asthma patients pinpoints seven oxidative-stress genes that decide how badly dirty air damages the lungs.</description><pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>asthma</category><category>air-pollution</category><category>oxidative-stress</category><category>genetics</category><category>lung-function</category><category>pm25</category><author>Sarah Okonkwo</author></item><item><title>Your Kombucha Is Only as Good as the Tea You Brewed It From</title><link>https://thefirstcohort.com/articles/2026-06-25-your-kombucha-is-only-as-good-as-the-tea-you-brewed-it-from</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-25-your-kombucha-is-only-as-good-as-the-tea-you-brewed-it-from</guid><description>A new five-tea kombucha study finds the antioxidant punch depends almost entirely on the tea you start with, with green and oolong on top and the label never telling you.</description><pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>kombucha</category><category>fermentation</category><category>antioxidants</category><category>polyphenols</category><category>gut-health</category><category>nutrition</category><author>Sarah Okonkwo</author></item><item><title>A Blocked Vaccine Study, and the Statistical Method Its Own Lead Author Warned About</title><link>https://thefirstcohort.com/articles/2026-06-24-a-blocked-vaccine-study-and-the-statistical-method-its-own-lead-author-warned-ab</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-24-a-blocked-vaccine-study-and-the-statistical-method-its-own-lead-author-warned-ab</guid><description>A CDC vaccine-effectiveness study pulled from the agency&apos;s own journal landed in JAMA, and the press called it censorship. The method it used has a documented blind spot its own lead author once published on.</description><pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>covid-vaccines</category><category>cdc</category><category>test-negative-design</category><category>vaccine-effectiveness</category><category>public-health</category><category>bhattacharya</category><author>Marcus Chen</author></item><item><title>The Bird Flu Was Hiding in the Udder. The Receptor Map Showed Up Two Years Late.</title><link>https://thefirstcohort.com/articles/2026-06-24-the-bird-flu-was-hiding-in-the-udder-the-receptor-map-showed-up-two-years-late</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-24-the-bird-flu-was-hiding-in-the-udder-the-receptor-map-showed-up-two-years-late</guid><description>A new University of Pittsburgh study explains why H5N1 infects cow udders instead of lungs. The receptor evidence pointed there in 2024; the federal response did not move as fast.</description><pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>h5n1</category><category>bird flu</category><category>dairy cattle</category><category>raw milk</category><category>usda</category><category>surveillance</category><author>Lena Marshall</author></item><item><title>The Crisis Was Unexpected. The Org Chart Wasn&apos;t.</title><link>https://thefirstcohort.com/articles/2026-06-24-the-crisis-was-unexpected-the-org-chart-wasn-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-24-the-crisis-was-unexpected-the-org-chart-wasn-t</guid><description>Internal NIH correspondence and the public record both point to a pandemic-response architecture, and the people to run it, assembled years before Covid arrived.</description><pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>nih</category><category>pandemic-preparedness</category><category>foia</category><category>cepi</category><category>accountability</category><category>covid</category><author>Mira Petrov</author></item><item><title>The Knee Procedure That Barely Beats a Convincing Fake</title><link>https://thefirstcohort.com/articles/2026-06-24-the-knee-procedure-that-barely-beats-a-convincing-fake</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-24-the-knee-procedure-that-barely-beats-a-convincing-fake</guid><description>A university press release pitches a minimally invasive knee procedure as a way to delay joint replacement, but the only sham-controlled trials show the fake version works nearly as well.</description><pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>osteoarthritis</category><category>knee</category><category>embolization</category><category>placebo</category><category>interventional-radiology</category><category>clinical-trials</category><author>Lena Marshall</author></item><item><title>The Protein Numbers on the Government Charts Were Never Meant to Help You Thrive</title><link>https://thefirstcohort.com/articles/2026-06-24-the-protein-numbers-on-the-government-charts-were-never-meant-to-help-you-thrive</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-24-the-protein-numbers-on-the-government-charts-were-never-meant-to-help-you-thrive</guid><description>A new Frontiers in Nutrition perspective argues official protein and exercise guidelines were built to prevent deficiency, not to maximize healthspan, and that older adults in particular need far more.</description><pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>protein</category><category>healthspan</category><category>aging</category><category>muscle</category><category>nutrition</category><category>guidelines</category><author>Sarah Okonkwo</author></item><item><title>Your Brain Files Speech Where You&apos;d Least Expect: In Hearing and Touch, Not the Motor Cortex</title><link>https://thefirstcohort.com/articles/2026-06-24-your-brain-files-speech-where-you-d-least-expect-in-hearing-and-touch-not-the-mo</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-24-your-brain-files-speech-where-you-d-least-expect-in-hearing-and-touch-not-the-mo</guid><description>A TMS study from McGill and Yale finds that newly learned speech is stored in the brain&apos;s hearing and touch regions, not the motor cortex long assumed to run the show.</description><pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>neuroscience</category><category>speech</category><category>brain-computer-interface</category><category>stroke</category><category>tms</category><author>Sarah Okonkwo</author></item><item><title>A Cancer Algorithm Found Answers in 71 Children. The &apos;Quantum&apos; Label Is the Least Interesting Thing About It.</title><link>https://thefirstcohort.com/articles/2026-06-23-a-cancer-algorithm-found-answers-in-71-children-the-quantum-label-is-the-least-i</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-23-a-cancer-algorithm-found-answers-in-71-children-the-quantum-label-is-the-least-i</guid><description>A University of Utah team used the linear algebra of quantum mechanics to pull two survival predictors from just 71 neuroblastoma patients. The science is real. The word doing the marketing is not.</description><pubDate>Tue, 23 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>neuroblastoma</category><category>ai</category><category>oncology</category><category>biomarkers</category><category>childhood-cancer</category><author>Marcus Chen</author></item><item><title>Fauci&apos;s Pardon Was Supposed to End This. It&apos;s the Reason He Can&apos;t Stay Quiet.</title><link>https://thefirstcohort.com/articles/2026-06-23-fauci-s-pardon-was-supposed-to-end-this-it-s-the-reason-he-can-t-stay-quiet</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-23-fauci-s-pardon-was-supposed-to-end-this-it-s-the-reason-he-can-t-stay-quiet</guid><description>Rand Paul subpoenaed Anthony Fauci on June 22 after declassified documents reopened the COVID-origins question, and the preemptive pardon meant to shield him is why he cannot refuse to answer.</description><pubDate>Tue, 23 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>covid-origins</category><category>fauci</category><category>lab-leak</category><category>gain-of-function</category><category>congressional-oversight</category><author>Lena Marshall</author></item><item><title>The Alzheimer&apos;s Field Spent Decades Trying to Destroy These Droplets. A Baylor Lab Says the Droplets Were Never the Problem.</title><link>https://thefirstcohort.com/articles/2026-06-23-the-alzheimer-s-field-spent-decades-trying-to-destroy-these-droplets-a-baylor-la</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-23-the-alzheimer-s-field-spent-decades-trying-to-destroy-these-droplets-a-baylor-la</guid><description>A Baylor lab reports that tubulin redirects Tau and alpha-synuclein away from toxic clumping in the test tube. It is elegant mechanism work, and not yet a drug, an animal, or a person.</description><pubDate>Tue, 23 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>parkinsons</category><category>tau</category><category>alpha-synuclein</category><category>tubulin</category><category>neurodegeneration</category><author>Sarah Okonkwo</author></item><item><title>The Ebola Vaccine We Celebrated Doesn&apos;t Touch the Strain Now Burning Through Congo</title><link>https://thefirstcohort.com/articles/2026-06-23-the-ebola-vaccine-we-celebrated-doesn-t-touch-the-strain-now-burning-through-con</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-23-the-ebola-vaccine-we-celebrated-doesn-t-touch-the-strain-now-burning-through-con</guid><description>Congo&apos;s Ebola outbreak has passed 1,000 cases and is rising faster than any before it, but it is caused by Bundibugyo virus, against which the licensed Ebola vaccine and antibody drugs were never designed to work.</description><pubDate>Tue, 23 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>ebola</category><category>bundibugyo-virus</category><category>vaccines</category><category>congo</category><category>pandemic-preparedness</category><author>Marcus Chen</author></item><item><title>A Cheap Amino Acid Pulled Mice Back From a Cytokine Storm. The Twist Is Which Organ Did the Saving.</title><link>https://thefirstcohort.com/articles/2026-06-22-a-cheap-amino-acid-pulled-mice-back-from-a-cytokine-storm-the-twist-is-which-org</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-a-cheap-amino-acid-pulled-mice-back-from-a-cytokine-storm-the-twist-is-which-org</guid><description>A Salk Institute mouse study found that dietary methionine cut deaths from severe inflammation by boosting the kidneys&apos; ability to flush pro-inflammatory cytokines into urine, without blunting the immune response to infection.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>methionine</category><category>inflammation</category><category>sepsis</category><category>kidney</category><category>nutrition</category><category>longevity</category><author>Sarah Okonkwo</author></item><item><title>A Repair Gene Turns Saboteur, and a $4 Billion Drug Class Sees an Opening</title><link>https://thefirstcohort.com/articles/2026-06-22-a-repair-gene-turns-saboteur-and-a-4-billion-drug-class-sees-an-opening</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-a-repair-gene-turns-saboteur-and-a-4-billion-drug-class-sees-an-opening</guid><description>A Penn State lab found that too much of the DNA repair gene EXO1 makes ordinary tumors behave like BRCA-mutant ones in a dish, and respond to the same drugs. The science is clean. The market context is not.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>cancer</category><category>dna-repair</category><category>parp-inhibitors</category><category>oncology</category><category>biomarkers</category><author>Lena Marshall</author></item><item><title>A Top Cancer Scientist, a Deleted Study, and the Question Washington Won&apos;t Fund</title><link>https://thefirstcohort.com/articles/2026-06-22-a-top-cancer-scientist-a-deleted-study-and-the-question-washington-won-t-fund</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-a-top-cancer-scientist-a-deleted-study-and-the-question-washington-won-t-fund</guid><description>A June 2026 Senate subcommittee hearing centered on a Brown University cancer researcher&apos;s review of 333 post-vaccination cancer case reports, and on the retractions, censorship, and cyberattack that met it.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>covid-vaccines</category><category>cancer</category><category>scientific-censorship</category><category>senate-hearing</category><category>regulatory-capture</category><category>mrna</category><author>Marcus Chen</author></item><item><title>Retracted by Its Title: A Vaccine-SIDS Paper and a Standard That Isn&apos;t Science</title><link>https://thefirstcohort.com/articles/2026-06-22-retracted-by-its-title-a-vaccine-sids-paper-and-a-standard-that-isn-t-science</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-retracted-by-its-title-a-vaccine-sids-paper-and-a-standard-that-isn-t-science</guid><description>A vaccine-safety paper sat in a peer-reviewed journal for five years, then was pulled in 2026 with a critic saying its title alone disqualified it. The science against the paper is strong; the retraction that followed wasn&apos;t science.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>vaccine-safety</category><category>sids</category><category>vaers</category><category>retraction</category><category>scientific-publishing</category><category>rfk</category><author>Marcus Chen</author></item><item><title>The Brain Was Starving Before the Plaques Showed Up: Alzheimer&apos;s Metabolic Reframe Has a Case, Not a Trial</title><link>https://thefirstcohort.com/articles/2026-06-22-the-brain-was-starving-before-the-plaques-showed-up-alzheimer-s-metabolic-refram</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-the-brain-was-starving-before-the-plaques-showed-up-alzheimer-s-metabolic-refram</guid><description>A rising camp says failing mitochondria, not amyloid plaques, may drive Alzheimer&apos;s first. The biology is compelling and the amyloid monoculture earned its reckoning, but the metabolic side has its own retractions and not one human trial showing it works.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>mitophagy</category><category>amyloid</category><category>metabolic-hypothesis</category><category>longevity</category><category>research-integrity</category><author>Sarah Okonkwo</author></item><item><title>The Obesity &apos;Revolution&apos; Everyone&apos;s Promising Comes From People Who&apos;d Cash In On It</title><link>https://thefirstcohort.com/articles/2026-06-22-the-obesity-revolution-everyone-s-promising-comes-from-people-who-d-cash-in-on-i</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-the-obesity-revolution-everyone-s-promising-comes-from-people-who-d-cash-in-on-i</guid><description>A new commentary says the GLP-1 era is just the prelude to a bigger obesity &quot;revolution.&quot; The authors have direct financial stakes in what comes next, and the celebrated new pill loses less weight than the shot.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>obesity</category><category>orforglipron</category><category>precision-medicine</category><category>conflicts-of-interest</category><category>metabolic</category><author>Sarah Okonkwo</author></item><item><title>WHO Tripled the Foodborne Death Toll. The Food Didn&apos;t Get Deadlier.</title><link>https://thefirstcohort.com/articles/2026-06-22-who-tripled-the-foodborne-death-toll-the-food-didn-t-get-deadlier</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-who-tripled-the-foodborne-death-toll-the-food-didn-t-get-deadlier</guid><description>WHO&apos;s new estimate says unsafe food kills 1.5 million people a year, more than triple its 2015 figure, even as it admits the burden has fallen. The jump is an accounting change, not an epidemic.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>who</category><category>food-safety</category><category>foodborne-illness</category><category>heavy-metals</category><category>one-health</category><category>global-health</category><author>Lena Marshall</author></item><item><title>Your Five-a-Day Isn&apos;t Enough Flavanols, Says the Company That Sells Them by the Capsule</title><link>https://thefirstcohort.com/articles/2026-06-22-your-five-a-day-isn-t-enough-flavanols-says-the-company-that-sells-them-by-the-c</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-22-your-five-a-day-isn-t-enough-flavanols-says-the-company-that-sells-them-by-the-c</guid><description>A new study says following dietary guidelines won&apos;t get you enough flavanols for heart protection. Two of its authors work for the company that sells flavanols in a capsule.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>flavanols</category><category>heart-health</category><category>conflict-of-interest</category><category>supplements</category><category>nutrition</category><category>cocoa</category><author>Sarah Okonkwo</author></item><item><title>A 14-Patient Hand-Exoskeleton Study Lands in Science Advances, With a Headline That Outruns the Data</title><link>https://thefirstcohort.com/articles/2026-06-21-a-14-patient-hand-exoskeleton-study-lands-in-science-advances-with-a-headline-th</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-a-14-patient-hand-exoskeleton-study-lands-in-science-advances-with-a-headline-th</guid><description>A Vienna-led team published a 14-patient feasibility study of a wearable hand exoskeleton with closed-loop electrical stimulation. The mechanism is genuinely novel; the headline is doing work the data cannot.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>neurorehabilitation</category><category>exoskeleton</category><category>stroke</category><category>spinal-cord-injury</category><category>medical-devices</category><category>feasibility-study</category><author>Marcus Chen</author></item><item><title>A DC judge dismissed the Study 329 suit. The court did not say the paper is honest.</title><link>https://thefirstcohort.com/articles/2026-06-21-a-dc-judge-dismissed-the-study-329-suit-the-court-did-not-say-the-paper-is-hones</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-a-dc-judge-dismissed-the-study-329-suit-the-court-did-not-say-the-paper-is-hones</guid><description>A DC court dismissed an attempt to force JAACAP and Elsevier to retract Study 329. The ruling did not find the paper sound. It found that no reader has standing to make a journal stop selling a fraudulent article.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>study-329</category><category>paroxetine</category><category>ghostwriting</category><category>retraction</category><category>academic-publishing</category><category>gsk</category><author>Mira Petrov</author></item><item><title>Brewed tea has the longevity receipts. The supplement aisle has a liver problem.</title><link>https://thefirstcohort.com/articles/2026-06-21-brewed-tea-has-the-longevity-receipts-the-supplement-aisle-has-a-liver-problem</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-brewed-tea-has-the-longevity-receipts-the-supplement-aisle-has-a-liver-problem</guid><description>A 2025 review finds 1.5 to 2 cups of brewed tea daily correlate with about 10% lower all-cause and 14% lower cardiovascular mortality. The EGCG-extract supplements built on the same chemistry have been linked to over 100 liver-injury cases, while bubble tea can match a Coke for sugar.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>tea</category><category>polyphenols</category><category>longevity</category><category>supplements</category><category>bubble-tea</category><category>wellness</category><author>Sarah Okonkwo</author></item><item><title>It Grows Like a Cancer, Not a Parasite. And It&apos;s in 37% of Seattle&apos;s Coyotes.</title><link>https://thefirstcohort.com/articles/2026-06-21-it-grows-like-a-cancer-not-a-parasite-and-it-s-in-37-of-seattle-s-coyotes</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-it-grows-like-a-cancer-not-a-parasite-and-it-s-in-37-of-seattle-s-coyotes</guid><description>A European strain of Echinococcus multilocularis has been found in 37 percent of Puget Sound coyotes, the first wild-host detection on the U.S. West Coast outside Alaska.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>parasitic-disease</category><category>zoonosis</category><category>public-health</category><category>pacific-northwest</category><category>surveillance</category><category>border-policy</category><author>Sarah Okonkwo</author></item><item><title>Ivermectin and Cancer: The Review the Horse-Paste Crowd Wasn&apos;t Supposed to Get</title><link>https://thefirstcohort.com/articles/2026-06-21-ivermectin-and-cancer-the-review-the-horse-paste-crowd-wasn-t-supposed-to-get</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-ivermectin-and-cancer-the-review-the-horse-paste-crowd-wasn-t-supposed-to-get</guid><description>A 2025 systematic review finds coherent anticancer biology in ivermectin across ten tumor types. The human evidence to match it does not exist. The question of why is what the punchline was designed to bury.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>ivermectin</category><category>cancer</category><category>repurposed-drugs</category><category>oncology</category><category>clinical-trials</category><author>Lena Marshall</author></item><item><title>The AI Models Just Failed the Clinical Test We Use to Spot Executive Dysfunction</title><link>https://thefirstcohort.com/articles/2026-06-21-the-ai-models-just-failed-the-clinical-test-we-use-to-spot-executive-dysfunction</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-the-ai-models-just-failed-the-clinical-test-we-use-to-spot-executive-dysfunction</guid><description>A new PNAS Nexus study put the same Stroop task neuropsychologists use to screen for executive dysfunction in front of GPT-5, Claude Opus, and Gemini. The accuracy collapse arrives months after the FDA quietly loosened oversight of AI clinical decision support.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>ai</category><category>fda</category><category>clinical-decision-support</category><category>executive-function</category><category>mental-health</category><author>Sarah Okonkwo</author></item><item><title>The amyloid-versus-tau war in Alzheimer&apos;s might be the wrong fight</title><link>https://thefirstcohort.com/articles/2026-06-21-the-amyloid-versus-tau-war-in-alzheimer-s-might-be-the-wrong-fight</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-the-amyloid-versus-tau-war-in-alzheimer-s-might-be-the-wrong-fight</guid><description>A four-person UC Riverside chemistry group argues amyloid beta and tau compete for the same microtubule binding sites, a unifying mechanism that cuts under Alzheimer&apos;s research&apos;s three-decade amyloid-versus-tau fight.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>amyloid</category><category>tau</category><category>microtubules</category><category>neurodegeneration</category><category>drug-development</category><author>Sarah Okonkwo</author></item><item><title>The &quot;Secret Reason&quot; Cancer Drugs Stop Working Was Published in February</title><link>https://thefirstcohort.com/articles/2026-06-21-the-secret-reason-cancer-drugs-stop-working-was-published-in-february</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-the-secret-reason-cancer-drugs-stop-working-was-published-in-february</guid><description>A Montreal team&apos;s antibody against the SLAMF6 brake on T cells made the rounds this week as a fresh discovery. The paper went up in February, the work is in mice, and the antibody has not been given to a person.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>oncology</category><category>immunotherapy</category><category>checkpoint-inhibitors</category><category>preclinical</category><category>press-cycle</category><author>Lena Marshall</author></item><item><title>The Supervised Prehab Worked. The Home Version Hospitals Want to Sell You Did Not.</title><link>https://thefirstcohort.com/articles/2026-06-21-the-supervised-prehab-worked-the-home-version-hospitals-want-to-sell-you-did-not</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-the-supervised-prehab-worked-the-home-version-hospitals-want-to-sell-you-did-not</guid><description>Two randomized trials in older surgical patients, one positive and one null, draw the same line under what &quot;prehabilitation&quot; actually requires, and why the version a hospital can hand you on paper did nothing.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>prehabilitation</category><category>surgery</category><category>exercise</category><category>nutrition</category><category>frailty</category><category>longevity</category><author>Sarah Okonkwo</author></item><item><title>Twelve Genes, One Overlooked Neuron, and the Rett Brain That Was Already Off Course</title><link>https://thefirstcohort.com/articles/2026-06-21-twelve-genes-one-overlooked-neuron-and-the-rett-brain-that-was-already-off-cours</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-twelve-genes-one-overlooked-neuron-and-the-rett-brain-that-was-already-off-cours</guid><description>A Baylor team&apos;s single-cell map of female Rett mice finds 12 dysregulated genes and a previously unsuspected vulnerable interneuron, weeks before any symptom appears.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>rett-syndrome</category><category>mecp2</category><category>neurology</category><category>single-cell</category><category>brain-development</category><category>trofinetide</category><author>Sarah Okonkwo</author></item><item><title>Ultra-Processed Food Is Quietly Taxing Your Attention. The Mediterranean Salad Next to It Won&apos;t Pay the Bill.</title><link>https://thefirstcohort.com/articles/2026-06-21-ultra-processed-food-is-quietly-taxing-your-attention-the-mediterranean-salad-ne</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-ultra-processed-food-is-quietly-taxing-your-attention-the-mediterranean-salad-ne</guid><description>A new Monash-led study finds ultra-processed foods track with worse attention and a higher dementia-risk score even after adjusting for Mediterranean diet quality. The biology of why is more interesting than the headlines admit.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>ultra-processed-foods</category><category>cognition</category><category>dementia</category><category>nutrition</category><category>brain-health</category><author>Sarah Okonkwo</author></item><item><title>Utah&apos;s Quiet Bet Against the Number-One Killer of New Mothers</title><link>https://thefirstcohort.com/articles/2026-06-21-utah-s-quiet-bet-against-the-number-one-killer-of-new-mothers</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-utah-s-quiet-bet-against-the-number-one-killer-of-new-mothers</guid><description>Utah is scaling a free, CBT- and mindfulness-based perinatal depression pathway through MyChart in a state where suicide is the leading cause of maternal death.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>maternal-health</category><category>perinatal-depression</category><category>prevention</category><category>telehealth</category><category>wellness</category><author>Sarah Okonkwo</author></item><item><title>We Fixed the Ozone Hole. The Replacement Is Now in Your Blood.</title><link>https://thefirstcohort.com/articles/2026-06-21-we-fixed-the-ozone-hole-the-replacement-is-now-in-your-blood</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-we-fixed-the-ozone-hole-the-replacement-is-now-in-your-blood</guid><description>A new Lancaster modeling study finds CFC replacement refrigerants and anesthetic gases have rained 335,500 tonnes of the forever chemical TFA across the planet since 2000, and it is now the dominant PFAS in American blood.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>forever-chemicals</category><category>pfas</category><category>environmental-health</category><category>montreal-protocol</category><category>anesthetics</category><category>regulatory-capture</category><author>Sarah Okonkwo</author></item><item><title>Your Kidneys Are Quietly Failing. The WHO&apos;s Plan Skips What&apos;s Actually Killing Them.</title><link>https://thefirstcohort.com/articles/2026-06-21-your-kidneys-are-quietly-failing-the-who-s-plan-skips-what-s-actually-killing-th</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-21-your-kidneys-are-quietly-failing-the-who-s-plan-skips-what-s-actually-killing-th</guid><description>The Lancet is pushing fast implementation of the first WHO kidney resolution, which expands screening and treatment access while leaving the ultraprocessed food and sugar driving the global CKD doubling untouched.</description><pubDate>Sun, 21 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>kidney-disease</category><category>who</category><category>metabolic-health</category><category>sglt2</category><category>ultraprocessed-food</category><category>pharma</category><author>Sarah Okonkwo</author></item><item><title>A molecule your body already makes coaxed exhausted brain cells back to fighting Alzheimer&apos;s</title><link>https://thefirstcohort.com/articles/2026-06-20-a-molecule-your-body-already-makes-coaxed-exhausted-brain-cells-back-to-fighting</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-20-a-molecule-your-body-already-makes-coaxed-exhausted-brain-cells-back-to-fighting</guid><description>Spanish and Swiss researchers report that OLE, a fatty-acid amino-acid the body already makes, coaxed sluggish microglia to surround amyloid plaques and improve memory in Alzheimer&apos;s mice.</description><pubDate>Sat, 20 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>microglia</category><category>neuroinflammation</category><category>drug-discovery</category><category>brain-aging</category><author>Sarah Okonkwo</author></item><item><title>&apos;A Reality, Not an Emergency&apos;: The Lancet Picks Another Political Side</title><link>https://thefirstcohort.com/articles/2026-06-20-a-reality-not-an-emergency-the-lancet-picks-another-political-side</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-20-a-reality-not-an-emergency-the-lancet-picks-another-political-side</guid><description>The Lancet&apos;s new editorial recasts immigration enforcement as the public-health pathology. The receipts on the journal that published it run from the Daszak letter to the Surgisphere fraud.</description><pubDate>Sat, 20 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>lancet</category><category>medical-journals</category><category>institutional-capture</category><category>editorial-activism</category><category>public-health</category><category>immigration</category><author>Lena Marshall</author></item><item><title>Becerra Got the Fauci Whistleblower File. The HHS Inspector General Did Not.</title><link>https://thefirstcohort.com/articles/2026-06-20-becerra-got-the-fauci-whistleblower-file-the-hhs-inspector-general-did-not</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-20-becerra-got-the-fauci-whistleblower-file-the-hhs-inspector-general-did-not</guid><description>A whistleblower told the Director of National Intelligence in August 2021 that Anthony Fauci lied to Congress about gain-of-function funding. The file was routed to Xavier Becerra, Fauci&apos;s cabinet boss, instead of the independent HHS Inspector General. The paper trail is now public.</description><pubDate>Sat, 20 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>fauci</category><category>covid-origins</category><category>whistleblower</category><category>becerra</category><category>intelligence-community</category><category>accountability</category><author>Mira Petrov</author></item><item><title>Magic Mushrooms and an 80-Year-Old&apos;s Memory: What the Hype Actually Has, and What It Doesn&apos;t</title><link>https://thefirstcohort.com/articles/2026-06-20-magic-mushrooms-and-an-80-year-old-s-memory-what-the-hype-actually-has-and-what</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-20-magic-mushrooms-and-an-80-year-old-s-memory-what-the-hype-actually-has-and-what</guid><description>An 80-something woman with advanced Alzheimer&apos;s took five grams of mushrooms and started speaking again. The biology behind why that might happen is real. The trial base it rests on is thinner than the headlines admit.</description><pubDate>Sat, 20 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>psychedelics</category><category>alzheimers</category><category>aging-brain</category><category>neuroplasticity</category><category>psilocybin</category><author>Sarah Okonkwo</author></item><item><title>Moderna&apos;s mRNA flu shot got a 9-0 vote. The comparator question that killed its first filing did not go away.</title><link>https://thefirstcohort.com/articles/2026-06-19-moderna-s-mrna-flu-shot-got-a-9-0-vote-the-comparator-question-that-killed-its-f</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-19-moderna-s-mrna-flu-shot-got-a-9-0-vote-the-comparator-question-that-killed-its-f</guid><description>An FDA panel voted 9-0 to back Moderna&apos;s first mRNA flu vaccine. Four months earlier, the same agency refused to even read the file over the comparator the trial used. The comparator did not change.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>mrna-vaccines</category><category>moderna</category><category>influenza</category><category>vrbpac</category><category>reactogenicity</category><author>Marcus Chen</author></item><item><title>The $200K Pediatric Diabetes Shot Just Won a Bigger Label. The Number That Won Isn&apos;t the One Families Will Ever See.</title><link>https://thefirstcohort.com/articles/2026-06-19-the-200k-pediatric-diabetes-shot-just-won-a-bigger-label-the-number-that-won-isn</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-19-the-200k-pediatric-diabetes-shot-just-won-a-bigger-label-the-number-that-won-isn</guid><description>The FDA gave Tzield an accelerated nod for kids 8 to 17 newly diagnosed with Stage 3 type 1 diabetes. The C-peptide number won. The endpoints families would actually feel did not.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>type-1-diabetes</category><category>fda</category><category>teplizumab</category><category>pediatric</category><category>sanofi</category><category>immunotherapy</category><author>Sarah Okonkwo</author></item><item><title>Vitamin C just landed on an 8-preservative hypertension list. It was the only one also tied to heart disease.</title><link>https://thefirstcohort.com/articles/2026-06-19-vitamin-c-just-landed-on-an-8-preservative-hypertension-list-it-was-the-only-one</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-19-vitamin-c-just-landed-on-an-8-preservative-hypertension-list-it-was-the-only-one</guid><description>A French cohort of 112,395 adults, followed eight years, flagged eight common preservatives for hypertension. Ascorbic acid was the only one that also independently associated with cardiovascular disease, and the lead author is calling on EFSA and FDA to reopen the file.</description><pubDate>Fri, 19 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>food-additives</category><category>preservatives</category><category>hypertension</category><category>cardiovascular-disease</category><category>ultraprocessed-food</category><author>Sarah Okonkwo</author></item><item><title>A $200 Flu Pill Just Got a Cheaper Twin. The 10 Percent Resistance Problem Came With It.</title><link>https://thefirstcohort.com/articles/2026-06-18-a-200-flu-pill-just-got-a-cheaper-twin-the-10-percent-resistance-problem-came-wi</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-18-a-200-flu-pill-just-got-a-cheaper-twin-the-10-percent-resistance-problem-came-wi</guid><description>The FDA cleared the first generic of baloxavir, the one-pill flu drug, in time for the 2026–2027 season. Cheaper is real. The mutation that turns the drug into a sugar pill is real too.</description><pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>influenza</category><category>fda</category><category>generics</category><category>antivirals</category><category>baloxavir</category><category>resistance</category><author>Marcus Chen</author></item><item><title>A viral diabetes-and-dementia explainer left out the trial that just killed its big drug story</title><link>https://thefirstcohort.com/articles/2026-06-18-a-viral-diabetes-and-dementia-explainer-left-out-the-trial-that-just-killed-its</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-18-a-viral-diabetes-and-dementia-explainer-left-out-the-trial-that-just-killed-its</guid><description>A widely shared &quot;ten ways diabetes and dementia are linked&quot; explainer is going around this week, and it skips the Phase 3 trial that, weeks earlier, demolished its brain-protection story for semaglutide.</description><pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>glp-1</category><category>alzheimers</category><category>semaglutide</category><category>diabetes</category><category>evoke-trial</category><author>Sarah Okonkwo</author></item><item><title>Decades of Failed Diarrhea Vaccines Kept Hitting the Wrong Coat. A WashU Team Just Found the Scissors Underneath.</title><link>https://thefirstcohort.com/articles/2026-06-18-decades-of-failed-diarrhea-vaccines-kept-hitting-the-wrong-coat-a-washu-team-jus</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-18-decades-of-failed-diarrhea-vaccines-kept-hitting-the-wrong-coat-a-washu-team-jus</guid><description>A WashU-led team identified a structurally conserved patch on three mucus-cleaving enzymes that ETEC, Shigella, and other gut pathogens all use to breach the intestinal barrier, offering a single antibody target the field has chased for decades.</description><pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>vaccines</category><category>infectious-disease</category><category>etec</category><category>shigella</category><category>public-health</category><category>gut-pathogens</category><author>Marcus Chen</author></item><item><title>The cheaper staph antibiotic just won the biggest trial ever run</title><link>https://thefirstcohort.com/articles/2026-06-18-the-cheaper-staph-antibiotic-just-won-the-biggest-trial-ever-run</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-18-the-cheaper-staph-antibiotic-just-won-the-biggest-trial-ever-run</guid><description>The largest randomized trial ever run for staph bloodstream infection finds the cheap generic antibiotic cefazolin works as well as the older standard, with less kidney damage and no pharma money behind the answer.</description><pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>antibiotics</category><category>staph-aureus</category><category>clinical-trials</category><category>antibiotic-stewardship</category><category>infectious-disease</category><author>Lena Marshall</author></item><item><title>Your Food Has 139,000 Molecules. Standard Nutrition Science Tracks About 150.</title><link>https://thefirstcohort.com/articles/2026-06-18-your-food-has-139-000-molecules-standard-nutrition-science-tracks-about-150</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-18-your-food-has-139-000-molecules-standard-nutrition-science-tracks-about-150</guid><description>A May 2025 NEJM review pegs the chemical complexity of the human diet at more than 139,000 molecules. USDA-style databases track around 150. That gap is not a footnote, and it is why so much nutrition guidance keeps aging badly.</description><pubDate>Thu, 18 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>nutrition</category><category>foodomics</category><category>dietary-guidelines</category><category>ultraprocessed-foods</category><category>microbiome</category><category>drug-discovery</category><author>Sarah Okonkwo</author></item><item><title>A 272,000-Person Study Linked Higher Tyrosine to Shorter Lifespans in Men. The Supplement Aisle Sells It for Focus.</title><link>https://thefirstcohort.com/articles/2026-06-17-a-272-000-person-study-linked-higher-tyrosine-to-shorter-lifespans-in-men-the-su</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-17-a-272-000-person-study-linked-higher-tyrosine-to-shorter-lifespans-in-men-the-su</guid><description>A UK Biobank analysis of 272,475 people using Mendelian randomization links higher blood tyrosine to about 0.91 fewer years of life in men, with no signal in women. The amino acid is sold widely as a focus and stress supplement. The study measured blood levels, not pills.</description><pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>tyrosine</category><category>supplements</category><category>mendelian-randomization</category><category>uk-biobank</category><category>longevity</category><category>sex-differences</category><author>Sarah Okonkwo</author></item><item><title>A heart-attack drug just regrew kidney tissue in mice, and the receipts have no pharma on them</title><link>https://thefirstcohort.com/articles/2026-06-17-a-heart-attack-drug-just-regrew-kidney-tissue-in-mice-and-the-receipts-have-no-p</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-17-a-heart-attack-drug-just-regrew-kidney-tissue-in-mice-and-the-receipts-have-no-p</guid><description>A UCLA monoclonal antibody designed to help hearts heal after a heart attack also repaired injured kidneys in mice, and it was developed without a dollar of pharma money.</description><pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>regenerative-medicine</category><category>kidney</category><category>monoclonal-antibody</category><category>preclinical</category><category>publicly-funded</category><author>Sarah Okonkwo</author></item><item><title>American Infant Mortality Just Hit a Record Low. The International Comparison Is Half an Accounting Trick. The Mississippi Gap Is Not.</title><link>https://thefirstcohort.com/articles/2026-06-17-american-infant-mortality-just-hit-a-record-low-the-international-comparison-is</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-17-american-infant-mortality-just-hit-a-record-low-the-international-comparison-is</guid><description>Preliminary CDC data put the 2025 U.S. infant mortality rate at 5.4 per 1,000 live births, a record low. The international comparison the headlines lean on is partly an artifact of how countries count. The domestic gap is not.</description><pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>infant-mortality</category><category>public-health</category><category>cdc</category><category>maternal-health</category><category>rsv</category><author>Marcus Chen</author></item><item><title>Sleep apnea&apos;s heart damage may run through the gut, not the airway</title><link>https://thefirstcohort.com/articles/2026-06-17-sleep-apnea-s-heart-damage-may-run-through-the-gut-not-the-airway</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-17-sleep-apnea-s-heart-damage-may-run-through-the-gut-not-the-airway</guid><description>Researchers at UCSD report that knocking out a single bile-acid receptor abolishes the arterial plaque sleep-apnea conditions would otherwise drive in mice. The mechanism fits the CPAP era&apos;s underwhelming trial record better than the airway story ever did.</description><pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>sleep-apnea</category><category>gut-microbiome</category><category>cardiovascular</category><category>bile-acids</category><category>preclinical</category><author>Lena Marshall</author></item><item><title>The FDA Just Approved a Third Over-the-Counter Naloxone. The Maker Once Doubled the Price of the Injectable.</title><link>https://thefirstcohort.com/articles/2026-06-17-the-fda-just-approved-a-third-over-the-counter-naloxone-the-maker-once-doubled-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-17-the-fda-just-approved-a-third-over-the-counter-naloxone-the-maker-once-doubled-t</guid><description>The agency calls Rextovy&apos;s OTC approval a win for access. The manufacturer&apos;s pricing history, and the market it just walked into, complicate the story.</description><pubDate>Wed, 17 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>naloxone</category><category>opioid-crisis</category><category>otc</category><category>pharma-pricing</category><category>amphastar</category><author>Lena Marshall</author></item><item><title>Aaron Siri Wrote a Book Made of Court Filings</title><link>https://thefirstcohort.com/articles/2026-06-16-aaron-siri-wrote-a-book-made-of-court-filings</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-16-aaron-siri-wrote-a-book-made-of-court-filings</guid><description>A new book by attorney Aaron Siri assembles a decade of FOIA wins, court filings, and depositions into one record of what the federal vaccine docket does and does not say.</description><pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>vaccines</category><category>foia</category><category>ican</category><category>fda</category><category>cdc</category><category>pharma-liability</category><author>Mira Petrov</author></item><item><title>Calcium and Vitamin D Got Demoted in the BMJ. The Trial Data Are More Stubborn Than the Headline.</title><link>https://thefirstcohort.com/articles/2026-06-16-calcium-and-vitamin-d-got-demoted-in-the-bmj-the-trial-data-are-more-stubborn-th</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-16-calcium-and-vitamin-d-got-demoted-in-the-bmj-the-trial-data-are-more-stubborn-th</guid><description>A BMJ meta-analysis of 153,902 older adults reports calcium and vitamin D supplements offer little meaningful benefit against fractures and falls, though the combined arm showed a statistically significant 16% reduction in hip fracture risk.</description><pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>calcium</category><category>vitamin-d</category><category>bone-health</category><category>supplements</category><category>bmj</category><category>osteoporosis</category><author>Lena Marshall</author></item><item><title>The bitter finish in your protein shake isn&apos;t the protein. It&apos;s the minerals.</title><link>https://thefirstcohort.com/articles/2026-06-16-the-bitter-finish-in-your-protein-shake-isn-t-the-protein-it-s-the-minerals</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-16-the-bitter-finish-in-your-protein-shake-isn-t-the-protein-it-s-the-minerals</guid><description>A new sensory study traces the bitter, peppery aftertaste in whey protein shakes to minerals that get concentrated during filtration, not the protein itself. The fix is a manufacturing tweak. The co-author is the supplier that sells the alpha-lactalbumin line.</description><pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>protein</category><category>supplements</category><category>nutrition</category><category>food-science</category><category>sensory</category><category>dairy</category><author>Sarah Okonkwo</author></item><item><title>The Shingles Vaccine Keeps Cutting Dementia Risk. The Reason May Not Be the Shingles.</title><link>https://thefirstcohort.com/articles/2026-06-16-the-shingles-vaccine-keeps-cutting-dementia-risk-the-reason-may-not-be-the-shing</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-16-the-shingles-vaccine-keeps-cutting-dementia-risk-the-reason-may-not-be-the-shing</guid><description>Four big studies now tie the shingles vaccine to lower dementia risk. The most useful finding is that the same effect shows up with an RSV vaccine that shares its adjuvant.</description><pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>dementia</category><category>vaccines</category><category>shingles</category><category>gsk</category><category>adjuvants</category><category>alzheimers</category><author>Marcus Chen</author></item><item><title>The textbook said B cells take turns. A new temporal map of a malaria infection says they don&apos;t.</title><link>https://thefirstcohort.com/articles/2026-06-16-the-textbook-said-b-cells-take-turns-a-new-temporal-map-of-a-malaria-infection-s</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-16-the-textbook-said-b-cells-take-turns-a-new-temporal-map-of-a-malaria-infection-s</guid><description>A new Nature Immunology temporal map of B cell responses to malaria in mice catches class-switching, clonal expansion, and somatic hypermutation overlapping from the first week, scrambling the tidy stepwise story textbooks still teach.</description><pubDate>Tue, 16 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>b-cells</category><category>malaria</category><category>immunology</category><category>vaccines</category><category>mouse-study</category><author>Sarah Okonkwo</author></item><item><title>Astellas Brings Real-World Numbers for Its Menopause Drug to ENDO 2026. The Black Box Warning Stayed Home.</title><link>https://thefirstcohort.com/articles/2026-06-15-astellas-brings-real-world-numbers-for-its-menopause-drug-to-endo-2026-the-black</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-15-astellas-brings-real-world-numbers-for-its-menopause-drug-to-endo-2026-the-black</guid><description>Astellas presented its first real-world numbers for Veozah at ENDO 2026, framed as a win. The 656-woman observational study had no placebo arm and the company&apos;s release did not mention the FDA black-box warning for liver injury.</description><pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>menopause</category><category>fezolinetant</category><category>astellas</category><category>fda-safety</category><category>industry-funded-research</category><author>Marcus Chen</author></item><item><title>Middle-aged Americans Are Weaker, Lonelier, and Forgetting More Than Their Parents Did at the Same Age</title><link>https://thefirstcohort.com/articles/2026-06-15-middle-aged-americans-are-weaker-lonelier-and-forgetting-more-than-their-parents</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-15-middle-aged-americans-are-weaker-lonelier-and-forgetting-more-than-their-parents</guid><description>A 17-country study finds U.S. adults in their 50s are doing worse on memory, grip strength, loneliness, and depression than their parents were. The United States is the only country going meaningfully backward.</description><pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>midlife</category><category>cognitive-decline</category><category>mental-health</category><category>longevity</category><category>public-health</category><author>Sarah Okonkwo</author></item><item><title>Testosterone Prescriptions Quadrupled. The Workups Didn&apos;t.</title><link>https://thefirstcohort.com/articles/2026-06-15-testosterone-prescriptions-quadrupled-the-workups-didn-t</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-15-testosterone-prescriptions-quadrupled-the-workups-didn-t</guid><description>A Michigan Medicine chart review presented at ENDO 2026 found that only 12 percent of men prescribed testosterone got the guideline-required workup, even as the U.S. wrote 11 million testosterone prescriptions in 2024.</description><pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>testosterone</category><category>hypogonadism</category><category>prescribing</category><category>endocrinology</category><category>pharma-marketing</category><category>telehealth</category><author>Marcus Chen</author></item><item><title>The sugar-free mice got sicker, and the press release left out what they were eating instead</title><link>https://thefirstcohort.com/articles/2026-06-15-the-sugar-free-mice-got-sicker-and-the-press-release-left-out-what-they-were-eat</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-15-the-sugar-free-mice-got-sicker-and-the-press-release-left-out-what-they-were-eat</guid><description>A 16-week mouse study presented at ENDO 2026 reported that sugar-free animals developed insulin resistance, gut dysbiosis and fatty liver at the same body weight as controls. The press release never says what replaced the sugar, and that single missing detail decides what the study actually means.</description><pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>nutrition</category><category>microbiome</category><category>metabolic-health</category><category>animal-study</category><category>gut-health</category><author>Sarah Okonkwo</author></item><item><title>A DoD-Funded Fentanyl Vaccine Is Headed to Phase 1. Antibodies Don&apos;t Stop a Supply Chain.</title><link>https://thefirstcohort.com/articles/2026-06-14-a-dod-funded-fentanyl-vaccine-is-headed-to-phase-1-antibodies-don-t-stop-a-suppl</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-14-a-dod-funded-fentanyl-vaccine-is-headed-to-phase-1-antibodies-don-t-stop-a-suppl</guid><description>A Pentagon-funded fentanyl vaccine licensed to startup ARMR Sciences will begin Phase 1 in the Netherlands in early 2026. Three decades of failed addiction vaccines, and a supply chain that runs through Chinese precursor labs, are the context the press release leaves out.</description><pubDate>Sun, 14 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fentanyl</category><category>opioids</category><category>vaccines</category><category>addiction</category><category>public-health</category><category>dod</category><author>Marcus Chen</author></item><item><title>A Fentanyl Vaccine for Mice. An Overdose Decline for Humans.</title><link>https://thefirstcohort.com/articles/2026-06-14-a-fentanyl-vaccine-for-mice-an-overdose-decline-for-humans</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-14-a-fentanyl-vaccine-for-mice-an-overdose-decline-for-humans</guid><description>Scripps Research published a clever chemistry redesign that let mice&apos;s immune systems recognize an entire class of fentanyl analogues. The headlines called it an overdose blocker. The mice are doing fine. Humans are years away, and the overdose decline is already happening without it.</description><pubDate>Sun, 14 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fentanyl</category><category>vaccines</category><category>addiction-treatment</category><category>scripps-research</category><category>overdose-deaths</category><author>Lena Marshall</author></item><item><title>Brain Gains Into Your 90s Are Probably Real. The Index Measuring Them Has a Patent Pending.</title><link>https://thefirstcohort.com/articles/2026-06-14-brain-gains-into-your-90s-are-probably-real-the-index-measuring-them-has-a-paten</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-14-brain-gains-into-your-90s-are-probably-real-the-index-measuring-them-has-a-paten</guid><description>A three-year UT Dallas study tracking nearly 4,000 adults to age 94 says brain function can climb at any age. The biology is plausible. The catch is that the people measuring the gain are the same people patenting the yardstick.</description><pubDate>Sun, 14 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>brain-aging</category><category>neuroplasticity</category><category>cognition</category><category>brain-training</category><category>longevity</category><category>conflicts-of-interest</category><author>Sarah Okonkwo</author></item><item><title>The Battlefield Medicine Revolution Was Built on Fake Wounds</title><link>https://thefirstcohort.com/articles/2026-06-14-the-battlefield-medicine-revolution-was-built-on-fake-wounds</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-14-the-battlefield-medicine-revolution-was-built-on-fake-wounds</guid><description>A British prosthetics graduate is heading to NHS ambulance crews and the British military to build realistic trauma wounds, the artisan end of the twenty-year battlefield-medicine revolution that turned hemorrhage into a survivable injury.</description><pubDate>Sun, 14 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>military-medicine</category><category>trauma-care</category><category>simulation</category><category>tccc</category><category>public-health-readiness</category><category>moulage</category><author>Marcus Chen</author></item><item><title>Your Thymus Quietly Stages a Lung. Researchers Just Named the Cell Playing the Part.</title><link>https://thefirstcohort.com/articles/2026-06-14-your-thymus-quietly-stages-a-lung-researchers-just-named-the-cell-playing-the-pa</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-14-your-thymus-quietly-stages-a-lung-researchers-just-named-the-cell-playing-the-pa</guid><description>A new Nature Immunology study identifies an alveolar lung-like cell hiding inside the thymus, where it appears to teach the immune system not to attack your real lungs.</description><pubDate>Sun, 14 Jun 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>thymus</category><category>autoimmunity</category><category>central-tolerance</category><category>mtec</category><category>lung-autoimmunity</category><category>immunology</category><author>Sarah Okonkwo</author></item><item><title>A Korean lab found cancer&apos;s DNA-repair off-switch. In a mouse.</title><link>https://thefirstcohort.com/articles/2026-06-13-a-korean-lab-found-cancer-s-dna-repair-off-switch-in-a-mouse</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-13-a-korean-lab-found-cancer-s-dna-repair-off-switch-in-a-mouse</guid><description>A Korean state lab reports that a tool compound called UNI418 strips out the DNA-repair proteins cancer cells use to escape PARP inhibitors. The data are preclinical: cell lines and mouse xenografts. UNI418 is not yet a drug.</description><pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>cancer</category><category>parp-inhibitors</category><category>dna-repair</category><category>preclinical</category><category>drug-resistance</category><author>Lena Marshall</author></item><item><title>A near-starvation diet shifted inflammation in gum-disease patients. The trial was tiny, and the diet came in a box.</title><link>https://thefirstcohort.com/articles/2026-06-13-a-near-starvation-diet-shifted-inflammation-in-gum-disease-patients-the-trial-wa</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-13-a-near-starvation-diet-shifted-inflammation-in-gum-disease-patients-the-trial-wa</guid><description>A 28-patient feasibility trial put severe gum-disease patients on three cycles of a 750-calorie ProLon diet. Inflammation markers trended lower; clinical gum measures weren&apos;t reported. The biology question is real; the data is thin.</description><pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>fasting</category><category>periodontitis</category><category>inflammation</category><category>pilot-trial</category><category>prolon</category><category>nutrition</category><author>Sarah Okonkwo</author></item><item><title>Medicare&apos;s Product-Hopping Loophole Is Back On The Chopping Block. The Bigger Pharma Giveaway Isn&apos;t.</title><link>https://thefirstcohort.com/articles/2026-06-13-medicare-s-product-hopping-loophole-is-back-on-the-chopping-block-the-bigger-pha</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-13-medicare-s-product-hopping-loophole-is-back-on-the-chopping-block-the-bigger-pha</guid><description>The Trump administration on Thursday proposed closing the product-hopping loophole that lets drugmakers reset Medicare&apos;s negotiation clock by tweaking inactive ingredients. It is the same fix the same administration quietly tabled in October.</description><pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>drug-pricing</category><category>medicare</category><category>pharma</category><category>glp-1</category><category>product-hopping</category><category>regulatory-capture</category><author>Sarah Okonkwo</author></item><item><title>The Same Mutations That Drive Blood Cancer Keep Turning Up in Alzheimer&apos;s Brains</title><link>https://thefirstcohort.com/articles/2026-06-13-the-same-mutations-that-drive-blood-cancer-keep-turning-up-in-alzheimer-s-brains</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-13-the-same-mutations-that-drive-blood-cancer-keep-turning-up-in-alzheimer-s-brains</guid><description>A new Cell paper finds Alzheimer&apos;s brains are riddled with the same mutations that drive blood cancers, in the immune cells that are supposed to be protecting neurons.</description><pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>microglia</category><category>somatic-mutations</category><category>neurodegeneration</category><category>clonal-hematopoiesis</category><category>amyloid</category><author>Sarah Okonkwo</author></item><item><title>8,300 Brazilian elders, one saltshaker, and the 80 percent of sodium nobody mentions</title><link>https://thefirstcohort.com/articles/2026-06-10-8-300-brazilian-elders-one-saltshaker-and-the-80-percent-of-sodium-nobody-mentio</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-10-8-300-brazilian-elders-one-saltshaker-and-the-80-percent-of-sodium-nobody-mentio</guid><description>A Frontiers in Public Health survey of 8,336 Brazilians over 60 found older men reach for the saltshaker most. Buried in the same paper: the shaker only accounts for 6 to 20 percent of total sodium. The other 70-plus percent already arrived from the factory.</description><pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>nutrition</category><category>public-health</category><category>ultra-processed-food</category><category>cognitive-decline</category><category>sodium</category><author>Sarah Okonkwo</author></item><item><title>American Doctors Get About 1.2 Hours of Nutrition Training a Year. RFK Jr. Just Found the Lever.</title><link>https://thefirstcohort.com/articles/2026-06-10-american-doctors-get-about-1-2-hours-of-nutrition-training-a-year-rfk-jr-just-fo</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-10-american-doctors-get-about-1-2-hours-of-nutrition-training-a-year-rfk-jr-just-fo</guid><description>Kennedy got eight organizations across U.S. medical training and 73 medical schools to commit to nutrition in licensing, accreditation, and a 40-hour pledge. The board exam matters; the rest is partly hedging.</description><pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>nutrition</category><category>medical-education</category><category>maha</category><category>rfk</category><category>usmle</category><category>chronic-disease</category><author>Sarah Okonkwo</author></item><item><title>Disappointment, Not Reward, Is What Breaks a Habit. Half of Older Adults Are on Drugs That Blunt Acetylcholine.</title><link>https://thefirstcohort.com/articles/2026-06-10-disappointment-not-reward-is-what-breaks-a-habit-half-of-older-adults-are-on-dru</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-10-disappointment-not-reward-is-what-breaks-a-habit-half-of-older-adults-are-on-dru</guid><description>An OIST team caught the mouse brain firing acetylcholine the moment an expected reward failed to land. That surge is what lets the animal switch strategy. Close to half of community-dwelling older adults are on drugs that block the same receptors.</description><pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>neuroscience</category><category>brain-chemistry</category><category>habits</category><category>anti-cholinergics</category><category>behavioral-flexibility</category><category>addiction</category><author>Sarah Okonkwo</author></item><item><title>Europe had this sunscreen in 1999. The FDA approved it Tuesday.</title><link>https://thefirstcohort.com/articles/2026-06-10-europe-had-this-sunscreen-in-1999-the-fda-approved-it-tuesday</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-10-europe-had-this-sunscreen-in-1999-the-fda-approved-it-tuesday</guid><description>A new chemical UV filter Europe approved in 1999 just cleared the FDA after a 21-year wait, while Americans relied on ingredients the agency&apos;s own 2019 review could not call safe.</description><pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>sunscreen</category><category>fda</category><category>regulatory-capture</category><category>skin-cancer</category><category>wellness</category><category>photoprotection</category><author>Sarah Okonkwo</author></item><item><title>Nitrate from spinach behaves nothing like nitrate from tap water. A 27-year cohort says the brain can tell.</title><link>https://thefirstcohort.com/articles/2026-06-10-nitrate-from-spinach-behaves-nothing-like-nitrate-from-tap-water-a-27-year-cohor</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-10-nitrate-from-spinach-behaves-nothing-like-nitrate-from-tap-water-a-27-year-cohor</guid><description>54,804 Danes followed for a quarter-century: less dementia from vegetable nitrate, more from drinking water. The risk signal shows up at roughly one-ninth of what the US EPA still permits.</description><pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>nitrate</category><category>dementia</category><category>drinking-water</category><category>epa</category><category>n-nitrosamines</category><category>regulatory-capture</category><author>Sarah Okonkwo</author></item><item><title>The AI Vaccine That &apos;Passed&apos; Its First Trial Three Years Ago</title><link>https://thefirstcohort.com/articles/2026-06-10-the-ai-vaccine-that-passed-its-first-trial-three-years-ago</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-10-the-ai-vaccine-that-passed-its-first-trial-three-years-ago</guid><description>Cambridge finished the Phase 1 trial in 2023. The press tour arrived in 2026. The paper, when you read it, said the immunogenicity was modest.</description><pubDate>Wed, 10 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>vaccines</category><category>ai-drug-design</category><category>coronavirus</category><category>clinical-trials</category><category>pandemic-preparedness</category><category>regulatory-capture</category><author>Lena Marshall</author></item><item><title>ALTAIR Missed Its Primary Endpoint. The Press Tour Found Something Else.</title><link>https://thefirstcohort.com/articles/2026-06-09-altair-missed-its-primary-endpoint-the-press-tour-found-something-else</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-09-altair-missed-its-primary-endpoint-the-press-tour-found-something-else</guid><description>A phase 3 trial testing chemotherapy in ctDNA-positive colorectal cancer patients missed its primary endpoint at p=0.107, and a post-hoc reanalysis is doing the public-facing work.</description><pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>colorectal-cancer</category><category>ctdna</category><category>clinical-trials</category><category>oncology</category><category>pharma-skepticism</category><author>Lena Marshall</author></item><item><title>Fish oil rewired the T-cells in non-obese diabetic rats, and the glucose moved with them</title><link>https://thefirstcohort.com/articles/2026-06-09-fish-oil-rewired-the-t-cells-in-non-obese-diabetic-rats-and-the-glucose-moved-wi</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-09-fish-oil-rewired-the-t-cells-in-non-obese-diabetic-rats-and-the-glucose-moved-wi</guid><description>A Brazilian team gave EPA-heavy fish oil to a non-obese diabetic rat strain for eight weeks. Glucose, insulin sensitivity, and lipids all moved in the friendlier direction. The T-cell balance shifted alongside them, and that is the part of the paper worth chewing on.</description><pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>omega-3</category><category>type-2-diabetes</category><category>insulin-resistance</category><category>inflammation</category><category>preclinical</category><category>lipids</category><author>Sarah Okonkwo</author></item><item><title>Six melanoma patients, six weeks, one common variable: the question oncology is choosing not to study</title><link>https://thefirstcohort.com/articles/2026-06-09-six-melanoma-patients-six-weeks-one-common-variable-the-question-oncology-is-cho</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-09-six-melanoma-patients-six-weeks-one-common-variable-the-question-oncology-is-cho</guid><description>An oncologist&apos;s bedside pattern, a Senate hearing, and a mechanism paper sitting in a mainstream oncology journal: the case that repeated mRNA boosters may be lifting the brakes off cancers oncologists thought they had quiet is no longer fringe enough to wave away.</description><pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>mrna-vaccines</category><category>oncology</category><category>immune-tolerance</category><category>melanoma</category><category>igg4</category><category>regulatory-capture</category><author>Lena Marshall</author></item><item><title>The Alzheimer&apos;s Drug That Bets the Plaques Are a Symptom</title><link>https://thefirstcohort.com/articles/2026-06-09-the-alzheimer-s-drug-that-bets-the-plaques-are-a-symptom</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-09-the-alzheimer-s-drug-that-bets-the-plaques-are-a-symptom</guid><description>An ETH Zurich team spent nearly twenty years tracing why Alzheimer&apos;s nerve cells run out of energy, and the answer points to a protein the amyloid-clearing drugs never touched.</description><pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>alzheimers</category><category>neuroscience</category><category>mitochondria</category><category>drug-development</category><category>amyloid-hypothesis</category><category>eth-zurich</category><author>Sarah Okonkwo</author></item><item><title>The Macaques Get a Reprieve. Pharma Gets a Faster Pipeline.</title><link>https://thefirstcohort.com/articles/2026-06-09-the-macaques-get-a-reprieve-pharma-gets-a-faster-pipeline</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-09-the-macaques-get-a-reprieve-pharma-gets-a-faster-pipeline</guid><description>The FDA&apos;s new draft guidance lets oncology developers cut animal studies for certain biologics and conjugated products. The replacement laboratory methods are still being validated.</description><pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>oncology</category><category>animal-testing</category><category>biologics</category><category>antibody-drug-conjugates</category><category>regulatory-reform</category><author>Lena Marshall</author></item><item><title>The thin trial behind England&apos;s next supermarket-layout mandate</title><link>https://thefirstcohort.com/articles/2026-06-09-the-thin-trial-behind-england-s-next-supermarket-layout-mandate</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-09-the-thin-trial-behind-england-s-next-supermarket-layout-mandate</guid><description>A non-randomized trial of 36 English discount stores produced a moment-of-implementation bump in produce sales that lost statistical significance by three months, and a household-purchasing signal that never landed. The authors&apos; immediate call for a national layout mandate is the louder finding.</description><pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>public-health</category><category>nutrition</category><category>uk</category><category>food-policy</category><category>regulation</category><category>choice-architecture</category><author>Marcus Chen</author></item><item><title>A 16-Foot Fire Tornado Burned an Oil Slick With 40% Less Soot. Cleanup Crews Have Been Breathing the Same Old Smoke Since the Exxon Valdez.</title><link>https://thefirstcohort.com/articles/2026-06-07-a-16-foot-fire-tornado-burned-an-oil-slick-with-40-less-soot-cleanup-crews-have</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-a-16-foot-fire-tornado-burned-an-oil-slick-with-40-less-soot-cleanup-crews-have</guid><description>A federally funded field trial used a controlled fire whirl to burn up to 95% of a crude oil pool while cutting soot by 40%, raising the question of why the standard in-situ burn, with its measured worker-lung cost, has gone unchallenged for thirty-five years.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>oil-spill</category><category>fire-whirl</category><category>environmental-health</category><category>particulate-matter</category><category>deepwater-horizon</category><author>Sarah Okonkwo</author></item><item><title>A 16-month-old died at an Arkansas splash pad. Its chlorinator had been broken for a month.</title><link>https://thefirstcohort.com/articles/2026-06-07-a-16-month-old-died-at-an-arkansas-splash-pad-its-chlorinator-had-been-broken-fo</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-a-16-month-old-died-at-an-arkansas-splash-pad-its-chlorinator-had-been-broken-fo</guid><description>A new global synthesis on free-living amoebae explains why a single bad month at a public splash pad is enough to kill a child, and why the CDC&apos;s existing protocol would have caught it.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>amoebae</category><category>naegleria-fowleri</category><category>water-safety</category><category>public-health</category><category>infrastructure</category><author>Marcus Chen</author></item><item><title>A Senate Subcommittee Just Put the COVID Shot Cancer Question on the Record</title><link>https://thefirstcohort.com/articles/2026-06-07-a-senate-subcommittee-just-put-the-covid-shot-cancer-question-on-the-record</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-a-senate-subcommittee-just-put-the-covid-shot-cancer-question-on-the-record</guid><description>A Senate Homeland Security subcommittee took testimony on whether mRNA COVID shots can plausibly cause cancer, and on the parallel campaign to keep that question out of the journals. Dr. John Campbell walked his audience through it.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>covid-vaccines</category><category>mrna</category><category>senate-hearing</category><category>regulatory-capture</category><category>cancer</category><category>rfk-jr</category><author>Marcus Chen</author></item><item><title>He Shou Wu&apos;s Hair-Loss Pitch Is Better Than I Expected. Its Liver Record Is Worse.</title><link>https://thefirstcohort.com/articles/2026-06-07-he-shou-wu-s-hair-loss-pitch-is-better-than-i-expected-its-liver-record-is-worse</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-he-shou-wu-s-hair-loss-pitch-is-better-than-i-expected-its-liver-record-is-worse</guid><description>Researchers at Guangdong Pharmaceutical University argue Polygonum multiflorum could become the next pattern-baldness lead. The follicle biology is interesting. The case series of acute liver failure on four continents are not.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>hair-loss</category><category>traditional-chinese-medicine</category><category>hepatotoxicity</category><category>supplement-safety</category><category>dermatology</category><category>polygonum-multiflorum</category><author>Sarah Okonkwo</author></item><item><title>Lilly&apos;s triple agonist hit 30% weight loss. The glucagon bet is why.</title><link>https://thefirstcohort.com/articles/2026-06-07-lilly-s-triple-agonist-hit-30-weight-loss-the-glucagon-bet-is-why</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-lilly-s-triple-agonist-hit-30-weight-loss-the-glucagon-bet-is-why</guid><description>Lilly&apos;s triple agonist hit nearly 30% weight loss at 104 weeks at ADA 2026. The glucagon bet is what makes retatrutide different from semaglutide and Mounjaro, and it&apos;s what makes the open safety signals different too.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>retatrutide</category><category>obesity</category><category>type-2-diabetes</category><category>glp-1</category><category>eli-lilly</category><category>ada-2026</category><author>Sarah Okonkwo</author></item><item><title>Ozempic&apos;s 30 Percent Breast-Cancer Headline, and the Trial Evidence It Walked Past</title><link>https://thefirstcohort.com/articles/2026-06-07-ozempic-s-30-percent-breast-cancer-headline-and-the-trial-evidence-it-walked-pas</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-ozempic-s-30-percent-breast-cancer-headline-and-the-trial-evidence-it-walked-pas</guid><description>A single-system observational study at ASCO 2026 attached a roughly 30% lower breast-cancer rate to GLP-1 use. The randomized record already on the table is quieter.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>ozempic</category><category>glp-1</category><category>breast-cancer</category><category>asco-2026</category><category>pharma</category><author>Lena Marshall</author></item><item><title>Retatrutide&apos;s Triple-Receptor Triumph Came With a One-in-Five Skin-Sensation Signal Nobody Wanted to Linger On</title><link>https://thefirstcohort.com/articles/2026-06-07-retatrutide-s-triple-receptor-triumph-came-with-a-one-in-five-skin-sensation-sig</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-retatrutide-s-triple-receptor-triumph-came-with-a-one-in-five-skin-sensation-sig</guid><description>Eli Lilly&apos;s investigational retatrutide hit bariatric-surgery-level weight loss at ADA 2026. The highest-dose arm of TRIUMPH-4 also saw 20.9% of patients report abnormal skin sensations, and a small cardiac imbalance turned up in the type-2 trial. Both got far less stage time than the headline numbe</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>obesity</category><category>retatrutide</category><category>eli-lilly</category><category>ada-2026</category><category>drug-safety</category><author>Sarah Okonkwo</author></item><item><title>The $401 CBC and the $32 CBC Are the Same Test</title><link>https://thefirstcohort.com/articles/2026-06-07-the-401-cbc-and-the-32-cbc-are-the-same-test</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-the-401-cbc-and-the-32-cbc-are-the-same-test</guid><description>A Reddit pitch for a Quest reseller put receipts on a markup the insurance-billed lab market has spent years obscuring. A Florida cost study confirms what the consumer market already figured out.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>lab-testing</category><category>healthcare-pricing</category><category>direct-to-consumer</category><category>quest-diagnostics</category><category>price-transparency</category><author>Lena Marshall</author></item><item><title>The Herbal Steroid That Hits Pharma&apos;s Holy-Grail Kidney Target</title><link>https://thefirstcohort.com/articles/2026-06-07-the-herbal-steroid-that-hits-pharma-s-holy-grail-kidney-target</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-the-herbal-steroid-that-hits-pharma-s-holy-grail-kidney-target</guid><description>A Shanghai lab reports a steroid from a Yunnan mountain plant, already sold over the counter to bodybuilders, suppresses the same kidney-fibrosis pathway Big Pharma keeps circling and never quite closes on.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>autoimmune-inflammation</category><category>kidney</category><category>fibrosis</category><category>longevity</category><category>herbal</category><category>tgf-beta</category><author>Sarah Okonkwo</author></item><item><title>The Hernia FAQ That Forgets to Mention the Implant</title><link>https://thefirstcohort.com/articles/2026-06-07-the-hernia-faq-that-forgets-to-mention-the-implant</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-the-hernia-faq-that-forgets-to-mention-the-implant</guid><description>A polished hernia FAQ walks patients through recovery time, return-to-work, and lifestyle. It skips the question with 26,153 pending lawsuits behind it, and the no-mesh option the international guideline still keeps on the table.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>hernia</category><category>surgery</category><category>medical-devices</category><category>mesh</category><category>chronic-pain</category><category>litigation</category><author>Sarah Okonkwo</author></item><item><title>The Oral GLP-1 Race Just Got a Third Serious Contender, and Its Curve Was Still Climbing</title><link>https://thefirstcohort.com/articles/2026-06-07-the-oral-glp-1-race-just-got-a-third-serious-contender-and-its-curve-was-still-c</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-the-oral-glp-1-race-just-got-a-third-serious-contender-and-its-curve-was-still-c</guid><description>Structure Therapeutics&apos; once-daily oral GLP-1 aleniglipron hit 11.3 percent placebo-adjusted weight loss at 36 weeks and kept climbing in the open label. The catch: oral semaglutide and orforglipron already cleared the FDA.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>obesity</category><category>metabolic</category><category>oral-medications</category><category>structure-therapeutics</category><category>phase-2b</category><author>Sarah Okonkwo</author></item><item><title>The Ozempic &apos;Resistance&apos; Headline the Data Didn&apos;t Quite Earn</title><link>https://thefirstcohort.com/articles/2026-06-07-the-ozempic-resistance-headline-the-data-didn-t-quite-earn</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-the-ozempic-resistance-headline-the-data-didn-t-quite-earn</guid><description>A new study identifies PAM-gene variants tied to weaker six-month HbA1c response to GLP-1 diabetes drugs, but the &apos;why Ozempic may not work&apos; framing imports a weight-loss conclusion the paper doesn&apos;t reach, and the buried trials that used longer-acting GLP-1 drugs showed no carrier effect at all.</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>ozempic</category><category>pharmacogenomics</category><category>novo-nordisk</category><category>diabetes</category><category>research-spin</category><author>Lena Marshall</author></item><item><title>The supplement aisle has spent twenty years getting older Americans wrong</title><link>https://thefirstcohort.com/articles/2026-06-07-the-supplement-aisle-has-spent-twenty-years-getting-older-americans-wrong</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-07-the-supplement-aisle-has-spent-twenty-years-getting-older-americans-wrong</guid><description>A May 2026 review by two geriatric researchers, syndicated this week by ScienceDaily, restates what twenty years of trial data have already shown: the supplement aisle is built around vague promises older Americans do not need, while protein, the gap that actually moves aging outcomes, sits in the m</description><pubDate>Sun, 07 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>supplements</category><category>aging</category><category>vitamin-d</category><category>nutrition</category><category>public-health</category><category>sarcopenia</category><author>Marcus Chen</author></item><item><title>A Senate hearing finally put the cancer question on the record. The journal notice had been up for months.</title><link>https://thefirstcohort.com/articles/2026-06-06-a-senate-hearing-finally-put-the-cancer-question-on-the-record-the-journal-notic</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-06-a-senate-hearing-finally-put-the-cancer-question-on-the-record-the-journal-notic</guid><description>Sen. Ron Johnson&apos;s June 3 subcommittee hearing on plausible mechanisms linking mRNA injections to cancer, the South Korean cohort behind it, and the editorial notice Springer had posted on the paper months earlier.</description><pubDate>Sat, 06 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>covid-vaccines</category><category>mrna</category><category>cancer</category><category>senate-hearing</category><category>retractions</category><category>ron-johnson</category><author>Lena Marshall</author></item><item><title>Cops shoved a doctor at the ADA meeting. The editorial they tore up has its own credibility problem.</title><link>https://thefirstcohort.com/articles/2026-06-06-cops-shoved-a-doctor-at-the-ada-meeting-the-editorial-they-tore-up-has-its-own-c</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-06-cops-shoved-a-doctor-at-the-ada-meeting-the-editorial-they-tore-up-has-its-own-c</guid><description>Police escorted ADA members out of New Orleans on Friday for passing out an editorial against Trump&apos;s NIH overhaul. The shove was bad. The editorial defending the status quo has a credibility problem the press is mostly missing.</description><pubDate>Sat, 06 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>diabetes</category><category>nih</category><category>maha</category><category>pediatric-obesity</category><category>research-funding</category><category>free-speech</category><author>Sarah Okonkwo</author></item><item><title>Pancreatic cancer&apos;s undruggable wall just cracked. The follow-up is 8.5 months and the money was already placed.</title><link>https://thefirstcohort.com/articles/2026-06-06-pancreatic-cancer-s-undruggable-wall-just-cracked-the-follow-up-is-8-5-months-an</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-06-pancreatic-cancer-s-undruggable-wall-just-cracked-the-follow-up-is-8-5-months-an</guid><description>Revolution Medicines&apos; daraxonrasib nearly doubled median overall survival versus chemotherapy in previously treated metastatic pancreatic cancer at ASCO 2026, with 8.5 months of follow-up and a two-billion-dollar Royalty Pharma deal already riding on what comes next.</description><pubDate>Sat, 06 Jun 2026 00:00:00 GMT</pubDate><category>cancer</category><category>pancreatic-cancer</category><category>kras</category><category>fda</category><category>oncology</category><category>drug-pricing</category><category>clinical-trials</category><author>Lena Marshall</author></item><item><title>The founder of Kentucky&apos;s biggest rehab chain was indicted this week. The wire fraud charge is the smaller of his problems.</title><link>https://thefirstcohort.com/articles/2026-06-06-the-founder-of-kentucky-s-biggest-rehab-chain-was-indicted-this-week-the-wire-fr</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-06-the-founder-of-kentucky-s-biggest-rehab-chain-was-indicted-this-week-the-wire-fr</guid><description>A federal grand jury in the Eastern District of Kentucky indicted the founder of Addiction Recovery Care on June 4 for selling the same COVID-era tax credit twice. The bigger case, the FBI Medicaid investigation into the company he built, is still open.</description><pubDate>Sat, 06 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>medicaid-fraud</category><category>opioid-crisis</category><category>regulatory-capture</category><category>kentucky</category><category>federal-indictment</category><category>political-donations</category><author>Mira Petrov</author></item><item><title>A gut hormone keeps showing up in the brain&apos;s reward circuit, and 600,000 veterans just gave us the biggest hint yet that it matters</title><link>https://thefirstcohort.com/articles/2026-06-04-a-gut-hormone-keeps-showing-up-in-the-brain-s-reward-circuit-and-600-000-veteran</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-04-a-gut-hormone-keeps-showing-up-in-the-brain-s-reward-circuit-and-600-000-veteran</guid><description>A VA cohort of 606,000 diabetic veterans on GLP-1 drugs showed lower risks of new substance use disorders and large drops in overdose and drug-related death versus a peer diabetes drug. The mechanism story is where it gets interesting.</description><pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate><category>metabolic-weight</category><category>glp-1</category><category>addiction</category><category>neuroscience</category><category>veterans-health</category><category>pharma</category><category>reward-circuit</category><author>Sarah Okonkwo</author></item><item><title>Alnylam Bet $2 Billion on AI-Designed RNAi. The Check It Actually Wrote Was $30 Million.</title><link>https://thefirstcohort.com/articles/2026-06-04-alnylam-bet-2-billion-on-ai-designed-rnai-the-check-it-actually-wrote-was-30-mil</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-04-alnylam-bet-2-billion-on-ai-designed-rnai-the-check-it-actually-wrote-was-30-mil</guid><description>Alnylam paid Inceptive Nucleics $30 million up front, with up to $2 billion in milestones tied to outcomes the rest of AI drug discovery has spent a decade failing to deliver.</description><pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>rnai</category><category>ai-drug-discovery</category><category>alnylam</category><category>biotech-deals</category><category>sirna</category><category>pharma</category><author>Marcus Chen</author></item><item><title>Harvard Just Mapped How a Mouse Smells, and It Quietly Rewrites What Smell Loss Means</title><link>https://thefirstcohort.com/articles/2026-06-04-harvard-just-mapped-how-a-mouse-smells-and-it-quietly-rewrites-what-smell-loss-m</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-04-harvard-just-mapped-how-a-mouse-smells-and-it-quietly-rewrites-what-smell-loss-m</guid><description>Harvard used MERFISH to image roughly 1,100 odorant receptors across the mouse nose at once and found tidy stripes, not chaos. The clinical stakes for smell loss just got harder to wave off.</description><pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate><category>brain-aging</category><category>olfaction</category><category>neuroscience</category><category>anosmia</category><category>smell-loss</category><category>parkinsons</category><category>harvard</category><author>Sarah Okonkwo</author></item><item><title>A Senior NIAID Scientist Got Caught Smuggling 113 Vials Through Detroit. He Says He Does It All the Time.</title><link>https://thefirstcohort.com/articles/2026-06-03-a-senior-niaid-scientist-got-caught-smuggling-113-vials-through-detroit-he-says</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-03-a-senior-niaid-scientist-got-caught-smuggling-113-vials-through-detroit-he-says</guid><description>Two NIAID scientists are charged with bringing 113 undeclared vials into Detroit during an active Congo mpox outbreak. One allegedly told a federal officer he does it all the time.</description><pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>nih</category><category>niaid</category><category>biosafety</category><category>mpox</category><category>rocky-mountain-labs</category><category>public-trust</category><author>Marcus Chen</author></item><item><title>Another Clot Problem at Abiomed: The FDA Flags an Impella Introducer, and the Pattern Keeps Growing</title><link>https://thefirstcohort.com/articles/2026-06-03-another-clot-problem-at-abiomed-the-fda-flags-an-impella-introducer-and-the-patt</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-03-another-clot-problem-at-abiomed-the-fda-flags-an-impella-introducer-and-the-patt</guid><description>FDA flags Abiomed&apos;s 14Fr Low Profile Introducer Kit after a higher than expected complaint rate of clots forming on the device during prolonged Impella CP support. Three serious injuries reported, no deaths. The pattern keeps growing.</description><pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>abiomed</category><category>impella</category><category>medical-devices</category><category>recall</category><category>cardiac</category><author>Sarah Okonkwo</author></item><item><title>Half a Billion in Detainee Health Care, and the Federal Watchdog Quietly Closed</title><link>https://thefirstcohort.com/articles/2026-06-03-half-a-billion-in-detainee-health-care-and-the-federal-watchdog-quietly-closed</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-03-half-a-billion-in-detainee-health-care-and-the-federal-watchdog-quietly-closed</guid><description>A KFF and AP investigation pulled more than 300 sworn allegations of medical neglect from 33,000 ICE habeas petitions, even as the detention ombudsman office quietly closed and the federal detainee care bill passed half a billion dollars.</description><pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>ice-detention</category><category>private-contractors</category><category>medical-neglect</category><category>federal-oversight</category><category>healthcare-spending</category><author>Lena Marshall</author></item><item><title>The Crunchy Mom and the MAHA Mom Were Fighting the Same War. The Pesticide Lobby Won Anyway.</title><link>https://thefirstcohort.com/articles/2026-06-03-the-crunchy-mom-and-the-maha-mom-were-fighting-the-same-war-the-pesticide-lobby</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-03-the-crunchy-mom-and-the-maha-mom-were-fighting-the-same-war-the-pesticide-lobby</guid><description>For one strange year, the EWG hiking-boots crowd and the MAHA red-hat moms were fighting the same pesticide war. Then Trump invoked the Defense Production Act on behalf of Bayer, the final MAHA report quietly stopped mentioning glyphosate, and a coalition that was actually winning got stomped by a C</description><pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>glyphosate</category><category>pesticides</category><category>maha</category><category>environmental-health</category><category>rfk-jr</category><category>food-policy</category><author>Sarah Okonkwo</author></item><item><title>The FDA Approved a Better Penile Implant. For Most Men, ED Is the Heart Warning Them First.</title><link>https://thefirstcohort.com/articles/2026-06-03-the-fda-approved-a-better-penile-implant-for-most-men-ed-is-the-heart-warning-th</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-03-the-fda-approved-a-better-penile-implant-for-most-men-ed-is-the-heart-warning-th</guid><description>The FDA approved Coloplast&apos;s Titan Prime inflatable penile prosthesis on June 3, 2026. For the men whose vasculature is past saving, it is a meaningful device upgrade. For most men with new ED, the more useful conversation is what the small arteries are failing to do years before the coronaries noti</description><pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>erectile-dysfunction</category><category>mens-health</category><category>cardiovascular</category><category>metabolic</category><category>fda</category><category>devices</category><author>Sarah Okonkwo</author></item><item><title>Yale&apos;s Olive Oil Cancer Story Did Not Actually Test Olive Oil</title><link>https://thefirstcohort.com/articles/2026-06-03-yale-s-olive-oil-cancer-story-did-not-actually-test-olive-oil</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-03-yale-s-olive-oil-cancer-story-did-not-actually-test-olive-oil</guid><description>A Yale mouse study reported in Cancer Discovery is being sold as proof that olive oil fuels pancreatic cancer. The lab fed the mice purified oleic acid, the effect only showed up in males, and no one has tested it in a person.</description><pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate><category>nutrition-food</category><category>pancreatic-cancer</category><category>ferroptosis</category><category>omega-3</category><category>mediterranean-diet</category><category>preclinical</category><category>yale</category><author>Lena Marshall</author></item><item><title>Andrew Huberman&apos;s peptide masterclass and the published evidence</title><link>https://thefirstcohort.com/articles/2026-06-02-andrew-huberman-s-peptide-masterclass-and-the-published-evidence</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-02-andrew-huberman-s-peptide-masterclass-and-the-published-evidence</guid><description>Andrew Huberman&apos;s June 1 episode on peptides walks through BPC-157 and seven other compounds. The published human evidence for its lead substance runs to fewer than thirty people.</description><pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>peptides</category><category>bpc-157</category><category>huberman</category><category>fda</category><category>melanotan</category><category>regulation</category><author>Lena Marshall</author></item><item><title>FDA&apos;s New Gene Therapy Shortcut Leans on &apos;Platform Knowledge.&apos; Six Months Ago, They Revoked Sarepta&apos;s After Three Patient Deaths.</title><link>https://thefirstcohort.com/articles/2026-06-02-fda-s-new-gene-therapy-shortcut-leans-on-platform-knowledge-six-months-ago-they</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-02-fda-s-new-gene-therapy-shortcut-leans-on-platform-knowledge-six-months-ago-they</guid><description>FDA&apos;s new gene therapy draft guidance invites sponsors to lean on &quot;platform knowledge&quot; to streamline submissions, six months after the agency revoked Sarepta&apos;s AAVrh74 platform designation following three patient deaths.</description><pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>fda</category><category>gene-therapy</category><category>regulatory-capture</category><category>rare-disease</category><category>accelerated-approval</category><category>genome-editing</category><author>Sarah Okonkwo</author></item><item><title>Six Negative Tests, Forty-Two Days: What Australia&apos;s Biosecurity Order Won&apos;t Say Out Loud</title><link>https://thefirstcohort.com/articles/2026-06-02-six-negative-tests-forty-two-days-what-australia-s-biosecurity-order-won-t-say-o</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-02-six-negative-tests-forty-two-days-what-australia-s-biosecurity-order-won-t-say-o</guid><description>Australia extended facility detention of six hantavirus contacts to a full 42 days under the Biosecurity Act after they tested negative. WHO&apos;s own guidance reserves that option for the high-risk tier; most peer countries chose monitoring.</description><pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate><category>investigations</category><category>biosecurity-act</category><category>quarantine</category><category>hantavirus</category><category>australia</category><category>public-health</category><category>civil-liberties</category><author>Mira Petrov</author></item><item><title>Xocova clears the FDA. What it actually prevents is the smaller story.</title><link>https://thefirstcohort.com/articles/2026-06-02-xocova-clears-the-fda-what-it-actually-prevents-is-the-smaller-story</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-06-02-xocova-clears-the-fda-what-it-actually-prevents-is-the-smaller-story</guid><description>The FDA approved Shionogi&apos;s ensitrelvir for post-exposure COVID prevention, citing a 67% relative risk reduction. Look at what the trial actually measured and a different story comes into focus.</description><pubDate>Tue, 02 Jun 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>covid-19</category><category>antivirals</category><category>fda</category><category>post-exposure-prophylaxis</category><category>shionogi</category><author>Marcus Chen</author></item><item><title>Hepatitis Delta Has Waited Forty-Nine Years for a Drug. The FDA Made American Patients Wait Three Extra.</title><link>https://thefirstcohort.com/articles/2026-05-30-hepatitis-delta-has-waited-forty-nine-years-for-a-drug-the-fda-made-american-pat</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-05-30-hepatitis-delta-has-waited-forty-nine-years-for-a-drug-the-fda-made-american-pat</guid><description>The FDA cleared bulevirtide for chronic hepatitis delta this week, six years after Europe started using it and three years after a U.S. application was turned down on manufacturing grounds. The wait is its own story.</description><pubDate>Sat, 30 May 2026 00:00:00 GMT</pubDate><category>drugs-fda</category><category>hepatitis</category><category>fda</category><category>gilead</category><category>regulatory-delay</category><category>viral-hepatitis</category><category>accelerated-approval</category><author>Marcus Chen</author></item><item><title>America&apos;s Ebola Fortress: History Has Tested This Strategy, and It Failed</title><link>https://thefirstcohort.com/articles/2026-05-29-america-s-ebola-fortress-history-has-tested-this-strategy-and-it-failed</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-05-29-america-s-ebola-fortress-history-has-tested-this-strategy-and-it-failed</guid><description>Washington has built a wall around the Ebola outbreak in Central Africa. The last time America tried this, the evidence says the wall leaked, and so did the response.</description><pubDate>Fri, 29 May 2026 00:00:00 GMT</pubDate><category>infectious-disease</category><category>ebola</category><category>public-health</category><category>biosecurity</category><category>infectious-disease</category><category>regulatory-failure</category><author>Marcus Chen</author></item><item><title>Doctor Mike Plays &apos;Never Have I Ever&apos; With a Firefighter. Watch What&apos;s Around the Bit.</title><link>https://thefirstcohort.com/articles/2026-05-29-doctor-mike-plays-never-have-i-ever-with-a-firefighter-watch-what-s-around-the-b</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-05-29-doctor-mike-plays-never-have-i-ever-with-a-firefighter-watch-what-s-around-the-b</guid><description>Doctor Mike&apos;s lighthearted Never Have I Ever video sits at the top of a funnel that includes a $997 media academy, a UNICEF vaccine-ambassador title, and an ongoing pitch to pharmaceutical executives about social-media trust.</description><pubDate>Fri, 29 May 2026 00:00:00 GMT</pubDate><category>investigations</category><category>media</category><category>influencer-medicine</category><category>pharma-marketing</category><category>public-trust</category><category>vaccines</category><category>doctor-mike</category><author>Marcus Chen</author></item><item><title>Vietnam&apos;s New Integrity Rule Arrives 251 Retractions Late</title><link>https://thefirstcohort.com/articles/2026-05-29-vietnam-s-new-integrity-rule-arrives-251-retractions-late</link><guid isPermaLink="true">https://thefirstcohort.com/articles/2026-05-29-vietnam-s-new-integrity-rule-arrives-251-retractions-late</guid><description>Vietnam&apos;s Ministry of Science and Technology issued a research-integrity framework with permanent bans on May 25, 2026. The Retraction Watch database already lists 251 retractions carrying Vietnamese affiliations.</description><pubDate>Fri, 29 May 2026 00:00:00 GMT</pubDate><category>investigations</category><category>research-integrity</category><category>vietnam</category><category>paper-mills</category><category>retractions</category><category>accountability</category><category>regulation</category><author>Mira Petrov</author></item></channel></rss>